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SUMMARY 
Reactions catalysed by oxidoreductases are indispensable for chemical synthesis. However, 
despite obvious advantages like mild reaction conditions and regio-, chemo-, and 
stereoselectivity, which simplifies product work-up, their implementation in the chemical 
industry is lacking. Therefore, an integrated approach involving catalyst and reaction 
engineering and proper reactor design is necessary for commercialising oxidoreductases for 
organic synthesis. Rational reaction design linking kinetic characterisation of the 
oxidoreductase and reaction optimisation formed the basis for this thesis. The overall aim of 
this PhD project was the application of 2-hydroxybiphenyl 3-monooxygenase (HbpA), for 
preparative scale synthesis of 3-phenylcatechol with an acceptable space time yield (STY). 
The key challenges limiting the biocatalytic process, namely biocatalyst operational stability, 
supply of the hydrophobic substrate, oxygen delivery, cofactor regeneration and mass transfer 
were identified and addressed. Formate dehydrogenase, FDH, was used for continuous 
NADH regeneration. Addition of the surfactant Tween 20 stabilised the enzymes in the 
presence of the organic solvent and allowed to recover 100% of the respective enzymatic 
activity opening the door for application of the biocatalysts in an aqueous/organic two-liquid 
phase segmented flow microreactor. A biphasic reaction system allowed high substrate 
loadings whereas the microreactor ensured excellent mass transfer rates between organic and 
aqueous phases. Finally, using a Teflon AF-2400 membrane in a tube-in-tube fashion allowed 
for radial delivery of oxygen and improved oxygen availability with respect to one point 
oxygen delivery in an aqueous/organic/air three phase segmented flow microreactor. Thereby 
a successful preparative scale biotransformation reaction in a segmented flow tube-in-tube 
reactor was possible yielding 740 mg of product purified by chromatography and subsequent 
sublimation. The STY of 14.5 g Ltotal-1 h-1 reached is the highest reported for this enzyme. It is 
38 times higher as compared to the batch reactions described earlier (Lutz et al. 2002). 
Oxygen transfer rates through Teflon AF-2400 membrane were as high as 24 mM min-1 i.e. 16 
times higher than in traditional biotechnological processes in stirred-tank reactors. The 
presented reactor is a promising tool for oxygen dependent biocatalytic reactions in 
microreactors, and may be regarded as a basis for applications in gram scale organic 
biosyntheses. Furthermore, it may become a platform for other gas dependent reactions since 
it extends the operational boundaries beyond the scope of available reactors with respect to 
aqueous/organic mass transfer and gas transfer rates. 
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ZUSAMMENFASSUNG 
Oxidoreduktasen katalysieren eine Vielzahl an interessanten Reaktionen und können bei 
chemischen Synthesen überaus hilfreich sein. Trotz der offensichtlichen Vorteile wie milde 
Reaktionsbedingungen und der sich durch die ausgezeichnete Regio-, Chemo- und 
Stereoselektivität ergebenden vereinfachten Produktaufreinigung, ist ihre Bedeutung für die 
produktive Katalyse lediglich sekundär. Für eine großflächige Verbreitung von 
Oxidoreduktasen in der organischen Synthese ist daher ein integrierter Ansatz notwendig, der 
sowohl die Entwicklung der Reaktionstechnik und des Katalysators aber auch des geeigneten 
Reaktorkonzeptes beinhaltet. Die Verknüpfung von kinetischer Charakterisierung eines 
Biokatalysators und der Optimierung der Reaktionsparameter bildete die Grundlage der 
vorliegenden Arbeit. Das Ziel dieser Arbeit war die Anwendung der 2-Hydroxybiphenyl 3-
Monooxygenase (HbpA) zur Synthese von 3-Phenyl-Catechol in präparativem Maßstab. Von 
zentraler Bedeutung war hierbei die Identifizierung der Hauptlimitationen des 
biokatalytischen Prozesses: die Stabilität des Katalysators, die Bereitstellung des 
hydrophoben Substrates, die Gewährleistung der Sauerstoffzufuhr, die Kofaktorregenerierung 
und der Massentransfer. Der Einsatz der Formiat-Dehydrogenase (FDH) erlaubte eine 
kontinuierliche NADH-Regeneration. Durch die Zugabe des Tensids Tween 20 konnten 
HbpA und FDH in Anwesenheit organischer Lösemittel stabilisiert werden, was eine 
Anwendung der Biokatalysatoren in organisch-wässrigen Zweiphasen-Systemen in 
‘segmented-flow‘ Mikroreaktoren erlaubte. Durch die zweiphasige Reaktionsführung wurden 
hohe Beladungen mit Substrat erzielt und durch die Anwendung des Mikroreaktors konnte der 
Massentransfer zwischen organischer und wässriger Phase maximiert werden. Die Sauerstoff-
Verfügbarkeit wurde durch den Einsatz einer Teflon AF-2400 Membran in einem Tube-in-
Tube Reaktor durch radiale Begasung gegenüber der traditionellen Ein-Punkt Begasung 
signifikant verbessert. Der Einsatz des Tube-in-Tube Mikroreaktors führte im präparativen 
Maßstab zu 740 mg 3-Phenyl-Catechol, isoliert mittels Chromatographie und anschließender 
Sublimation. Die zugrundeliegende Raum-Zeit-Ausbeute (STY) von 14,5 g Ltotal-1 h-1 ist im 
Vergleich zu Batch-Reaktionen (Lutz et al. 2002), 38-fach erhöht und weist somit die höchste 
jemals berichtete STY für diese Reaktion auf. Mit 24 mM min-1 ist die Sauerstoff Transferrate 
durch die Teflon AF-2400 Membran etwa 16-fach höher als in traditionell für 
biotechnologische Prozesse eingesetzte Rührkessel-Reaktoren. Das in dieser Studie 
untersuchte Reaktorkonzept stellt für sauerstoffabhängige, biokatalytische Reaktionen einen 
vielversprechenden Ansatz dar, welches als Grundlage für die Synthese organischer 
Komponenten im Gramm-Maßstab angesehen werden kann. Darüber hinaus kann der Tube-
in-Tube Reaktor zu einer generell anwendbaren Plattform für Gas-abhängige Reaktionen 
entwickelt werden, da er die systembedingten Limitierungen vorhandener Reaktorkonzepte in 
Bezug auf organisch-wässrigen Massentransfer und Gas-Transferrate überwindet.
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REDOX REACTIONS 
Functionalisation of non-activated carbons within the paradigm of Green Chemistry 
Early industrial syntheses and later development of the pharmaceutical industry was based on 
processes that ignored the toxic nature of their reagents, waste to product ratios, and non-
renewable origins of the catalysts.1 For changing the paradigm and making new processes 
environmentally friendly a set of 12 Principles of Green Chemistry was published in 1998 by 
Anastas and Warner.2 Those read as follows: 
1. Prevention - It is better to prevent waste than to treat or clean up waste afterwards. 
2. Atom Economy - Design synthetic methods to maximise the incorporation of all 
materials used in the process into the final product. 
3. Less Hazardous Chemical Syntheses - Design synthetic methods to use and generate 
substances that minimise toxicity to human health and the environment. 
4. Designing Safer Chemicals - Design chemical products to affect their desired 
function while minimising their toxicity. 
5. Safer Solvents and Auxiliaries - Minimise the use of auxiliary substances wherever 
possible; make them harmless when used. 
6. Design for Energy Efficiency - Minimise the energy requirements of chemical 
processes and conduct synthetic methods at ambient temperature and pressure if 
possible. 
7. Use of Renewable Feedstocks - Use renewable raw material or feedstock whenever 
possible. 
8. Reduce Derivatives - Minimise or avoid unnecessary derivatisation if possible, which 
requires additional reagents and generates waste. 
9. Catalysis - Catalytic reagents are superior to stoichiometric reagents. 
10. Design for Degradation - Design chemical products so they break down into 
harmless products that do not persist in the environment. 
11. Real-time Analysis for Pollution Prevention - Develop analytical methodologies 
needed to allow for real-time, in-process monitoring and control prior to the formation 
of hazardous substances. 
12. Inherently Safer Chemistry for Accident Prevention - Choose substances and the 
form of a substance used in a chemical process to minimise the potential for chemical 
accidents, including releases, explosions, and fires. 
Those principles became the basis for developing environment-friendly processes in organic 
chemistry as well as in biotechnology. 
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In the context of those principles the chemical oxidation of hydrocarbons is not a ‘green 
process’. In organic chemistry oxidation may be defined as elimination of hydrogen as in the 
dehydrogenation of ethane leading to acetylene, or as a replacement of a hydrogen atom 
bonded to a carbon by a more electronegative atom e.g. oxygen.3 Harsh reaction conditions 
are often needed in order to activate C-C or C-H bonds, which in the course of the reaction are 
oxidised to C-O, C=C or C-N. The selectivity of those reactions is compromised when strong 
acids and bases are used and in earlier times quantitative amounts of metal salts were required 
for an oxidative addition reaction.4 For example the oxidation of toluene by trifluoroperacetic 
acid and hydrogen peroxide does not stop at 2-hydroxytoluene but continues and yields a 
mixture of the former as well as 2,3-dihydroxytoluene and 2,5-dihydroxytoluene5 requiring 
complex product work-up. Also the very successful Suzuki-coupling reaction6 is rather 
difficult in terms of the Green Chemistry principles. Heavy metal catalysts, organic solvents, 
and an acidic environment are necessary to couple halides and organoborane species for the 
synthesis of e.g. substituted biphenyls.7 In contrast to chemical oxidation reactions, enzyme 
catalysed reactions run at ambient temperature and pressures, and under neutral pH. 
Biodegradable catalysts (enzymes or cells) are used, which are derived from renewable 
resources. Reactions are regio-, chemo-, and stereoselective (Figure 1-1), and no group 
activation, protection or deprotection is required. Biocatalytic processes involve less steps 
than competitive organic syntheses, hence less waste is generated and the quality of product is 
often superior with respect to classical processes.1 The use of oxidoreductases (either soluble 
or as a whole cell biocatalyst, see later) is therefore advantageous compared to the traditional 
chemical approaches. Additionally, oxygenases often directly give the required regio- and 
chemoselectivity,8 making them very important catalysts in chemistry. Over past decades 
biocatalysis has emerged as an important tool for organic chemistry.9 The discovery of the 
structure of nucleic acids by Watson, Crick and Franklin in 1953, and establishment of 
recombinant DNA technology was a milestone for first recombinant E. coli producing indigo 
dye.10 Chemical producers like Hoffmann – La Roche recognised the potential of the 
biocatalytic paths for the production of vitamins by fermentation in 1998 and turned to 
biocatalysis replacing their existing chemical process for vitamin B-2 (riboflavin).11 The 
diversity of biocatalysts should be regarded as an aid for complicated organic synthases, and 
where possible should replace chemical steps, if this makes sense regarding ecological and 
economical aspects.12 
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Figure 1-1: Enzyme selectivity on the base of styrene monooxygenase StyAB. Chemo-selectivity refers to the 
preference of an enzyme to react with one chemical compound over another. Regio-selectivity refers to the 
preference of the direction of the new bond formation where one bond direction is preferred over another. 
Stereo-selectivity refers to the preference of one enantiomer over another.13 
 
ISOLATED ENZYMES VS WHOLE CELL BIOCATALYSTS 
Whether a biocatalyst is applied as a whole-cell or an isolated enzyme should be based on the 
requirement of the process e.g. duration, available reactors, skills of the technical personnel, 
and in the very end on the economic feasibility (Figure 1-2). 
 
Figure 1-2: Industrial processes with oxidoreductases. A – Oxidation of 2,5-methylprrazine with whole cell 
catalyst P. putida ATCC 33015 producing xylene monooxygenase at Lonza.14 B – Dehydrogenation of 2-oxo-4-
phenyl-butyric acid with solubilised (R)-lactate-NAD oxidoreductase at Ciba-Geigy.14 C – Synthesis of the 
atorvastatin intermediate by an isolated ketoreductase (KRED) and halohydrin dehalogenase (HHDH) developed 
by Codexis.15 
 
(S)-Styrene oxide
(R)-Styrene oxide
chemo-selectivity regio-selectivity stereo-selectivity
O
O
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Although examples for the industrial application of soluble oxidoreductases exist, those are 
scarce,14 despite having industrial relevance.16 Table 1-1 summarises advantages and 
disadvantages of applying either whole cells or isolated enzymes. 
Table 1-1: Application of a whole-cell catalyst vs. soluble enzyme for biocatalytic redox reaction – advantages 
and disadvantages. 
Whole cells Isolated enzymes 
In-vivo cofactor regeneration Cofactor regeneration required  
Renewable biocatalyst No skills in fermentation required 
Volumetric activities limited by enzyme levels in 
cell and by endogenous respiration17 
High catalyst loadings possible 
Limited oxygen transfer rates17 Oxygen used only for reaction, not for endogenous 
respiration 
Separation and purification of the enzymes 
avoided1 
Prior enzyme purification required, additional stabilisation 
necessary, high production cost,18 limited enzyme 
availability19 
Product/substrate toxicity of the host,20 different 
growth and reaction conditions21 
No growth inhibition or substrate/product toxification of 
the host, reaction conditions uncoupled from the growth 
Limited substrate uptake22 
 
Substrate/product transport not limited by the cell 
membrane 
Tedious downstream processing Separation of the product by ultrafiltration/membranes23 
 
Two major issues are to be considered when working with isolated enzymes, cofactor 
regeneration and enzyme stabilisation. While in a whole cell enzymes are usually in a 
protected environment and undergo the overall protein turn-over of their host cell, they are 
prone to deactivation due to oxidation, and susceptible to changing pH outside the cell 
environment. Especially challenging is the stability issue when non-aqueous solvents are 
used. In this context enzyme inactivation and strategies for stabilisation will be introduced 
below in detail. 
Cofactor Regeneration 
A crucial limitation when working with isolated enzymes is the necessity of cofactor 
regeneration. Different strategies for regeneration of cofactors exist. The simplest method is 
the application of the whole cell biocatalyst, which takes advantage of the natural cellular 
cofactor regeneration capacity.24 In such an approach the biotransformation reaction requiring 
the cofactors is coupled to the metabolism of the host delivering reducing equivalents (e.g. 
NADH). However, the reaction has to compete with host’s metabolism and various 
background activities, which consume the respective cofactors. A possible solution is the 
application of resting, so non-growing, but metabolically active cells as an alternative to 
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growing cells. Often these show higher specific activities for the biotransformation because 
cell metabolism can be exploited more effectively for the reaction of interest.25 
If working with isolated enzymes an additional system for cofactor regeneration needs to be 
introduced into the overall reaction scheme. Due to cofactors high price, it is economically 
not feasible to add these in stoichiometric amounts. Thus, they need to be generated in-situ 
and used in catalytic amounts.26 Different enzymatic cofactor regeneration methods exist. 
Most popular enzyme coupled regeneration systems are formate dehydrogenase (FDH),27 
alcohol dehydrogenase (ADH),28 glucose dehydrogenase (GDH),29 and phosphite 
dehydrogenase.30 The respective biotransformation reaction is coupled to a second reaction, 
which uses the same cofactor in its different oxidation state. These methods require 
stoichiometric addition of a second sacrificial substrate e.g. ammonium formate or 2-propanol 
for FDH and ADH respectively, which is consumed in the course of the regeneration. 
Advantage of those two enzymatic systems is their irreversible character when their products 
(carbon dioxide or acetone) are continuously removed. Using FDH in a low water system is 
also possible, expanding its application range.31 
Out of the non-enzymatic regeneration methods of reduced nicotinamide cofactors it is worth 
mentioning the organometallic pentamethylcyclopentadienyl rhodium bipyridine complex 
[Cp*Rh*(bpy)(H2O]2+, which is a versatile catalyst used in electrochemical regeneration of 
NADH,32 as well as in formate coupled direct regeneration of flavins (FADH2),33 The 
reduction of NAD(P)+ to NAD(P)H is highly selective yielding only the 1,4–NAD(P)H 
enzymatically active form,26 therefore, no cofactor loss occurs during the reaction. The 
disadvantage of that system is however its low turnover frequency (kcat, s-1) of 36 h-1 with 
respect to 2.4 s-1 for formate-driven NADH regeneration.26 
One more interesting method that solves the cofactor requirement for oxidoreductases but 
does not regenerate the cofactor in-situ is the application of a cofactor mimics i.e. a synthetic 
form of a nicotinamide analogue that replaces natural cofactor. Recent advances allowed for 
efficient application of the mimic for the enoate reductase catalysed C=C reduction 
reactions.34 Cheap analogues of NADH like 1-butyl-1,4-dihydropyridine-3-carboxamide 
showed excellent performance exceeding that of the natural cofactor, maintaining the same 
enantioselectivity as with their natural counterparts. 
Further methods for solving the cofactor dependency of oxidoreductases go beyond the scope 
of this introduction and are covered in available reviews.26, 35 
Among the mentioned cofactor regeneration methods the one that received most attention for 
the industrial application is the formate dehydrogenase coupled NADH regeneration (Figure 
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1-3). Examples of processes applying this cofactor regeneration method are listed in the Table 
1-2. 
 
Figure 1-3: Reaction scheme of FDH catalysed cofactor regeneration. Regeneration half-reaction and 
biotransformation half-reaction are shown. 
 
Table 1-2: Selection of the biotransformations utilising formate dehydrogenase for NADH regeneration.14 
Substrate Product Enzyme Conversion Time (h) Volume (L) 
Productivity 
(g L-1 h-1) 
1-phenyl-2-
propanone  
(15 mM) 
1-phenyl-
propanol 
Alcohol 
dehydrogenase 
R. erythropolis 
72% 0.33 h 0.05 2.6 
2-oxo-4-phenyl-
butyric acid 
(200 mM) 
2-hydroxy-
4-phenyl-
butyric acid 
R-lactate-NAD 
oxidoreductase 
S. epidermidis 
91% 4.6 0.2 6.9 
trimethylpyruvic 
acid (500 mM) 
tert-leucine 
L-leucine-NAD 
oxidoreductase 
B. sphaericus 
74% 2 
Not 
specified 
26.6 
 
Application of formate dehydrogenase catalysed NADH regeneration has multiple 
advantages: its cheap substrate sodium formate (80.5 €/kg (>99% BioUltra)36) is a non-toxic 
salt that is widely tolerated by enzymes.35c There are examples however, when formate, as a 
monovalent salt inhibits the biotransformation enzyme. CO2 evolves as only side product of 
the regeneration reaction. It is a non-toxic gas constantly leaving the reaction mixture, and 
thus driving the reaction to completion.35c 
If an efficient way to produce and purify heterologous proteins in sufficient amounts exists 
and the cofactor problem can be solved by applying a second catalyst e.g. formate 
dehydrogenase or alcohol dehydrogenase, then application of isolated enzyme is an attractive 
alternative to a whole cell process. The section below introduces some interesting redox 
enzymes and lists accessible biotransformations. 
NADH+ H+NAD+
CO2HCOO- Na+
enzyme
FDH
substrateproduct
regeneration reaction
biotransformation reaction
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INTERESTING ENZYMES FOR CELL FREE APPLICATIONS 
Redox enzymes 
The class of enzymes referred to as oxidoreductases (EC 1) catalyse the transfer of electrons 
between redox partners. Oxidoreductases may be sub-divided into four groups as proposed 
earlier,37 namely oxidases, peroxidases, oxygenases/hydroxylases, and dehydrogenases/ 
reductases. Oxidases utilize oxygen as electron acceptor reducing it to water or hydrogen 
peroxide without incorporating it into the substrate (hydride transfer). They are cofactor 
independent and contain iron, copper or flavin in their active site.38 Glucose oxidase 
catalysing oxidation of β-D-glucose to gluconic acid is an example of a flavin containing 
oxidase.39 Peroxidases use hydrogen peroxide as an electron acceptor in order to regenerate its 
oxidised prosthetic group.12 The majority of peroxidases are heme-enzymes, some may 
contain manganese, vanadium or selenium. Catalase is an example of a peroxidase catalysing 
breakdown of hydrogen peroxide into water and oxygen. Oxygenases/hydroxylases catalyse 
NAD(P)H dependent incorporation of single oxygen (monooxygenases) or two oxygen atoms 
(dioxygenases) into their substrate using molecular oxygen as an oxidant. Examples are 
styrene monooxygenase, which catalyses oxidation of styrene to styrene oxide,24 and benzene 
dioxygenase catalysing dihydroxylation of benzene to cis-benzene glycol respectively.40 
Dehydrogenases (aka reductases) display a broad substrate spectrum and stereo-specificity 
towards NAD(P)+ dependent reversible oxidation of primary and secondary alcohols and 
amines.12 An example of an alcohol dehydrogenase catalysed reaction is oxidation of ethanol 
to acetaldehyde. A brief summary of different types of reactions catalysed by oxidoreductases 
is given in Figure 1-4. 
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Figure 1-4: Selection of reactions catalysed by oxidoreductases (adapted after Hollmann et al. (2011)12 ). A – 
selective oxidation to the aldehyde/acid. B- regioselective oxidation of polyol. C – kinetic resolution of alcohols. 
D – kinetic resolution of amines and amino acids. E – hydroxylation of phenols. F - halogenation and nitration of 
phenols. G – oxidation of p-alkylphenols. H – oxidation of catechols. I – oxidation of heteroatoms. J – 
hydroxylation of non-activated C-H bonds. K – aromatic cis-hydroxylation. L – ozonolysis reaction. M – double 
bond epoxidation. N – Baeyer-Villiger oxidation. Structure depicted inside is the tetrameric form of 2-
hydroxybiphenyl 3-monooxygenase. 
 
2-hydroxybiphenyl 3-monooxygenase 
2-hydroxybiphenyl 3-monooxygenase (HbpA) (EC 1.14.13.44) is a monooxygenase 
catalysing regioselective ortho-hydroxylation of 2-substituted phenols. It is a tetrameric 
enzyme with a mass of 256 kDa exhibiting broad substrate specificity,41 and thus is an 
interesting biocatalyst for the production of 3-substituted catechols. Among many substrates 
(Figure 1-5) 2-hydroxybiphenyl is the most preferred one (Vmax 3.5 U mgprot-1, kcat 3.7 s-1 and 
Km 2.8 µM).42 Its reaction scheme is presented in Figure 1-6. HbpA belongs to the group of 
FAD dependent flavin monooxygenases42-43 and requires NADH, molecular oxygen and the 
respective hydrophobic substrate for catalytic activity. The 3-substituted catechols, the 
reaction products, or their oxidised analogues (3-substituted quinones) are found in the 
structure of several naturally occurring compounds, namely miltirone, urushiol, barbatusol, 
and taxodione,41a and can serve as synthons in their synthesis.  
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Figure 1-5: Substrate spectrum of 2-hydroxybiphenyl 3-monooxygenase. Arrow indicates the ortho- position at 
which hydroxylation takes place.41 
 
To the best of our knowledge there is only one direct synthetic route that yields 2,3-
dihydroxybiphenyl form 2-hydroxybiphenyl involving protection of the hydroxyl group by 
methoxymethyl (MOM) with a subsequent metalation, boronation, and final oxidation.7a, 44 
An alternative synthetic route starts with a 1,2 dimethoxybenzene and proceeds through the 
Suzuki reaction.7b The reported overall yield is 58% and 53% respectively which is good 
value for a 3-4 steps synthesis. HbpA has broad substrate spectrum,20, 41b and is therefore an 
interesting biocatalytic alternative for this ortho-hydroxylation reaction. 
Application of isolated HbpA offers several advantages. The biocatalytic reaction may be 
uncoupled from the cell growth, and higher catalyst loadings are possible since the biocatalyst 
amount is not limited by gene expression and protein levels in the cell. All the oxygen 
available in the bioreactor can be used exclusively for the biotransformation and not the 
endogenous cell respiration. Additionally, there is no host toxification and growth inhibition 
by high substrate/product levels.20 However, when applied in the isolated form, a continuous 
cofactor regeneration strategy needs to be implemented into the overall reaction scheme (see 
above). 
 
 
Figure 1-6: Reaction scheme of NADH dependent 2-hydroxybiphenyl 3-monooxygenase catalysed 
hydroxylation of 2-hydroxybiphenyl to 2,3-dihydroxybiphenyl (3-phenylcatechol). 
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MULTIPHASIC REACTIONS – ADVANTAGES, LIMITATIONS AND CURRENT 
APPLICATIONS 
Introducing multiphasic systems 
From the chemistry standpoint conducting reactions in pure organic solvents would be highly 
valued for many important reactions. Apart from simplified work-up of the reaction products, 
higher substrate loading would be possible and there would be no interfacial mass transfer 
limitations. Unfortunately, apart from a couple of examples of conducting biocatalysis in pure 
organic solvents, an additional aqueous phase is often required for enzymes to remain active 
or dissolve necessary cofactors or salts. There are two types of biphasic systems. One of them 
is a low water system where the organic phase constitutes for most of the volume and the 
residual water ensures the necessary mobility of the enzyme and proper interactions with 
counter-ions;45 less than 1% water (v/v) is usually efficient.46 The other is a conventional 
liquid/liquid two phase system (2LP) where aqueous and organic phases are added at different 
ratios and a clear interface can be distinguished.47 Whether one or another is used depends on 
the type of the enzyme and the involved reactants. 
Two phase systems may be beneficial for a given reaction, if either substrates and/or products 
are poorly soluble in the aqueous phase itself, substrates/products inhibit the enzymatic 
reaction, and/or synthesis is favoured over the hydrolysis.48 A vast number of 2LP processes 
for biocatalysis were developed in the 1980s, using mainly lipases and proteases. There are 
examples of other enzymatic reactions in 2LP systems or in low water media for peroxidases, 
oxidases, dehydrogenases but the field was dominated by simple hydrolytic enzymes.49 Those 
processes are listed and discussed by Halling (1987).46 The reason for application of lipases 
instead of other enzymes was their availability, cofactor independency, solubility of their 
substrates in organic solvents, and the fact that they were highly active in non-aqueous media, 
which still poses an exception among known enzymes.50 
Organic solvents may be categorized on the base of their logPo/w value, which is a measure of 
their tendency to partition between the phases of different polarity,51 and has been first 
introduced by Laane et al. (1987).52 LogPo/w is calculated as logarithm of the solubility ratio 
of a compound in octanol to its solubility in water. As a rule of thumb solvents with a logPo/w 
< 2 are not suited for biocatalysis as they interact with the water molecules essential for the 
enzyme, they tend to reside in water and therefore form a homogenous mixture (miscible 
solvents). Solvents with logPo/w between 2 and 4 distort the water and affect the catalysis only 
to some extent, and the last group of solvents with a logPo/w ≥ 4 do not interact with the 
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essential water coat of an enzyme and are therefore well suited for biocatalysis.52 The logPo/w 
values of the most common solvents (over hundred) are listed therein.52 
Beside the logPo/w, the partition ratio, KD, of substrate and product between the phases should 
be considered when working with 2LP systems, for the enzyme has to be surrounded with the 
reactants for efficient catalysis. In most of the cases the hydrophobic substrates will be 
present mostly in the bulk organic phase51 and enter the aqueous phase via continuous 
diffusion, whereas the hydrophobic products will be extracted after the reaction back into the 
organic phase. The organic phase thus serves as a substrate reservoir and product sink and 
helps to overcome problems caused by reactant solubility limits and/or substrate/product 
inhibition.46 This situation is particularly favourable when the biocatalyst is inhibited by high 
substrate and/or product concentrations. 
The solvent needs to be carefully selected so that it does not have an adverse effect on the 
biocatalyst. The interfacial effects i.e. a direct contact of the biocatalyst with the liquid/liquid 
interface53 is a common shortcoming impairing enzyme stability (see below). Also the 
partitioning behaviour of substrates and products needs to be considered, such that the 
equilibrium concentration of the substrates (Cx*), in aqueous phase is higher than the 
Michaelis-Menten constant value, Km, for the enzyme to sustain catalysis, and the product 
equilibrium concentration in the aqueous phase should be lower than the inhibitory product 
concentration, Ki. Satisfying all above requirements is often difficult and usually a 
compromise has to be made between partially impaired biocatalyst and productivity.48 For 
instance, when in a particular solvent system the substrate Cx* is lower than the Km value for 
that substrate, but the biocatalyst is stable and thus sustains longer reaction times leading to 
higher final conversions, the compromise of the reaction rate is acceptable. In that particular 
case one may increase enzyme concentration and compensate for the lower enzyme specific 
activity, when mass transfer between the phases is fast enough and the reaction is not mass 
transfer limited (see below). 
Applying a 2LP for reactions catalysed by oxidoreductases is beneficial when their substrates 
display low water solubility. For example the epoxidation of 1,7-octadiene by Pseudomonas 
oleovorans whole-cell catalyst resulted in higher substrate conversions in the presence of a 
cyclohexane phase than in the respective pure aqueous system.54 In the case of the production 
of iodine by immobilised lactoperoxidase the reaction suffered from a strong product 
inhibition. This problem was solved by a concomitant iodine extraction with an organic 
solvent.55 
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Biotransformations with soluble enzymes in an aqueous/organic two liquid phase system 
As already mentioned, the application of soluble enzymes in an aqueous/organic two liquid 
phase system may have a deleterious effect on the biocatalysts. Cofactor dependent alcohol 
dehydrogenases and monooxygenases are often used with bovine serum albumin (BSA) as a 
stabilising agent because BSA is known to be a ‘hard protein’ that prevents interfacial 
inactivation of biocatalysts by replacing them at the aqueous/organic interface.56 However, 
there are examples of biotransformations where no particular means of enzyme stabilisation 
was used and biocatalysts were applied in an aqueous/organic two liquid phase system for up 
to 192 h without activity loss57 (Table 1-3). In this case, i.e. the conversion of cholic acid 
methyl ester to 12-ketochenodeoxycholic acid methyl ester catalysed by l2α-hydroxysteroid 
dehydrogenase, the reaction was limited by the mass transfer and/or equilibrium substrate 
concentration in the aqueous phase and not by the enzyme inactivation. Measured product 
formation rates were over 10 times lower in a 2LP system than in a respective single phase 
aqueous reaction with more hydrophilic substrate. Additionally, the high Km value (0.47 mM) 
for cholic acid methyl ester, and its low equilibrium concentration in the aqueous phase in the 
beginning of the biotransformation (0.3 mM) limited the reaction. This example shows the 
importance of choosing the right organic phase with the appropriate physical properties, e.g. 
partition ratio of substrate/product between the phases. Most important aspects concerning the 
enzyme stability and maximising the mass transfer in 2LP systems will be discussed later (see 
below). 
 
  
Table 1-3: Examples of biotransformations with soluble enzymes in aqueous/organic reaction systems. 
Biocatalyst Substrate Product Organic solvent Time remark Ref. 
Subtilisin Carlsberg Bacillus sp. 
  
Substrate itself 48h emulsion 58 
Triacylglycerol acylhydrolase 
Arthrobacter sp. 
  
Methanesulphonyl chloride ≥7h - 59 
Catalase H2O2 H2O+O2 Potassium tert-butoxide >1h - 14 
(S)-Alcohol dehydrogenase R. 
erythropolis/ formate dehydrogenase 
C. boidinii   
n-heptane 92h - 60 
l2α-hydroxysteroid dehydrogenase/ 
glutamate dehydrogenase (GlDH) 
Cholic acid methyl 
ester 
12-ketochenodeoxycholic acid methyl 
ester 
Butyl acetate 192h emulsion 57 
β-hydroxysteroid dehydrogenase P. 
testosterone/ lactate dehydrogenase 
Testosterone 4-androstene-3,17-dion Butyl acetate 50h emulsion 61 
P450 monooxygenase (CYP102A1)/ 
formate dehydrogenase Pseudomonas 
sp. 101  
Cyclohexane Cyclohexanol Cyclohexane 100h 
BSA 10 g L-1, 
catalase  
600 U mL-1 
62 
Styrene monooxygenase 
Pseudomonas sp. VLB120/ formate 
dehydrogenase Pseudomonas sp. 101   
Dodecane 11h 
emulsion,  
BSA 2 g L-1 
63 
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Enzyme stability – reasoning for stabilisation and various stabilisation methods 
Although isolated enzymes are prone to O2 oxidation, and susceptible to changing pH outside 
the cell environment, in this subsection only the effects of the organic solvents on the enzyme 
stability will be discussed. As mentioned above the presence of organic solvent in the reaction 
mixture may have a negative effect on the biocatalysts. Different mechanisms of biocatalyst 
inactivation should be distinguished from one another in order to decide for a successful 
stabilisation strategy. For example, hydrophobic organic species dissolved in the aqueous 
phase can inhibit or denature the enzyme by disrupting the hydrogen bonding of an enzyme 
and changing its native conformation.64 However, interfacial inactivation, as reported for 
epoxide hydrolase,65 may be more damaging to an enzyme than the presence of low 
concentrations of organic solvent in the aqueous phase. In this case interfacial inactivation can 
be minimised by applying surfactants like Tween 20 as proposed earlier.66 However, since 
coverage of the aqueous/organic interface with surfactant is a dynamic process requiring time 
for distributing the surfactant molecules,67 interfacial inactivation cannot be completely 
prevented.68 Application of surfactants is one possibility, other techniques e.g. adsorption, 
covalent attachment, cross-linking, or embedding/entrapping the enzyme in a matrix are 
discussed below. 
 
Enzyme immobilisation techniques 
Although in the past most work on the enzyme immobilisation was done in order to render 
biocatalysts more suitable for application in water saturated organic solvent, e.g. to facilitate 
mixing and prevent inactivation in solvents with low logPo/w values, or to simplify their 
recovery after complete reaction, here immobilisation is discussed mainly as a means of 
preventing interfacial inactivation in two liquid phase systems. Immobilisation techniques can 
be divided into carrier-bound and carrier-free methods, or entrapment. The former involves 
adsorption to a support or covalent attachment of an enzyme to a support material, whereas 
the carrier-free method does not require any support material and mainly involves direct 
cross-linking of the enzyme molecule. Irrespective of the method, immobilisation is carried 
out to create a protective environment around the enzyme and simplify its recovery and 
recycling. Enzyme immobilisation methods are summarised in Figure 1-7. 
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Figure 1-7: Immobilisation methods for enzymes. Adapted and modified from Přenosil et al (2000).69 
 
Carrier-free immobilisation methods: Lipases were often ‘stabilised’ by precipitation from 
buffer by cold acetone, and subsequent drying with air and under vacuum, they exhibited a 
unique feature of functioning as a precipitate. Enzymes in the resulting powder were ‘locked’ 
in the right conformation, which means that the pH of the buffer that they were precipitated 
from had a great influence on their ionization state and hence their conformation. If the lipase 
was precipitated from the buffer with favourable pH and later assayed in the organic solvent it 
exhibited high activity, whereas when the pH of the buffer was not the optimal one for the 
reaction then it was also reflected in the subsequent assay conducted in organic solvent.50 
Those early methods of lipases preparation are similar to the methodology proposed by Cao 
and co-workers,70 with the difference that the resulting powder was further cross-linked to 
provide the catalyst that could be used in 2LP systems. This method provided a basis for 
developing cross-linked enzyme aggregates (CLEAs). These catalysts were easy to prepare,1 
could be used in 2LP systems, and were easily separated from the reaction products and 
recycled. 
Carrier-bound immobilisation methods: Another common technique for increasing 
operational stability of enzyme is adsorption onto an activated matrix e.g. Sepharose, glass 
beads or ionic binding with an ion exchange resin like DEAE. For more thorough discussion 
on various enzyme immobilisation techniques, see a monograph by Cao (2006).71 
The choice of the immobilisation method needs to be driven by the enzyme and reaction 
design. For instance, adsorbed and covalently bound enzymes are much less leaky in aqueous 
solutions than non-covalently bound ones, but on the downside their activity may be impaired 
due to structural changes. If leaking of the enzyme is not possible because it is used in a low-
water system adsorption itself may be sufficient. Another advantage of simple adsorption is 
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the ease of recovery of carrier-material, as immobilised biocatalyst will be released after 
subsequent washing steps with an aqueous solution. 
Entrapment: Entrapment in the polymeric matrix is yet another method of preparing insoluble 
biocatalysts. It is based on the principle that a solubilised or dispersed enzyme is brought to 
contact with a reagent that causes a spontaneous solidification/gelation of the matrix thus, 
resulting in the entrapment of the enzyme.72 An example of such method is gelation of sodium 
alginate caused by Ca2+ ions and successful immobilisation/encapsulation of glucose 
oxidase,73 or entrapment of 2-hydroxybiphenyl 3-monooxygenase and formate dehydrogenase 
in a gelatine/chitosan matrix stabilised by crosslinking with glutaraldehyde.74 Application of a 
hydrophilic polymer like alginate, gelatine or chitosan, and subsequent preparation of the 
immobilised biocatalyst will affect the environment around an enzyme making it hydrophilic 
by retaining water, therefore despite the immobilisation enzymes are entrapped in an aqueous-
like environment and can be successfully applied in a 2LP system up to 50 hours.74 
Mass transfer 
The mass transfer is the transfer of a species (mass) from a region of high concentration 
towards the region of low concentration until the equilibrium is established between the two 
regions. Molecular and convective transport are distinguished.75 The molecular transport of 
molecules is driven by diffusion i.e. movement of particles by Brownian motion.76 As 
proposed earlier,77 in diffusional mixing one may define the mean transport length as ݈ ൌ
√2ܦݐ	, where l is the distance a particle moves in a time t, and D is its diffusion coefficient. 
With typical diffusion coefficients D in liquids of 10-9 m2 s-1 one may calculate the time the 
particle requires to travel 1 mm to be 500 s. In this case diffusion would not be enough to 
provide sufficient mixing. Fortunately mass transfer can be additionally improved by the bulk 
flow of the fluid, which is called convective mass transport.75 The overall mass transfer with 
respect to diffusion and convection can be given as: 
Equation 1-1 
௫ܰ ൌ ݇௅ሺܥ௑∗ െ	ܥ௑ሻ 
 
Where, Nx is the flux of the component ‘x’ over the interface, kL is the mass transfer 
coefficient (cm s-1), Cx* is the concentration of ‘x’ in the liquid phase at saturation, and Cx is 
the actual liquid concentration of ‘x’. Mass transfer is an important issue in 2LP reaction 
systems,46 independent of the reactor format applied. In those systems, interfacial surface area 
is often difficult to be determined experimentally therefore, the mass transfer equation of the 
component ‘x’ over the interface is often given as: 
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Equation 1-2 
݀ܥ௑ ݀ݐ⁄ ൌ ݇௅ܽ	ሺܥ௑∗ െ	ܥ௑ሻ 
Where a is a surface area per liquid volume (cm2 cm-3), hence, the product of kL and a is 
called the volumetric mass transfer coefficient (kLa) and has a unit of reciprocal of time (s-1). 
Amongst various reaction systems the kLa is higher for microchannel based systems, than for 
shake flasks or stirred tank reactors (Table 1-4). Within given examples, microchannel 
reactors profit mainly from a large interfacial area and short diffusional distances, and 
compared to other reactors provide higher mass transfer rates, which subsequently facilitate 
fast reactions, which rely on substrate/product transport across the interface, and would 
otherwise be mass transfer limited. More examples of mass transfer characteristics of 
microstructured reactors can be found in literature.78 
Table 1-4: Mass transfer coefficients and interfacial area in typical reaction formats. 
Reaction format 
Interfacial area 
(m2 m-3) 
Overall mass transfer coefficient 
kLa (s-1) 
Reference 
Shake flask 
Baffled (40% filling)a 
Non-baffled (40% filling)a 
Baffled (10% filling)b 
Non-baffled(10% filling)b 
 
not available 
not available 
not available 
not available 
 
0.0164±0.0021 
0.0085±0.0019 
0.083 
0.033 
 
79 
79 
80 
80 
Stirred tankc not available 0.01-0.05 81 
Static mixerd 100-1000 0.1-2.5 82 
Microchannel 
Gas-liquid microchannele 
Liquid-liquid microchannelf 
 
3400-9000 
590-4800 
 
0.3-21 
0.13-0.98 
 
83 
84 
a gas/liquid mass transfer – 250 mL open shake flask, 100 mL liquid, 250 rpm, 37°C 
b gas/liquid mass transfer – 125 mL shake flask, 12,5 mL liquid, 250 rpm, 37°C 
c gas/liquid mass transfer – 1.8 L water, agitation 100-1000 rpm, aeration 1-5 Lair min-1, different impellers 
d gas/liquid mass transfer – horizontal pipe, 52.6 mm in diameter, with static mixers., interfacial area without a 
mixer was 15-40 m2 m-3. 
e gas/liquid mass transfer – rectangular channel 1 mm in depth, 0.5 mm in width 
f liquid/liquid mass transfer, extraction of iodine from water by kerosene, capillary inner diameter 0.5-1 mm. 
 
Application of enzymes in microstructured reactors 
Microstructured reactors were introduced in the late 70’ as devices for flow injection analysis 
(FIA) and continuous segmented flow analysis.85 They can be regarded as precursors of 
immobilised enzyme reactors used for high throughput sample analysis under continuous flow 
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conditions. Miniaturising the dimensions of the reactors and conducting reactions in 
microchannels results in lower diffusional distances and better mixing within shorter time. In 
microchannels when two immiscible liquids flow one after another in an ordered fashion 
often referred to as segmented, bubble, or slug flow the internal circulations within the 
segment, so called Taylor vortices, which promote axial mixing, can be observed.86 Taylor 
vortices can be seen in liquid/liquid, or liquid-gas flows, and arise from the shear force 
between the liquid and the channel wall and between two consecutive slugs (Figure 1-8). 
Intense internal circulations promote mixing within the slugs and are therefore responsible for 
large enhancement of the interfacial mass transfer rates in liquid/liquid slug flow reactors.87 
Because of two independent and controllable transport mechanisms i.e. convection and 
diffusion, microchannels (microreactors, microstructured reactors) provide excellent 
conditions for enhancing the performance and tuning of mass transfer limited reactions.87 
 
Figure 1-8: Taylor flow pattern in a two-liquid flow in a microreactor. 
 
Mass transfer intensification and enhanced interfacial area over conventional stirred tank 
reactors are main advantages of microreactors88 (Table 1-4), additionally precise control of 
the temperature and the reaction times is possible.89 They enable rapid screening of reaction 
conditions and generation of compound libraries with minimised reagents or enzymes 
consumption.90 Other advantages of running the reactions in flow are faster reaction rates, less 
waste generation, lower solvent usage, simplified downstream processing due to lack of 
emulsion formation, or possibility of running sequential reactions without the need of 
intermediate purification91 (and references therein). Many examples of chemical processes in 
flow and examples of process intensification with respect to conventional reactors have been 
discussed by Ley (2012).91 Also enzymatic flow reactors have been successfully implemented 
in small scale synthesis (Table 1-5). Many reviews have been published on the topic.76, 92 
flow direction
dispersed phase continuous phase channel wall film region
  
Table 1-5: Examples of two liquid phase soluble enzyme processes in microreactors. Adapted from Bolivar and Nidetzky (2013).88 
Reaction Enzymes Phases Residence 
time [h] 
Reactor  
volume [mL] 
STY  
[g L-1 h-1] 
Remark Reference 
Synthesis of 
isoamyl acetate 
C. antarctica lipase B 
(Lipozyme CALB L) 
adsorbed on the interface 
1-butyl-3-
methylpyridinium 
dicyanamide/n-heptan 
0.56 0.155 174 Reaction rate in liquid/liquid two phase 
Taylor flow in microchannel 3-fold 
higher than in a batch reaction. Emulsion 
formation observed. 
93 
Degradation of 
p-chlorophenol 
Trametes sp. Laccase 
adsorbed on the interface 
Isooctane/succinic buffer 0.0056 0.0005 1.26a Liquid/liquid two-phase parallel flow. 
Conversion and efficiency increased 
with respect to gently shaken batch 
reaction. 
94 
Reduction of 1-
heptaldehyde 
Soluble thermophilic 
alcohol dehydrogenase and 
formate dehydrogenase 
Hexadecane/potassium 
phosphate buffer 
1.75 37.6 5.2 Liquid/liquid two-phase segmented flow. 95 
Synthesis of 
cyanohydrins 
from respective 
aldehyde  
Soluble (S)-Hevea 
brasiliensis hydroxynitrile 
lyase 
MTBE/aqueous buffer Up to 0.5 0.0016 404b Liquid/liquid two-phase parallel flow. 
Screening of reaction parameters. 
96 
Asymmetric 
reduction of α,β 
unsaturated 
activated 
alkenes 
Soluble pentaerythritol 
tetranitrate reductase 
Isooctane/potassium 
phosphate buffer 
0.33 not specified 8.02c Liquid/liquid  two-phase drop flow.  97 
a calculated for dehalogenation of p-chlorophenol with a 20 sec residence time at a flow rate of 1.5 µL min-1 resulting in 65% conversion of 100 µM solution. 
b calculated for the conversion of benzaldehyde (230 mM) to 2-hydroxy-2-phenylacetonitrile with 2.5 min residence time and 55% conversion 
c calculated for the reduction of 2,6,6-trimethylcyclohex-2-ene-1,4-dione (20 mM) to 2,2,6-trimethylcyclohexane-1,4-dione with 20 min residence time and 88% conversion. 
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The choice of the reactor system necessitates careful investigation of the respective reaction 
parameters. Karande et al. (2011)95 proposed to use the Damköhler number which describes 
the relation between the mass transfer rate and the reaction rate (Equation 1-3),95 as a decision 
basis. 
Equation 1-3 
ܦܽ	 ൌ 	݇௖௔௧	݁଴	߮݇௅ܽ	ܥ௫∗ 	 
kcat is the catalytic turnover frequency, e0 is the enzyme concentration, φ is the phase ratio, kLa 
is the overall volumetric mass transfer coefficient, and Cx* is the equilibrium substrate 
concentration in the aqueous phase. Da = 1 implies a reaction rate equal to the mass transfer 
rate, Da < 1 points towards a kinetically limited reaction and for Da > 1, the reaction is mass 
transfer limited and the turnover frequency of enzymes (kcat, s-1) is no longer used effectively. 
Shifting a system from the kinetic limited regime into the mass transfer controlled regime is 
done by increasing enzyme loading or by reducing substrate concentration in the organic 
phase while keeping all the other parameters constant. By assuming that Da = 1, one may 
calculate the kLa below which reaction will be mass transfer limited and decide whether 
conducting the reaction in microreactors makes sense or if the mass transfer will be fast 
enough also in a shake flask or stirred tank reactor. 
 
Oxygen availability in microreactors  
Oxygen is a critical parameter when working with oxidoreductases. There are three main 
strategies of delivering oxygen for the reaction in microreactors, it may be dissolved in 
liquids, delivered in a gas segment next to an aqueous or organic segment, or continuously 
perfused through a gas permeable membrane (Figure 1-9). 
 
Figure 1-9: Modes of gas delivery for the reaction in microreactors. A – Gas dissolved in liquids. B – Gas 
delivered in a separate gas segment. C – Gas continuously delivered through a gas permeable membrane. 
 
Depending on the chosen method, the amount of oxygen present in the reactor will be 
different and will affect the maximum reaction time after which all the oxygen is consumed. 
Aqueous
Organic
Gas
A B C
gas permeable membrane
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The first two methods (Figure 1-9AB) are one-point-delivery methods, meaning that the 
amount of oxygen is finite and maximum at the point of inlet, and is continuously consumed 
along the reactor length, thus defining the maximum reactor length. Maximum product 
concentration cannot exceed the initial concentration of oxygen, therefore with a fixed reactor 
volume, enzyme concentration and product formation rate, the residence time is limited by the 
oxygen concentration. The third one (Figure 1-9C) is a continuous method where the 
concentration of oxygen is constant in the whole reactor as oxygen is delivered through the 
gas permeable membrane throughout the overall reactor length. The advantage of the third 
method is obvious, it provides unlimited amount of oxygen, the residence time is independent 
of the initial oxygen concentration allowing for higher conversions at longer residence times, 
and also the reaction conditions with respect to oxygen are constant in the whole reactor. 
When lower conversions, not exceeding initial concentration of oxygen are acceptable, and 
the effect of decreasing concentration of oxygen, as the reaction progresses, is negligible, it is 
still possible to use air (or pure oxygen) segments at an atmospheric or higher pressures for 
oxygen supply. The first two methods do not require specialized membranes and can be 
readily applied in a single channel microreactor without any modifications. Absolute 
concentrations of oxygen in microreactors with different modes of delivery are listed in Table 
1-6. 
Table 1-6: Oxygen concentration in microreactors at 30°C and total pressure of 101.325 kPa depending on the 
mode of delivery. Concentrations are calculated for water as aqueous phase and decanol as organic phase. 
Respective phase ratios are given in parentheses. 
Mode of delivery 
Concentration at O2 partial 
pressure 21.28 kPa. (0.21 atm) 
[mM]a 
Concentration at O2 partial 
pressure 101.325 kPa. (1 atm) 
[mM]b 
Dissolved in liquids, (aq:org 1:1) 0.89 initial 4.26 initial 
In segments, (aq:org:gas 1:1:1) 3.34 initial 15.89 initial 
Through membrane, (aq:org 1:1) 0.89 constant 4.26 constant 
a Concentration of oxygen at 30°C and 101.325 kPa (1 atm) total pressure in water, decanol, and air is 0.22 mM, 
1.35 mM,98 and 8.44 mM respectively (with oxygen having a molar fraction of 0.21 in air and a molar volume of 
24.87 L mol-1). 
b at higher total pressures exceeding 1 atm oxygen concentrations will be proportionally higher. 
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CHAPTER’S SUMMARY 
From the above it can be seen that noteworthy work has been done in the field of enzymatic 
microreactors. Unfortunately most of the enzymatic processes in such systems are based on 
the usage of proteolytic enzymes immobilised on the microchannel walls or glass beads filling 
the channel and used for protein or peptide digestion.92f Examples listing other enzymes, 
some of which are used in multiphasic systems also exist.99 However, application of soluble 
enzymes in the multiphase microreactors is still scarce (Table 1-5). Motivations for moving 
away from batch reactors towards miniaturised systems are obvious: increased reaction rates 
in phase transfer catalysis due to higher mass transfer rates, better control of the reaction time 
and reaction temperature, or minimised reactants usage.88 Although methods for multiphasic 
chemical catalysis are well established,91, 100 and advantages of running reactions in 
microreactors, are obvious, transferring this knowledge for biocatalysis is challenging and 
careful investigation of the reaction parameters (educts concentration and supply, (bio)catalyst 
stability, solvent selection etc.) is needed. In series of experiments a set of 
boundaries/constraints like e.g. suitable reactor format, educts concentrations, residence 
times, and minimum product concentrations, can be defined. 
AIMS OF THE THESIS 
This thesis aims at applying 2-hydroxybiphenyl 3-monooxygenase (HbpA) and formate 
dehydrogenase (FDH) in a two-liquid phase system in a segmented flow microreactor for 
continuous production of 2,3-dihydroxybiphenyl (3-phenylcatechol). Gram-scale preparation 
of the soluble HbpA and FDH by expanded bed anion exchange chromatography or 
ammonium sulphate precipitation, and their characterisation with respect to the storage 
stability, and operational stability in contact with second organic phase is shown in chapter 2.  
Chapter 3 summarises the preparation of Cross-Linked Enzyme Aggregates (CLEAs) of 
HbpA and FDH, which were prepared in order to stabilise the biocatalysts that proved 
susceptible towards the aqueous/organic interfaces. Their application in the two-liquid phase 
system is presented therein. Also the crystal structure and the implication of the surface 
residues and domain mobility which might influence efficiency of CLEA methodology are 
discussed. 
Chapter 4 is a proof of concept and shows an alternative, low water system for NADH 
regeneration with formate dehydrogenase and formic acid ester. This novel cofactor 
regeneration concept enables using high organic to aqueous phase ratios which facilitate 
solubilising of high amounts of usually hydrophobic substrates. The formic acid ester serves 
also for a continuous product removal. 
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Chapter 5 aims at application of soluble HbpA and FDH in a segmented flow microstructured 
reactor. Two different reactor concepts, namely aqueous/organic/air three-liquid phase 
microreactor, and tube-in-tube microreactor with a gas permeable Teflon AF-2400 membrane 
are compared. HbpA-catalysed reaction is discussed with respect to the cofactor regeneration, 
hydrophobic substrate supply and oxygen supply. Tube-in-tube microreactor is later chosen 
for continuous preparative gram scale synthesis of 2,3-dihydroxybiphenyl described in 
chapter 6, which also touches the downstream processing. Ultimately the chapter 6 gives a 
proof of concept of applying an ePFTE membrane for constructing TiTR for achieving 
complete aqueous, organic, and gas phase separation. This setup is later discussed with 
respect to its potential for later scale-up purposes (Chapter 7). 
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ABSTRACT 
Application of isolated enzymes requires established protocols for their production and 
purification. Moreover providing means of enzyme stabilisation for in-vitro reactions is of 
equal importance. Here methods are presented for production and purification of two enzymes 
2-hydroxybiphenyl 3-monooxygenase (HbpA), and formate dehydrogenase (FDH). These 
biocatalysts were characterised in terms of storage and reaction stability. Both enzymes have 
been produced in recombinant E. coli JM101, subsequently purified/enriched by means of a 
single step expanded bed adsorption chromatography and stored in 50% glycerol for months 
without losing activity. However, when applied to a two liquid phase system comprising of n-
decanol and buffer, in a capillary microreactor, stability was poor. Addition of the surfactant 
Tween 20 stabilised the enzymes in the presence of the organic solvent and it was possible to 
recover 100% of the respective enzymatic activity. This set the stage for enzymatic synthesis 
of 3-phenylcatechol using aqueous/organic two-liquid phase segmented flow microreactors. 
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INTRODUCTION 
Biocatalytic hydroxylation of non-activated carbons is an important tool for synthesis of 
valuable compounds, either intermediates or final products. Their chemical equivalents often 
do not exist, or require multiple synthetic steps; therefore every new application of a whole-
cell biocatalyst or a soluble enzyme in this field unravels a way to a new, attractive product.  
2-hydroxybiphenyl 3-monooxygenase (HbpA) is a flavin dependent monooxygenase, which 
catalyses synthesis of 3-phenylcatechol from 2-hydroxybiphenyl in Pseudomonas azelaica 
HBP141b (Chapter 1, Figure 1-6). Synthesis of catechols is difficult in abiotic conditions and 
biocatalysis presents a green-alternative. HbpA has already been used for the gram scale 
synthesis of 3-substituted catechols in recombinant E. coli,20, 41a, 101 and in soluble form in a 
2-liquid phase system.21, 102 As HbpA is dependent on the cofactor NADH, a continuous 
supply thereof is required. Due to cost reasons, it cannot be added in stoichiometric amounts. 
Therefore various strategies for the turnover of NADH have been developed of which 
utilisation of the intrinsic host cell metabolism is by far the easiest one. In case of isolated 
enzymes, application of formate dehydrogenase FDH has been widely established (see also 
chapter 1). Although successful, yielding gram amounts of product, previous processes21, 102 
suffered from low productivities (up to 0.46 g L-1 h-1) believed to be limited by the mass 
transfer, catalyst loading, and/or oxygen supply.21, 102 Therefore, application of soluble HbpA 
and FDH in microstructured reactors may be a possibility to relieve these bottlenecks as such 
systems are characterised by high mass transfer rates.87 To evaluate the applicability of 
capillary microreactors for the HbpA-catalysed reaction, significant amounts of enzymes were 
needed. The most commonly used host for the preparation of heterologous proteins is E. coli. 
It is easy to cultivate and depending on the chosen expression system produces high levels of 
heterologous protein (up to 40%-50% of the total cell protein).103 Although there are means of 
protein secretion from the E. coli host, translocated proteins are often insoluble due to the 
presence of the respective signal sequence,104 therefore the majority of heterologous proteins 
are produced intracellularly and need to be purified from disrupted cells. The cell homogenate 
obtained after cell disruption contains cell debris, intact cells, and soluble cell components, all 
of which need to be separated to obtain a protein solution of defined purity and activity 105. 
Solid particles may be removed by centrifugation or filtration, and further protein purification 
may be realised by chromatography, ultrafiltration,106 or fractional precipitation with 
ammonium sulphate.107 Separation of solid debris and the subsequent chromatography step 
may be combined in a one-step expanded bed adsorption chromatography.105, 108 The 
advantage of that method is the reduction of unit operations required for the primary 
purification of proteins. In the obtained protein solution the target protein is usually enriched 
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by a factor of up to 15 times.108 What distinguishes it from a typical packed bed 
chromatography is the fact that the bed is not constrained and can expand before and during 
sample loading (Figure 2-1). It allows cell debris to pass through the column without being 
trapped and clogging the column. Charged particles (e.g. proteins) interact and adsorb onto 
the column matrix. Cell debris and loosely bound proteins are removed in the consecutive 
washing step. Flow is then reduced allowing the bed to settle and the sample is eluted in a 
reverse (downward) flow.105 
 
Figure 2-1: Schematic presentation of consecutive steps of expanded bed adsorption chromatography. 
 
After appropriate selection of a column matrix and adjustment of the elution method, 
expanded bed adsorption chromatography may yield almost pure (95%) protein preparation, 
which has been shown for the purification of the formate dehydrogenase.109 
Biocatalysts are subjected to denaturation in the environments other than the cell if 
appropriate precautions (stabilisation) are not taken. It is therefore important to determine the 
stability of the biocatalysts under reaction conditions and provide necessary means of 
stabilisation. Different stabilisation methods as well as the reasoning for application of 
enzymes in multiphasic microreactors are discussed in details in chapter 1. 
In this chapter the ways to produce and purify 2-hydroxybiphenyl 3-monooxygenase (HbpA), 
and formate dehydrogenase (FDH) are described. Moreover the biocatalysts are characterised 
regarding storage and reaction stability and its performance in a 2-liquid phase system. 
 
 
 
sedimented
adsorbent
equilibration
sample
loading washing elution
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MATERIALS AND METHODS 
Chemicals 
NADH disodium salt and 1-decanol were obtained from Applichem (Darmstadt, Germany), 
sodium formate, NAD+ disodium salt and FAD from Fluka (Buchs, Switzerland), 2-
hydroxybiphenyl, and 2,3-dihydroxybiphenyl from Wako Pure Chemical Industries Ltd. 
(Osaka, Japan). All other chemicals have been bought either at Fluka, Applichem or Sigma-
Aldrich and used as received. 
Media 
If not stated otherwise either LB supplemented with 150 mg L-1 ampicillin or M9 minimal 
medium supplemented with 0.5% glucose (v/v), 150 mg L-1 ampicillin, 0.001% (w/v) 
thiamine, 2 mM MgSO4, 0.1 mM CaCl2 and 1 mL L-1 of US* trace elements solution, 
prepared as described previously,110 was used for cultivations. 
Bacterial strains and plasmids 
Table 2-1: Bacterial strains and plasmids used in this work. 
Strain or plasmid Characteristic Source or reference 
Strains   
E. coli JM109 recA1 supE44 endA1 hsdR17 gyrA96 relA1 thi Δ(lac-proAB) F’ 
[traD36 proAB+ lacIq lacZ ΔM15] 
111 
E. coli JM101 supE thi Δ(lac-proAB) F’ [traD36 proAB+ lacIq lacZ ΔM15] 111 
Plasmids   
pHBP461 pUCBM20 derivative carrying hbpa containing cassette (3.2 kbp) 
cloned into the SalI restriction site. AmpR. 
101 
pBTac2 (C23S) cloning vector with pBR322 origin carrying a modified (C23S) fdh 
gene. AmpR, TetR  
112 
 
Cultivation and biomass production 
2-hydroxybiphenyl 3-monooxygenase HbpA 
For optimal HbpA production, hbpA was expressed in E. coli JM101 carrying the plasmid 
pHBP461.101 1st pre-culture was grown overnight (30°C, 200 rpm) in a Multitron orbital 
shaker (Infors HT, Homberg, Germany) in 5 mL LB medium and was subsequently used to 
inoculate 100 mL of M9 medium (2nd pre-culture) in a shake flask. Batch cultivation was 
started by inoculation of 1.7 L M9 medium in a 3L stirred tank bioreactor (Bioengineering 
AG, Wald, Switzerland) with 5% (v/v) of the 2nd pre-culture. Cells were grown in batch mode 
(30°C, 1000 rpm, aeration 60 L h-1) until all glucose (15 g L-1) was completely consumed 
(approx. 7-8h). Fed batch was started with glucose exponential feed (50% glucose (v/v), 
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80 mM MgSO4) to a growth rate of μ=0.1-0.12 h-1. To ensure plasmid retention, ampicillin 
was added once again (150 mg L-1) at the beginning of the fed batch and then every 4h. At 
7.5 gCDW L-1 cells were induced with 1 mM IPTG and cultivated until finally 25 gCDW L-1 were 
reached. Supernatant was removed by centrifugation at 4000 g for 20 min at 4°C in a Heraeus 
Multifuge 1 S-R bench top centrifuge (Thermo Fischer Scientific, Langenselbold, Germany) 
and the obtained cell paste was kept at -20°C until further use. During the growth pO2 level 
was kept above 20% by controlling stirrer speed and aeration.  
Formate dehydrogenase FDH 
Formate dehydrogenase (FDH) C23S was produced in E. coli JM101 pBTac2 (C23S)112a 
similar as described above for HbpA. 
Preparation of HbpA 
HbpA purification protocol was adapted from previously published work.21, 102 HbpA was 
enriched in a single step by expanded bed adsorption (EBA) chromatography (Labomatic 
Instruments, Allschwil, Switzerland) on a Streamline 50 DEAE anion exchange column (100 
cm high, 5 cm inner diameter, total 2L volume) (Amersham Bioscience, Uppsala, Sweden). 
140 g of E. coli JM101 pHBP461 cell paste was resuspended to 20% (w/v) in 10 mM Tris-
HCl, pH 7.5, containing 2.5 mM MgCl2, 0.5 mM CaCl2 and DNaseI and left to thaw. Cell 
disruption occurred via one to two passages through a French Pressure Cell Press Unit (cell 
volume 40 mL) (Aminco SLM Instruments, Urbana, IL, USA). The resulting homogenate was 
spun at 15000 g for 40 min at 4°C in a SLA-1500 rotor on a Sorvall RC 5B PLUS Superspeed 
Centrifuge (Thermo Fischer Scientific, Langenselbold, Germany). Clear supernatant was 
collected and its conductivity was adjusted to ≤5 mS/cm with Seralpur Pro 90 CN water 
(Seral Druck, Ransbach-Baumbach, Germany). The cell extract was stored on ice until being 
loaded onto the column. 
The Streamline 50 column filled with 510 mL Streamline DEAE anion exchanger material 
(Amersham Bioscience, Uppsala, Sweden), was equilibrated (1.5 CV of 20 mM Tris-HCl, pH 
7.5) at room temperature with an upward oriented flow (200 cm h-1) (Watson Marlow 502S 
pump) forming a stable expanded bed with a 2.2-fold expansion. Sample was loaded with the 
same flow rate and then the column was washed with 20 mM Tris-HCl until a clear flow-
through liquid was collected. The flow rate was decreased (45 cm h-1) to allow the bed to 
settle, and elution was started in a packed bed mode with a downward oriented flow of 
120 cm h-1 (3 CV of 5 mM NaCl in 20 mM Tris-HCl) followed by a NaCl gradient from 5 
mM to 280 mM over 3 CV until finally the NaCl concentration was kept constant (1.5 CV, 
280 mM NaCl in 20 mM Tris-HCl). 100 mL fractions were collected. Due to the bound FAD, 
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HbpA containing fractions were identified by the 450 nm signal on UVIS-205 Absorbance 
Detector (Linear Instruments, Reno, NV, USA). Enzyme activity was measured using a 
standard spectrophotometer based assay (see below) and fractions containing the highest 
HbpA activity were pooled and either freeze-dried or concentrated by ultrafiltration through a 
30 kDa filter paper in an Amicon Stirred Cell 8400 (Merck Millipore, Billerica, USA). The 
obtained HbpA concentrate was mixed with glycerol at 1:1 (v/v) ratio and stored at -20°C. 
The obtained protein preparation was of technical purity (approx. 40-50%). Such prepared 
HbpA could be used for at least a year without losing activity. 
Preparation of FDH 
Formate dehydrogenase (FDH) of technical purity was purified similarly as HbpA, modifying 
the EBA chromatography elution step. After the first 2 CV of 20 mM Tris-HCl, the NaCl 
concentration was set to 160 mM for 1.5 CV, followed by 1 CV of 220 mM NaCl and finally 
1 CV of 280 mM NaCl. Enzyme detection was monitored by recording the 280 nm signal. 
Enzyme activity was measured using a standard spectrophotometer based assay (see below) 
and fractions containing the highest activity were pooled, ultrafiltered through a 30 kDa filter 
paper, mixed with glycerol at 1:1 (v/v) ratio and stored like HbpA. No activity loss was 
observed at these storing conditions for at least a year. 
Purification of HbpA and FDH by precipitation with ammonium sulphate 
An alternative purification method for HbpA and FDH by ammonium sulphate precipitation 
was also established. It was quicker than the EBA chromatography and minimised 
consumption of the buffers used for the elution from the DEAE column. For example, 1.08 g 
of E. coli JM101 pHBP461 cell paste was resuspended in potassium phosphate buffer (50 
mM, pH 7.5, up to 4 mL). A sample was passed once through the French Press, and the 
resulting cell lysate was centrifuged (40 min, 4°C, 12300 g) in a Sorvall RC 5B PLUS 
Superspeed Centrifuge (Thermo Fischer Scientific, Langenselbold, Germany). 3 mL of the 
supernatant was removed and combined with 2.09 mL of saturated ammonium sulphate 
solution (51.4% w/v, 0°C) for reaching 41% saturation at 0°C. It was mixed by inverting and 
incubated on ice for 30 min. A sample was centrifuged and 4.75 mL of the supernatant was 
recovered. Similarly, 1.25 g of E.coli JM101 pBTac2 (C23S) cell paste was resuspended in 
potassium phosphate buffer (50 mM, pH 7.5, up to 4 mL). A sample was passed once through 
the French Press, and the resulting cell lysate was centrifuged (40 min, 4°C, 12300 g) in a 
Sorvall RC 5B PLUS Superspeed Centrifuge. 3 mL of the supernatant was removed and 
combined with 3.95 mL of saturated ammonium sulphate solution (51.4% w/v, 0°C) for 
reaching 56% saturation at 0°C. It was mixed by inverting and incubated on ice for 30 min. 
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Sample was centrifuged and 6 mL of supernatant was recovered. Alternatively if the initial 
mass of the cell pellet was greater, instead of adding a saturated solution of ammonium 
sulphate, one may add it in a solid form, for example to bring 3 mL of unsaturated solution to 
41% saturation (at 0°C) 0.71 g of salt has to be added, or for reaching 56% saturation (at 0°C) 
in 3 mL sample 1.02 g of solid ammonium sulphate has to be added.107 
For preparative scale purification the resulting supernatant was diluted at least 3 times with 
100 mM KPi buffer (pH 7.5) and ultra-filtered through a 30 kDa filter paper in an Amicon 
Stirred Cell 8400. The obtained enzyme concentrate was mixed with glycerol at 1:1 (v/v) ratio 
and stored at -20°C. HbpA and FDH activities of such prepared glycerol stocks were 
109.7±2.3 U mL-1 and 50.8±0.98 U mL-1 respectively. This protein preparation was 
exclusively used for the tube-in-tube ePTFE membrane reactor. 
HbpA-activity assay  
HbpA activity was determined by measuring the consumption of NADH (ε = 6220 M-1 cm-1) 
at 340 nm using a Cary 300 Bio UV-vis spectrophotometer (Varian, Darmstadt, Germany). 1 
unit of enzyme activity (U) refers to 1 µmol of NADH consumed in 1 min at 30°C. A 
standard assay was conducted as follows: 960 µL of 100 mM KPi buffer (pH 7.5) 
supplemented with 12 µL of 25 mM NADH and 10 µL of 0.8 mM FAD was mixed in a 1.5 
mL PMMA cuvette and thermostated at 30°C for 5 minutes, 10 µL of enzyme solution (ca. 
0.03 U) was added and the endogenous NADH oxidation in the absence of a substrate was 
determined. Subsequently the reaction was started by the addition of 8 µL of 25 mM 
methanolic solution of 2-hydroxybiphenyl. The reaction was monitored for 1 min. Substrate 
specific activity was corrected for endogenous NADH oxidation. 
FDH activity assay 
Determination of FDH activity was done similar to the spectrophotometric method described 
for HbpA activity. A standard assay was conducted as follows: 840 µL of 100 mM KPi buffer 
(pH 7.5) supplemented with 100 µL of 2 M sodium formate was mixed in a PMMA cuvette 
thermostated at 30°C for 5 minutes. Subsequently 10 µL of enzyme solution (ca. 0.03 U) and 
50 µL of 10 mM NAD+ were added to start the reaction. The reaction was monitored for 1 
min. 
Protein determination 
Protein concentrations were determined with the Quick Start Bradford Protein Assay (Bio-
Rad, Munich, Germany), using BSA as a protein standard. Protein concentrations were 
measured in the range of 0 to 1 mg mL-1 in a 1 mL assay format. 
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Protein stability in batch or continuous flow mode 
HbpA and FDH glycerol stock solutions were diluted with 50 mM KPi buffer up to the 
required protein concentration or volumetric activity. Depending on the experiment enzyme 
solutions were either incubated in 2 mL reaction cups on a thermoshaker (Eppendorf 
Thermomixer Comfort, Hamburg, Germany), pumped into the PTFE microcapillary reactor 
by means of a 4 channel Ismatec Reglo pump (Ismatec, Glattbrugg, Switzerland) with a 1.14 
mm i.d. Tygon tube, or circulated therein. After respective time a sample was taken and its 
activity was measured in a standard UV activity assay. 
For the experiments in a two liquid phase system decanol was used as organic phase at a ratio 
of 1:1 aqueous to organic phase. For the experiments conducted in the flow system the ratio 
was kept equal by pumping the aqueous and organic phase at equal flow rates. 
Stability in organic solvents 
Glycerol stocks of HbpA and FDH were dissolved in 50 mM KPi buffer pH 7.5 for reaching a 
volumetric activity of 10.2±0.05 and 8.9±0.4 U mL-1 for HbpA and FDH respectively 
(measured before addition of the organic solvent). 0.6 mL of that solution was transferred into 
a 2 mL reaction cup and subsequently an equal volume of a respective organic solvent i.e. 
either heptan, methylcyclohexan, S-(-)-limonene, octane, octanol, o,m,p-xylene mixture, 
perfluorodecalin, or decanol was added. Reaction cups were incubated on a thermoshaker 
(Eppendorf Thermomixer Comfort, Hamburg, Germany) at 1200 rpm and 30°C. 100 µL 
samples of aqueous and organic phase were taken at 15, 30 and 60 min after a short spin (10 
sec and 10000 rpm). After sampling the mixing was resumed. Aqueous samples were diluted 
3 times with KPi buffer and stored on ice until activity measurements as described above. 
RESULTS 
Growth of E. coli pHBP461 and production of HbpA 
For choosing the right host for the production of HbpA, two E. coli strains (JM101 and 
JM109) carrying the pHBP461 plasmid were grown on different carbon sources (glucose or 
glycerol) with or without induction with IPTG (Figure 2-2). 
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Figure 2-2: Growth curves of E. coli pHBP461 on different carbon source with or without induction with 1mM 
IPTG. A – E. coli JM109 pHBP461. B – E. coli JM101 pHBP461. Cell dry weight was estimated by correlating 
optical density measurements at 450 nm with cell dry weight. Correlation factor was 0.166 g L-1 for OD=1. 
 
Both strains showed better growth on glucose. The induction with IPTG resulted in slightly 
reduced growth rates but did not affect final biomass concentrations reached (Table 2-2). 
Validation of the protein yield by SDS-PAGE (Figure 2-3) revealed higher HbpA levels in E. 
coli JM101. In this strain cultures grown on glycerol clearly had higher expression rates than 
when grown on glucose, however, under these conditions pHBP461 was leaky and expression 
of hbpA was strong with or without IPTG (Figure 2-3B). 
 
Table 2-2: Summary of the growth experiment with E. coli strains carrying pHBP461. 
E coli strain 
Specific growth 
rate µ [h-1] 
E coli strain 
Specific growth 
rate µ [h-1] 
JM109 pHBP461 glucose (0.5% v:v) 
1mM IPTG 
0.41 
JM101 pHBP461 glucose (0.5% v:v) 
1mM IPTG 
0.47 
JM109 pHBP461 glucose (0.5% v:v) 
no IPTG 
0.47 
JM101 pHBP461 glucose (0.5% v:v) 
no IPTG 
0.48 
JM109 pHBP461 glycerol (0.6% v:v) 
1mM IPTG 
0.19 
JM101 pHBP461 glycerol (0.6% v:v) 
1mM IPTG 
0.21 
JM109 pHBP461 glycerol (0.6% v:v) 
no IPTG 
0.21 
JM101 pHBP461 glycerol (0.6% v:v) 
no IPTG 
0.21 
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Figure 2-3: Production of HbpA during the growth of E. coli (pHBP461) in a shake flask on M9 minimal 
medium with glucose (0.5% w/v) or glycerol (0.6% w/v) as a carbon source. Protein samples were analysed by 
SDS PAGE under reducing and denaturing conditions, stained with Coomassie Brilliant Blue. Panel A – E. coli 
JM109. Panel B – E. coli JM101 Induction with 1 mM IPTG at time point 0. Arrows indicate monomer of HbpA 
(64kDa). Lanes M – molecular marker (Fermentas PageRuler SM0661, VWR, Darmstadt, Germany). 
 
Due to catabolite repression, the cultures grown on glucose did not show high protein levels. 
By changing the carbon source this effect was circumvented. Due to these findings E coli 
JM101 pHBP461 was chosen as host organism and in the shake flask experiments glycerol 
was supplied as carbon source, although at the expense of a reduced growth rate (Table 2-2). 
Biomass production in 3L KLF bioreactor 
For the large scale production of the biocatalysts, hbpA and fdh were expressed in E. coli 
JM101 strains carrying respective plasmid (pHBP461 for hbpA or pBTac2 for fdh) and 
cultivated in a 3L bioreactor as described in the materials and methods section. Growth curves 
of the respective cultivations are presented in the Figure 2-4. Both cultures showed 
exponential growth over the whole fed-batch phase, and their growth rates did not decrease 
after induction with 1 mM IPTG. Glucose feed was adjusted to keep the growth rate low at 
µ=0.1 h-1 to allow for high HbpA and FDH production (Figure 2-5). Exponential glucose-
limited feed with additional IPTG induction resulted in higher protein levels than with 
glycerol as a carbon source. Because glucose was immediately consumed after addition, its 
concentration in the bioreactor was low (not detectable by conventional glucose-strip test) 
exerting no catabolite repression on hbpA or fdh expression. Nevertheless, induction with 
IPTG was required to render the lac operon active by binding to the repressor protein and 
permitting transcription.113 
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Figure 2-4: Production of biomass in a 3L KLF bioreactor on M9 minimal medium with exponentially fed 
glucose. Batch phase: 30°C, 1000 rpm, aeration 60 L h-1, 15 g L-1 glucose, pH 7.5 – 7-8 h. Fed-batch: 30°C, 
glucose exponential feed adjusted to specific growth rate μ=0.1-0.12 h-1, induction at 7.5 g L-1 with 1 mM IPTG, 
stirring and aeration controlled to maintain pO2 above 20%. All the other conditions as described in the 
respective materials and methods section. 
 
 
Figure 2-5: A – Production of HbpA during the growth of E. coli JM101 pHBP461 on M9 minimal medium in a 
3L KLF bioreactor. Time above the lanes indicates time after starting the fed batch with glucose (50% w:v, 80 
mM MgSO4). Induction with 1mM IPTG at 2h. B - Production of FDH during the growth of E. coli JM101 
pBTac2 C23S on M9 minimal medium in a 3L KLF bioreactor. Time above the lanes indicates time after 
starting the fed batch with glucose (50% w:v, 80 mM MgSO4). Induction with 1 mM IPTG at 2h. 
Purification of HbpA by expanded bed anion exchange chromatography 
HbpA was produced on a gram scale from E. coli JM101 (pHBP461) cell paste prepared as 
described in materials and methods. The overall purification procedure was similar to the one 
previously published.102 HbpA eluted in a broad first peak (Figure 2-6). Pooled fractions were 
yellow in colour because of the bound flavin cofactor. SDS-PAGE gel conducted after 
filtration through the 30 kDa filter paper revealed that HbpA was the main protein in the final 
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sample (Figure 2-7). Typical purification table (Table 2-3) summarises all purification steps. 
From the initially used 140 g cell pellet (cell wet weight) 11.7 kU of HbpA were prepared 
with an overall specific activity of 1.5 U mg-1. 
 
 
Table 2-3: Typical purification table of HbpA isolation using expanded bed anion exchange chromatography. 
140 g E. coli JM101 pHBP461 cell pellet (gCWW) was used. 
Sample 
Volumetric activity 
[U mL-1] 
Protein concentration 
[mg mL-1] 
Specific activity 
[U mg-1] 
Total activity 
[U] 
Centrifugation 22.35 - - 8958 
AEX fraction pool 7.85 - - 10952 
Ultrafiltration (30kDa 
cut-off) 
60 40.1 1.50 11670 
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Figure 2-6: Typical chromatogram from the 
purification of HbpA on the Streamline 50 DEAE 
expanded bed anion exchange column (100 cm 
high, 5 cm inner diameter, total 2L volume) 
(Amersham Bioscience, Uppsala, Sweden). 
Figure 2-7: Typical 12% SDS-PAGE gel of HbpA and FDH after EBA 
chromatography. 10 µg protein sample/well have been loaded. Protein weight 
marker (Fermentas PageRuler SM0661, VWR, Darmstadt, Germany) is shown 
in lane M, concentrated samples of the most active fractions of HbpA and FDH 
from expanded bed anion exchange chromatography filtered through 30 kDa 
cut-off filter paper are shown in lanes HbpA and FDH respectively. 
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Optimisation of FDH purification on expanded bed anion exchange chromatography 
FDH was purified from E. coli JM101 pBTac2 (C23S) cell paste prepared as described in 
materials and methods. The French press was preferred over the bead mill for it offered better 
cell opening efficiencies (Figure 2-8A). By stepwise optimisation of the NaCl gradient it was 
possible to elute the loaded proteins in three distinct peaks from the column (Figure 2-8C). 
Subsequent elongation of the first step (160 mM NaCl) to 1.5 CV instead of initially used 1 
CV resulted in better peak separation and almost no FDH activity was detected in the 
following peaks (Figure 2-8D). Some FDH activity was detected in the fractions 2 and 3 as a 
result of the pump break-down that initially failed to operate continuously and lead to the 
dissociation of the proteins once switched back on. 
 
Figure 2-8: Optimisation of FDH purification by expanded bed anion exchange chromatography. A – cell 
disruption done by bead mill, 40 g cell pellet, gradient elution (5-280 mM NaCl over 3 CV). B – cell disruption 
method changed to French Press, 40 g cell pellet, gradient elution (5-280 mM NaCl over 3 CV). C – Step-wise 
elution profile with 1 CV at 160 mM NaCl, 1 CV at 220 mM NaCl, and 1 CV at 280 mM NaCl, 10 g cell pellet, 
French Press. D – Step-wise elution profile with extended first step 1.5 CV at 160 mM NaCl and then 1 CV at 
220 mM NaCl, and 1 CV at 280 mM NaCl, 30 g cell pellet, French Press. 
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After successful optimisation of the elution protocol 270 gCWW of the cell pellet was used at 
once to prepare 5.8 kU of FDH with an overall 69% yield (Table 2-4). After ultrafiltration 
FDH was the most abundant protein in the sample, as confirmed by SDS-PAGE analysis 
(Figure 2-7). 
Table 2-4: Typical purification table of FDH isolation using expanded bed anion exchange chromatography. 270 
g of E. coli JM101 pBTac2 (C23S) cell pellet (gCWW) was used. 
Sample 
Volumetric activity 
[U mL-1] 
Protein 
concentration 
[mg mL-1] 
Specific 
activity 
[U mg-1] 
Total 
activity [U] 
Purification 
factor 
Cell extract 9.9 34.2 0.29 8877 1 
Centrifugation 11.4 30.94 0.37 9125 1.3 
Flow through 0.36 - - 533 - 
AEX fraction pool 9.88 9.25 1.02 4940 3.5 
Ultrafiltration (30kDa 
cut-off) 
65±1.7 48.2±1.7 1.3±0.04 6500 4.5 
 
Purification by ammonium sulphate precipitation 
This simplified purification protocol allowed for quick preparation of technical pure proteins 
(50-70% estimated on the base of SDS PAGE analysis) without using time consuming 
chromatography. Resulting protein samples were of comparable purities to the one prepared 
by EBA chromatography (Table 2-5). The SDS-PAGE analysis showed an efficient 
purification with respect to the cell extract sample. The overall yield based on the unit 
recovery was 60% for HbpA and FDH. For long term storage, proteins can be concentrated by 
ultrafiltration and stored in 50% glycerol as samples originating from EBA chromatography.  
Table 2-5: Typical purification table of HbpA and FDH for the ammonium sulphate precipitation method. 
Sample 
Volumetric activity 
[U mL-1] 
Protein concentration 
[mg mL-1] 
Specific activity 
[U mg-1] 
Volume 
[mL] 
Total activity 
[U] 
Purification 
factor 
HbpA       
Cell extract 44.4±1.0 29.0 1.53 4 178 1 
Centrifugation 44.3±0.7 28.2 1.57 3.5 155 1.03 
Precipitation 22.3±0.3 11.6 1.92 4.75 106 1.25 
       
FDH       
Cell extract 21.5±1.3 29.5 0.73 4 85.8 1 
Centrifugation 22.7±0.9 28.6 0.79 3.75 84.9 1.08 
Precipitation 8.7±1.1 6.1 1.43 6 52.3 1.96 
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Figure 2-9: SDS PAGE gel of proteins after purification of HbpA (panel A) and FDH (panel B) by ammonium 
sulphate precipitation. Lane M – molecular marker (Fermentas PageRuler SM0661), CE – cell extract, C – 
sample after centrifugation, S – supernatant after precipitation, P – resuspended pellet.  
 
HbpA stability in a single aqueous phase 
Storage stability at 30°C 
To assess storage stability of HbpA at different protein concentrations (2 mg mL-1 to 5 
mg mL-1) samples of 1 mL prepared in KPi buffer were incubated in 2 mL reaction cups at 
30°C without shaking with periodical sample removal for activity assessment. HbpA showed 
high stability over 70 hours, displaying only minor differences between the samples with 
different protein concentrations. Overall activity loss was lower than 20% for the least 
concentrated sample and only 6% for the sample containing 5 mg mL-1. 
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Figure 2-10: Time course of inactivation of HbpA at 
different protein concentrations upon incubation at 
30°C without stirring (batch mode). Initial 
volumetric activities were 15.0 U mL-1 and 6.4 
U mL-1 for 5 mg mL-1 and 2 mg mL-1 respectively. 
Error bar represent standard deviation of 3 
consecutive measurements. 
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Stability in microreactors in flow 
In the following experiments HbpA and FDH stability was evaluated under continuous flow 
conditions in a 9-m-long polymeric PTFE tube with an i.d. of 0.25 mm. The respective 
protein samples were circulated through the tube and samples were removed regularly to 
determine enzyme activity. At higher concentrations of HbpA (5 mg mL-1) no decrease in 
activity was observed over 50 hours of circulation. Only in diluted protein samples (1 
mg mL-1) the interfacial effect between solid and liquid phase has an impact (not shown). 
Compared to the reference sample (without circulation) almost 50% activity was gradually 
lost in 24 hours. FDH was stable irrespective of the protein concentration in the sample. 
Stability of HbpA and FDH in a 2 liquid phase system 
In the following enzyme stability was assessed in the presence of an organic phase used 
as substrate carrier. 
 
Batch mode 
Aqueous/organic interfacial effects were first studied in batch mode where the surface to 
volume ratio is lower than in microreactors,78 therefore, slower inactivation was expected. At 
the interface of the hydrophobic organic solvent proteins are prone to be inactivated, as due to 
their amphiphilic nature they will unfold and denature as described previously.65-66 First, 
residual activity of HbpA and FDH was tested after orbital shaking with an organic solvent. 
Various solvents were checked (see materials and methods section). At high catalyst loadings 
(9-10 U mL-1 equivalent to 6-7 mg mL-1) no significant inactivation was observed after 15 or 
30 min of shaking, therefore residual enzyme activity was again tested after a total incubation 
time of 60 min (Figure 2-11A). White precipitate in various amounts was observed at the 
interface after orbital shaking and phase separation with every solvent (Figure 2-11B). It was 
assumed, that this precipitate was denatured enzyme, which may be correlated to the degree 
of enzyme activity loss. Amongst all solvents tested only octanol and decanol were able to 
solubilise 2,3-dihydroxybiphenyl. Given the fact that the enzymes had comparable stabilities 
in octanol and decanol, decanol was the solvent chosen as an organic phase for further 
studies.  
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Figure 2-11: A – Influence of the different organic solvent on the residual activity of the HbpA and FDH upon 
mixing in the two liquid phase system. Activities were measured after 1h of mixing at 1200 rpm at 30°C in a 
spectrophotometric assay and compared to the enzymes’ initial activities. The error bar represent the standard 
deviation of 2 consecutive measurements. B – Enzyme precipitate present at the interface of an aqueous and 
organic phase. Respective organic solvents are 1 – heptan , 2 – methylcyclohexan, 3 – limonene, 4 – octane, 5 – 
octanol, 6 – o,m,p-xylene 7 – perfluorodecalin, and 8 – decanol. Initial volumetric activities were 10.2±0.05 and 
8.9±0.4 U mL-1 for HbpA and FDH respectively. 
 
Subsequent experiments with reduced enzyme loadings (low protein concentrations) in a 
two-liquid phase system with decanol as organic phase, showed that the lower the enzyme 
concentration, the faster the inactivation of the respective sample. However, the absolute 
amount of denatured protein was always in the range of 30 to 63 µg mL-1 irrespective of the 
protein concentration loaded (Table 2-6). For FDH, results were similar to those of HbpA, 
110 µg of protein denatured in comparison to 63 µg in the HbpA sample, which comprises 
37% of total activity loss. 
Table 2-6: Inactivation of HbpA and FDH in moderate to low protein concentrations in two-liquid phase system 
upon orbital mixing at 1400 rpm (batch mode). 
HbpA FDH 
Initial protein concentration [µg mL-1] 500 100 50 500 
volumetric activity [U mL-1] 1.55 0.45 0.09 0.43 
after 30 min activity loss 21% 93% 99% 37% 
relative protein loss [µg mL-1] 105 93 49.5 185 
absolute protein loss [µg] 63 56 30 110 
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Continuous mode – stability in microreactors 
Next to the above described batch assays the experiments were repeated in continuous mode 
in the microcapillary tube with an extended protein concentration range. Again, the same 
trend as in batch mode was observed, meaning the relative activity loss (percentage of the 
total protein that becomes inactivated) was greater in more diluted samples for both HbpA 
and FDH. In addition the inactivation was faster in narrow (0.5 mm i.d.) capillaries as 
compared to the wider (1.0 mm i.d.) ones (Figure 2-12). Residence time in the microreactor 
was only 1 min and the rate of inactivation was greater than observed in the experiments 
conducted in batch mode. For an efficient biotransformation it is required to extend the 
residence times. It will result in even lower residual activity at the reactor outlet. To extend 
the catalyst’s stability an efficient and simple stabilisation approach is necessary. 
 
Figure 2-12: Residual activity of HbpA (panel A) and FDH (panel B) at different protein concentrations after 
contacting enzyme solution with an organic solvent (decanol) for 1 min in flow in 1 mm or 0.5 mm i.d. PTFE 
capillary. For 0.5 mm i.d. capillary the flow rate of aqueous and organic phase was 0.05 mL min-1 each, for 1 
mm i.d. capillary the flow rate of aqueous and organic phase was 0.2 mL min-1 each for a respective residence 
time of 1 min. Initial volumetric activities for HbpA were 2.8, 1.9, 0.9, 0.35, and 0.2 U mL-1 for 0.75, 0.5, 0.25, 
0.1, and 0.05 mg mL-1 respectively, while for FDH 2.3, 1.0, 0.5, and 0.2 U mL-1 for 2.5, 1.0, 0.5 and 0.2 mg mL-1 
respectively. Error bar represent standard deviation of two consecutive measurements. 
Effect of surfactant on enzyme residual activities in microreactors 
The effect of different surfactants on the HbpA residual activity was studied in microreactors. 
Diluted protein samples of HbpA (0.1 mg mL-1) containing Triton X-100 or Tween 20 were 
pumped through the microreactor in the presence of a second organic phase (decanol). 
Tween 20 and Triton X100 had a stabilising effect on HbpA. However Tween 20 proved to be 
more efficient than Triton X-100 and at 0.15 mg mL-1 allowed for 80% activity recovery in 
the narrow PTFE capillary (0.5 mm) whereas close to 100% HbpA activity was recovered at 
0.6 mg mL-1 (Figure 2-13). 
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Consequently, influence of 0.15 mg mL-1 Tween 20 on the reaction with HbpA and FDH was 
tested. More than 80–90% of FDH activity and 70–100% HbpA activity was recovered as 
compared to 30 to 50% activity recovery of FDH and HbpA when no surfactant was used 
(Figure 2-14).  
 
Figure 2-14: Residual activity of HbpA and FDH after biotransformation in PTFE capillary (5.3 m long, 0.5 mm 
i.d.). A - No surfactant. B - Aqueous phase supplemented with 0.15 mg mL-1 of Tween 20. Flow rate of aqueous 
and organic phase was equal to 0.05 mL min-1 each. Residence time reached was 8 to 9 min. Ratio of the 
volumetric activity of FDH to HbpA was equal to 1.5. Error bar represent standard deviation of at least two 
consecutive measurements HbpA and FDH specific activities were 3 and 1 U mg-1 respectively. 
Flow stability 
The flow stability in above presented experiments was dependent on the concentration of the 
protein and the surfactant in the aqueous phase. When no enzyme was added, despite apparent 
pulsation caused by the nature of the peristaltic pumps, the flow was stable and segments 
Figure 2-13: Effect of increasing concentration of 
Tween 20 on HbpA residual activity in flow in 0.5 and 
1.0 mm internal diameter PTFE capillary. HbpA 
concentration was 0.1 mg mL-1 and initial volumetric 
activities were 0.33 to 0.38 U mL-1. Error bar represent 
standard deviation of at least two consecutive 
measurements. 
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could be distinguished at the microreactor outlet. The same holds true for low protein 
concentration; here some precipitate was seen but the segmented flow was observed 
throughout. Increasing protein concentration destabilised the flow. It could be stabilised by 
adding Tween 20 (0.15 mg mL-1), but even with the surfactant that covered the interface, 
forcing the proteins to reside in the bulk of the liquid, at higher protein concentrations the 
nature of the flow changed yielding pear shaped segments and segments’ coalescence. The 
flow characteristic summary is given in Table 2-7. 
Table 2-7: Flow characteristic of the segmented two liquid phase flow in the microreactor (0.5 mm i.d.) with and 
without surfactant at different initial enzyme volumetric activities. Peristaltic pumps were employed for those 
experiments. Flow rate of aqueous and organic phase was equal to 0.05 mL min-1 each. Residence time reached 
was 8 to 9 min. FDH to HbpA unit ratio was equal to 1.5. 
Prot conca 
(mg mL-1) no surfactant 
Prot conca 
(mg mL-1) Tween 20 (0.15 mg mL
-1) 
0.4 
stable segmented 
flow with some 
precipitate 
0.4 very stable flow, equal segments, at the whole length of the tubing visible small bubbles like in a sparkling wine 
0.7 unstable flow 0.55 
stable flow, some segments merged at the beginning and 
carried load of precipitated protein, more bubbles than 
previously, transparent precipitate 
1.8 unstable flow 1.6 
pear shaped segments, segments can still be distinguished at 
the end of the tube, some long merged segments visible, 
precipitate present 
3.7 unstable flow 3.1 
flow unstable, lots of pear shaped segments, precipitate 
present but less than when no surfactant applied; flow more 
stable than for the same sample without the surfactant 
a sum of the concentration of HbpA and FDH protein sample. 
DISCUSSION 
HbpA and FDH have been successfully purified by means of single step expanded bed 
adsorption chromatography. Initially two E. coli hosts for the HbpA production were 
considered. E. coli JM109 and E. coli JM101 carrying plasmid pHBP461 were previously 
used and proved efficient for HbpA production.41a, 42, 101-102 Here, the choice was based on the 
protein synthesis on different carbon sources in M9 medium. Despite similar growth 
characteristic (Table 2-2), high HbpA titres were only observed in the JM101 strain (Figure 
2-3), which was eventually chosen as host organism. E. coli JM109 is recA1-, which 
minimises recombination of foreign DNA with that of a host, yielded only low protein levels 
and was disregarded later. 
Glucose catabolite repression was previously reported for hbpA expression under the control 
of the lac promoter,20 but fermentations were possible with an exponential glucose-limited 
feed and concomitant IPTG induction (Figure 2-5A). 
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Expanded bed adsorption chromatography was chosen for simple preparation of technical 
pure HbpA and FDH. According to literature this chromatography method allows for simple 
and cost efficient purification of an enzyme directly from crude cell extract.105, 108 Despite the 
fact, that EBA can be operated directly with crude cell extract, in this study crude cell extracts 
were centrifuged prior to loading. Thereby, the extent of the bed expansion was reduced and 
the following washing step was shortened. One centrifugation step at 15000 g was enough to 
keep the extent of the bed expansion below 5-10% when loading the sample at a constant flow 
rate of 200 cm h-1. Fractions containing enriched HbpA were of an overall purity of 
approximately 50% based on the specific activity and the SDS PAGE gel analysis. The purity 
reached is similar to reported values for HbpA.102 Although the purification protocol of FDH 
was optimised with respect to cell breakage and elution profile from the chromatography 
column, the purity and specific activity of the final protein preparation (1.3 U mg-1) are much 
lower than literature values reporting a specific activity of 5.5 U mg-1 of a pure protein.112a 
However, based on the SDS PAGE gel analysis (Figure 2-7), the FDH was 40-50% pure with 
an overall 4.5-fold purification (Table 2-4), which was sufficient for its later application. 
Pure proteins are often prone to fast inactivation. Addition of proteic feeders (e.g. pepsin or 
BSA) is a means to increase protein stability in special applications like CLEA preparation114 
or two-liquid phase biotransformations.63, 65 Natural impurities originating from the cell 
extract may fulfil a similar role, as long as they do not interact with the catalytic activity of 
the respective enzyme (e.g. by an excessive consumption of reducing equivalents), and may 
be regarded as ‘natural proteic feeders’, which prolong catalytic activity of a catalyst and 
prevent its denaturation. 
Throughout this chapter the protein preparations used for characterisation purposes originated 
from different fermentation batches, therefore discrepancies in their specific activities are 
present. Surprisingly HbpA stored in the 50% glycerol showed unexpected gradual specific 
activity increase. Initially the glycerol stock’s specific activity was 2.3 U mg-1 and increased 
over the two month to more than 3 U mg-1. This was also observed for subsequent HbpA 
glycerol stocks similarly. There was no precipitate present in the glycerol stocks and the 
activity increase resulted from higher volumetric activities assayed. No further study was 
however taken to explain this phenomenon. 
Characterisation of the enzymes revealed lower stability in the presence of organic solvent (n-
decanol) in microreactors where surface-to-volume ratios were higher than in conventional 
reactions. Addition of the surfactant Tween 20 stabilised the enzymes in the presence of the 
organic solvent and allowed to recover 100% of the respective enzymatic activity (depending 
on the concentration of the surfactant applied). 
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Next to the catalytic activity the operational stability is important. As shown in the Table 2-7 
the flow stability in a microreactor system was improved when surfactants were used; ordered 
flow patterns were observed and the amount of precipitate was reduced. The surfactant 
beneficial effect may be attributed here to the dynamic surface coverage of the interface by 
the surfactant’s molecules,66a, 67, 115 this phenomenon, with an emphasis on the interfacial 
effects, is discussed in more details in chapter 7. Surfactants are therefore useful for 
stabilising the flow by uniform interface coverage, thereby having a positive impact on the 
operational stability, as well as on the catalytic activity of the respective enzymes. 
At the same time surfactants lower the surface tension of the segments. In systems driven by 
peristaltic pumps, where the flow is subjected to pulsations, lower surface tension leads to 
segments’ coalescence. Especially two liquids forming consecutive segments having different 
viscosities (e.g. water and n-decanol) resulting in different translational velocities of segments 
in a microchannel are prone to this phenomenon. Coalescence is a rapid process facilitating 
mixing of two coalescing segments,92b it causes reorganization of the segment interface and 
enzyme denaturation because no protection is provided until the full surface coverage is 
renewed. 
CONCLUSIONS 
In this chapter efficient ways to produce biocatalysts have been presented. E. coli JM101 was 
chosen as host for enzyme production. HbpA and FDH were purified to technical purity by 
means of expanded bed adsorption chromatography and could be stored without activity loss 
in 50% glycerol. They showed excellent stability in single phase experiments. Their stability 
was however impaired when an organic solvent was used in a two liquid phase system. By 
using a surfactant, which covered the interface between organic and aqueous phase, enzyme 
denaturation was partially prevented. Different ways of biocatalyst stabilisation for 
application in a two liquid phase system are discussed in the next chapter.  
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ABSTRACT 
Two component cross-linked enzyme aggregates (Combi-CLEAs) consisting of 2-
hydroxybiphenyl 3-monooxygenase (HbpA) and formate dehydrogenase (FDH) were applied 
in a two-liquid phase system for the hydroxylation of 2-substituted phenols with concomitant 
cofactor regeneration. Replacing glutaraldehyde with dextran polyaldehyde as crosslinking 
agent lead to activity recoveries of up to 40% for single CLEA and 15% for Combi-CLEA 
preparations. Addition of the surfactant Tween 20 had a positive impact on CLEA stability 
and handling, and allowed for consecutive reaction cycles of the immobilised catalysts on the 
100 mL scale. 
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INTRODUCTION 
Immobilised enzymes are important catalysts for organic synthesis.116 Particularly their 
activity and stability in the presence of organic solvents are advantageous for preparative 
applications. Various stabilisation techniques for isolated proteins such as entrapment in 
matrices,72 covalent binding,117 and cross-linking69, 118 are available. The cross linking of 
enzymes is an immobilisation method, which has been introduced by Quiocho and Richards 
(1964).119 They reported using glutaraldehyde for carrier-free covalent cross-linking of 
enzyme crystals (CLECs) intended for diffraction studies. Sheldon and co-workers simplified 
the CLEC concept towards cross-linked enzyme aggregates (CLEAs).70 This method has ever 
since been widely used mainly for immobilisation of hydrolases.120 CLEAs were also 
successfully prepared from tyrosinase,121 laccases and peroxidases.122 However, 
monooxygenase CLEAs, to the best of our knowledge, have not been reported yet. The 
enzyme used in this study is 2-hydroxybiphenyl 3-monooxygenase (HbpA) (EC 1.14.13.44). 
It is a tetrameric enzyme that catalyses regioselective ortho-hydroxylation of 2-substituted 
phenols. This enzyme exhibits a broad substrate specificity41 and thus, is an interesting 
biocatalyst for the production of 3-substituted catechols. HbpA belongs to the group of FAD 
dependent flavin monooxygenases42-43 and requires NADH, molecular oxygen, and the 
respective substrate for catalytic activity. Therefore an efficient regeneration system like the 
well-known formate dehydrogenase (FDH) for the continuous supply of reducing equivalents 
123 is essential for effective in vitro applications of HbpA. In addition, substrate and product 
pairs for oxygenases most often display low water solubility, which may be facilitated by 
adding an organic solvent to the reaction mixture forming a two liquid phase system (2LP). 
2LP systems typically comprise a water immiscible organic solvent and an aqueous phase. 
Hydrophobic substrates dissolve in the organic phase and enter the aqueous phase via 
continuous diffusion, whereas the hydrophobic products are extracted into the organic phase 
(Figure 3-1A). The organic phase thus serves as a substrate reservoir and product sink and 
helps to overcome problems caused by reactant solubility limits and/or substrate/product 
inhibition.48 However, due to the ambivalent nature of proteins, they act as surface active 
compounds, adsorb to the phase boundary and denature.66a, 124 To extend enzyme stability and 
allow for repeated-batch or continuous operations of a given process, it is thus most often 
necessary to stabilise the biocatalyst. 
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Figure 3-1: A – 2 liquid-phase (2LP) biotransformation – organic phase serves as a substrate reservoir and 
product sink. B – Possible 2LP biotransformation setups with HbpA and FDH, with or without cofactor 
regeneration. Bar between the enzymes indicate crosslinking event. 
 
In this study HbpA:FDH Combi-CLEAs were evaluated for the ortho-hydroxylation of 2-
hydroxybiphenyl in a 2LP system. The performance of the CLEA based approach was 
compared to soluble enzyme. Respective data are presented and the suitability of the 
monooxygenase Combi-CLEAs for catalysis is discussed. 
MATERIALS AND METHODS 
Chemicals 
β-Nicotinamide adenine dinucleotide disodium salt, sodium formate and 2-hydroxybiphenyl 
have been obtained from Fluka (Buchs, Switzerland), β-Nicotinamide adenine dinucleotide 
reduced disodium salt, 1-decanol were from Applichem (Darmstadt, Germany), 2,3-
dihydroxybiphenyl were from Wako Pure Chemical Industries Ltd. (Osaka, Japan). All other 
chemicals have been bought at Fluka, Applichem or Sigma-Aldrich at the highest purity 
required. 
Enzyme production and purification 
The production and purification of HbpA and FDH was based on the procedures described in 
chapter 2. The enzymes were of technical purity (FDH 1.21 U mg-1 approx. 22% pure, HbpA 
1.37 U mg-1 approx. 40% with respect to the maximum reported velocity of a pure protein) 
and were used directly as 50% (v:v) glycerol stocks stored at -20ºC. Enzyme activity was 
measured using a standard spectrophotometer described in chapter 2. 
HbpA-CLEAs and HbpA:FDH Combi-CLEAs 
If not stated otherwise CLEAs were prepared accordingly: 125 µL of protein solution (either 
HbpA for CLEAs of HbpA or an enzyme mixture of HbpA and FDH for Combi-CLEAs) was 
mixed with 250 µL or 839 µL of 50% (w/v) (NH4)2SO4 solution to a final saturation of 61% 
or 80% at RT respectively (100% saturation equals 54.12% (w/v) (NH4)2SO4107). The solution 
with cofactor regeneration
FDH
HbpA
A B
aqueous
organic HbpA:FDH
combi CLEA-
NAD+
NAD+
HbpA CLEA
soluble FDH
NAD+
NAD+
HbpA CLEA
with NADH
NADH
NADH
soluble HbpA
soluble FDH
NAD+
NAD+
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was mixed on a thermoshaker (30 min, 600 rpm, RT) and subsequently supplemented with 
DPA (0.2 M) to a final cross-linker concentration in the range of 12 to 50 mM. The mixture 
was stirred at RT for 3h at 600 rpm. Subsequently 100 mM solution of sodium 
cyanoborohydride was added to a final concentration of 10 mM and stirred again at RT for 30 
min at 900 rpm. Then an equal volume of water was added and the preparation was stirred 
again at RT for another 30 min at 900 rpm. CLEAs were eventually collected by 
centrifugation (10 min, 16200 g, RT), the resulting precipitate was washed thrice with 800 µL 
of 50 mM potassium phosphate buffer (KPi) (pH 7.5) (vortexed and centrifuged (10 min, 
16200 g, RT) between every washing step). CLEAs were finally resuspended in 500 µL of 
buffer and kept at 4°C for further use. The procedure is summarised in the Table 3-1. If not 
stated otherwise Combi-CLEAs mentioned in the text refer to the HbpA:FDH Combi-CLEA 
prepared as described below. 
Table 3-1: Summary of CLEA preparation conditions. 
 HbpA:FDH Combi-CLEA HbpA-CLEA 
HbpA 62.5 µL glycerol solution
a  
(3.8±0.3U, 2.7±0.1 mg) 
125 µL glycerol solutiona  
(7.5±0.5U, 5.5±0.2 mg) 
FDH 62.5 µL glycerol stock
b  
(3.9±0.2U, 3.3±0.2 mg) - 
(NH4)2SO4 
(50% w/v) 839 µL (for 80% saturation) 250 µL (for 61% saturation) 
DPA (0.2M)c 41.8 µL (8.4 mM) 41.8 µL (20 mM) 
NaCNBH3 
(100mM) 235 µL (for 19 mM) 47 µL (for 10 mM) 
H2O 800 µL 470 µL (1:1 ratio) 
Temperature 23°C 23°C 
a HbpA glycerol stock solution of 164.1±11 U mL-1, 119.4±4 mgprot mL-1, specific activity 1.37 U mg-1prot,  
diluted to 60.4 U mL-1 prior to use. 
b FDH glycerol stock solution of 63.1±2.5 U mL-1, 52.1±2.7 mgprot mL-1, specific activity 1.21 U mg-1prot 
c Combi-CLEAs have been prepared using an enzyme:cross-linker ratio of 1:2050, while for HbpA-CLEAs a 
ratio of 1:1010, because the ratio was based on the amount of HbpA only. 
 
Residual CLEA activity 
Residual CLEA activity was given as the ratio of the total activity of the CLEA to the activity 
of the respective soluble enzyme used for its preparation expressed in percents. Activity was 
measured as described above. Specific activities are based on the concentration of the soluble 
enzyme under the assumption that all proteins precipitate during CLEA preparation.  
Determination of the apparent Km values 
0.083 U mL-1 HbpA (0.06 mgprot), 0.083 U mL-1 FDH (0.07 mgprot) - for soluble enzymes 
reaction, or 70 µL of Combi-CLEA solution (prepared from 0.53 U mL-1 HbpA (0.38 mgprot) 
and 0.53 U mL-1 FDH (0.44 mgprot)) - for HbpA:FDH Combi-CLEA reaction, were mixed 
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with 50 µL of 200 mM sodium formate, 50 µL of 1 mM NAD+, 5 µL of 8 µM FAD in a small 
reaction cup and filled with 50 mM KPi up to 500 µL. Above prepared mixtures were 
combined with 500 µL of decanol containing varying concentrations of 2-hydroxybiphenyl 
(1-150 mM). Substrate concentration in the aqueous phase was calculated on the base of the 
partition ratio KD for 2-hydroxybiphenyl between organic and aqueous phase of 480. Reaction 
was conducted on the Eppendorf thermo mixer comfort (Eppendorf, Hamburg, Germany) at 
30°C and 1400 rpm for 1 h. For sampling (15, 30, 60 min), agitation was paused and samples 
were left to settle for 2 min for phase separation. After 15 µL of the upper organic phase were 
removed, agitation was resumed, withdrawn samples were immediately centrifuged (1min, 
16200 g, RT) and 10 µL of organic phase was transferred to 990 µL acetonitrile 
(supplemented with 0.1% v/v TFA) solution for RP-HPLC analysis. Initial reaction rates were 
plotted against the initial substrate concentration in the aqueous phase. Apparent Km values 
were calculated by using a Michaelis-Menten fitting function of the Origin 8.6 software 
(OriginLab Corporation, Northampton, MA, USA). 
Synthesis of dextran polyaldehyde (DPA) 
In this work dextran polyaldehyde was synthesised in-house according to the protocol given 
in.125 Shortly, 1.65 g of dextran (mean molecular mass 100-200 kDa) was dissolved in 50 mL 
of Seralpur Pro 90 CN water (Seral Druck, Ransbach-Baumbach, Germany) followed by 3.85 
g of sodium periodate. This mixture was stirred at RT for 90 min. Subsequently it was 
dialyzed 4 times against (>2h each time) 5 L of Seralpur water using a 12.2 kDa cut-off 
dialysis sleeve. The liquid was transferred to a glass vial and kept at 4°C. 
Standardisation of DPA 
The degree of substitution of formyl groups in DPA was determined according to the method 
described in.126 Shortly, 0.25 M hydroxylamine solution (pH 4) was prepared by dissolving 
3.5 g of dried reagent and 0.6 mL of methyl orange (0.1% solution) in a final volume of 200 
mL Seralpur water. 
Three DPA samples (approx. 100 mg, exactly 3 mL) were dried to a constant mass in a 
freeze-dryer. 25 mL of hydroxylamine solution was added to every dried DPA sample and for 
4 h at RT to dissolve. The pH dropped from 4 to 1.6, indicated by a colour change from 
orange to pink. Samples were later titrated with 0.096 M NaOH solution. The end of titration 
was indicated by the colour change matching that of a blank (i.e. hydroxylamine solution with 
no DPA added), pH values with respect to the volume of added base were recorded. The 
volume of NaOH solution needed to neutralise all HCl liberated in the reaction of aldehyde 
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with hydroxylamine could be calculated from the point of inflection of the respective titration 
curves (Figure 3-2B). Aldehyde substitution was calculated according to the Equation 3-1.127 
Equation 3-1: Calculation of the molarity of the DPA solution 
ݒ݋݈	݅݊	݉ܮே௔ைு	 ൈ 	 ேܰ௔ைு 	ൈ 10ିଷ	݉݋݈ ൈ 10
ଷ
ݒ݋݈	݅݊	݉ܮ	஽௉஺	௦௢௟௨௧௜௢௡ ൌ
݉݋݈	݋݂	݈݄ܽ݀݁ݕ݀݁
1	݈݅ݐݎ݁஽௉஺	௦௢௟௨௧௜௢௡	 
HbpA activity determined by product formation – RP-HPLC analysis 
Monitoring of the HbpA catalysed biotransformation reaction was achieved by determining 
the concentration of the product 2,3-dihydroxybiphenyl. Measurements were done using a 
Shimadzu UFLC system equipped with a UV-Vis SPD-M20A detector or Hitachi Elite 
LaChrom HPLC system (Merck Hitachi, Darmstadt, Germany) equipped with a Hitachi Elite 
LaChrom L-2450 Diode Array Detector. All measurements were performed either on an 
XTerra RP 18 3.5 µM column (Waters, Dublin, Ireland) or on a CC Nucleosil 100-5 C18 HD 
column (Macherey Nagel, Düren, Germany). An isocratic method at a total flow rate of 1 
mL min-1 50:50 (% v/v) ACN-water (both supplemented with 0.1% TFA) was used for 
elution. The product 2,3-dihydroxybiphenyl as well as the substrate 2-hydroxybiphenyl were 
detected at 2.69 and 3.19 min retention time respectively on an XTerra RP column and 4.89 
and 7.39 min retention time respectively on the CC Nucleosil column. Results were analysed 
using the LC Solution software. Concentrations of 2,3-dihydroxybiphenyl were calculated as 
a peak area ratio of 2-hydroxybiphenyl to 2,3-dihydroxybiphenyl. 
Protein determination 
Protein concentrations were determined with the Quick Start Bradford Protein Assay (Bio-
Rad, Munich, Germany), using BSA as a protein standard. Protein concentration measured in 
the range of 0 to 1 mg mL-1 in a 1 mL assay format. 
Two phase biotransformation at a 2 ml scale 
Biotransformations were conducted in a 2LP system (Figure 3-1A). Unless stated otherwise 
standard reaction conditions were as follows: 5 µL of 0.8 mM FAD, 50 µL of 2 M sodium 
formate and either soluble enzyme, single CLEA or Combi-CLEAs (respective amounts are 
specified in the experiments) were topped to 475 µL with KPi buffer and mixed with 500 µL 
of 2-hydroxybiphenyl solution (5-50 mM) in decanol in a 2 mL reaction cup. The reaction 
was started by adding 25 µL of 10 mM NAD+. The tubes were thermostated at 30°C in an 
Eppendorf thermo mixer comfort (Eppendorf, Hamburg, Germany) with a constant agitation 
of 1400 rpm. For sampling, agitation was paused and samples were left to settle for 2 min for 
phase separation. After 15 µL of the upper organic phase were removed, agitation was 
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resumed, withdrawn samples were immediately centrifuged (1 min, 16200 g, RT) to allow 
phase separation and 10 µL of organic samples were transferred to 990 µL acetonitrile 
(supplemented with 0.1% v/v TFA) solution for RP-HPLC analysis. 
Two phase biotransformation at a 200 ml scale  
To validate the performance of CLEAs on a bigger scale they were tested in 200 mL 2LP 
biotransformations. Reactions were conducted in a RALF stirred tank bioreactor with a 
working volume of 300 mL (Bioengineering AG, Wald, Switzerland) where pH, temperature, 
aeration and stirring speed were controlled. Initial composition of the aqueous phase was as 
follows: 200 mM formate, 8 µM FAD and 1 mM NAD+ have been added to initiate the 
reaction; organic phase was a 20 mM decanolic solution of 2-hydroxybiphenyl. The reaction 
mixture was supplemented with Tween 20 to a final concentration of 0.2 mg mL-1, phase ratio 
1:1. Initially 10.6 U (7.7 mg) of soluble HbpA and 10.9 U of soluble FDH and an equivalent 
of HbpA (49.2 mg) and FDH for CLEA reaction were used. For analysis, an emulsion sample 
of 300 µL was withdrawn without interrupting the mixing. The sample was immediately 
centrifuged (1 min, 16200 g, RT) to allow phase separation and 10 µL of the organic sample 
was mixed with 990 µL acetonitrile containing 0.1% TFA and analysed on the HPLC. 
SDS-PAGE analysis 
SDS-PAGE samples were prepared by mixing respective protein samples with an equal 
volume of loading buffer. Samples were vortexed and kept on a thermoshaker at 95°C and 
600 rpm for 7 min. 10 µL of the sample are eventually loaded on to a 12% SDS PAGE 
acrylamide gel prepared and operated according to the standard procedure given in.128 
RESULTS 
Optimising CLEA preparation 
To prepare an active CLEA catalyst one has to find optimal precipitation as well as 
crosslinking conditions. Ammonium sulphate was chosen as a precipitant (Figure 3-2A). DPA 
was applied as a crosslinker. A molar ratio of 1:2050 enzyme to crosslinker was chosen as a 
compromise between decreasing residual activity and increasing leaching stability122a, 129 
(Figure 3-3AB). Extending the crosslinking time did not have any effect on CLEAs’ 
performance (Figure 3-3C). Unless stated otherwise HbpA:FDH Combi-CLEAs with a 1:1 
HbpA to FDH activity unit ratio were used throughout the studies. 
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Figure 3-2: A - Precipitation curves for HbpA and FDH. Residual activities in the pellet and the supernatant were 
determined using the standard spectrophotometric assay described in the method section. 1.0 refers to an activity 
of 8.2 U mL-1 in the case of HbpA and 3.2 U mL-1 for FDH, respectively. After precipitation, supernatant and 
pellet were separated; the pellet was resuspended in KPi buffer (50 mM, pH 7.5) and the residual HbpA and 
FDH activity was measured in both fractions. B - Titration curves for determination of aldehyde substitution in 
oxidised dextran polyaldehyde. Masses of the samples taken for investigation are indicated on the graph. 
Maxima of first derivatives plotted indicate the point of inflection of the titration curves (6.2, 6.3 and 6.5 
respectively) – this point was also determined by the methyl orange colour shift from pink to yellow as 
compared to blank sample. 
 
Figure 3-3: Influence of preparation conditions on CLEA activity and leaching. A – Influence of the molar ratio 
of dextran polyaldehyde (DPA) to HbpA on Combi-CLEA activity. Total cross-linking time 3 h. B– Leaching of 
the catalyst during consecutive preparation steps as a percentage of the total activity present in Combi-CLEA 
(80% precipitant saturation level, 1:2050 HbpA to crosslinker ratio). ‘Supernatant’ refers to supernatant collected 
after crosslinking and reduction with NaCNBH3. ‘1st wash’ and ‘2nd wash’ are consecutive washes; for washing 
sample was resuspended in potassium phosphate buffer, left at RT for 10 min and spun down; supernatant was 
collected and activity determined in a 2LP biotransformation. C - Influence of the cross-linking time and DPA to 
HbpA molar ratio on the Combi-CLEA activity recovery. 
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SEM micrographs and CLEA pictures 
SEM micrographs of Combi-CLEAs presented in Figure 3-4A and C show rather uniform 
particle size distribution (130 to 220 nm in diameter) regardless of the type of the crosslinker 
used. Only a slight variation of the particle size was observed in case of 12 mM DPA. In this 
case the single aggregate particle sizes varied from 80 to 250 nm in diameter, which 
represents the overall size distribution of all CLEAs prepared in this study. However, one has 
to keep in mind, that prior to image acquisition the samples had to be freeze-dried, which 
might alter the structure of the aggregates and thus the SEM images might not truly reflect the 
CLEAs arrangement in the aqueous environment which can be seen on Figure 3-5. 
 
 
Figure 3-4: SEM images illustrating Combi-CLEAs. A – 50 mM glutaraldehyde used as a crosslinker; B – 12.5 
mM DPA used as crosslinker; C – 20 mM DPA used as a crosslinker. D – Image C at a 4 fold lower 
magnification. Precipitant saturation level 61%. The molecular weight of HbpA tetramer is 256 kDa. According 
to Erickson (2009)130, assuming that the protein is a perfect sphere, the radius and the volume of that protein will 
be 4.2 nm and 310 nm3 respectively. Meaning that, for example, a 169 nm diameter CLEA-sphere presented in C 
could contain approx. 8000 HbpA tetramers according to the relation (rCLEA-sphere/rHbpA)3. 
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Figure 3-6: A – Combi-CLEA pellet after 3rd wash and final centrifugation; B – Combi-CLEA resuspended and 
homogenized in 500 µL KPi buffer (50 mM, pH 7.5) 
 
Activity of CLEAs and Km values 
Combi-CLEAs were investigated and compared to the soluble enzyme under otherwise 
identical conditions. As shown in Table 3-2 the specific activity of Combi-CLEAs accounted 
for almost 15% of the soluble enzyme and increased to 40% in the presence of 10 mM 
NADH. Combi-CLEAs were equally active as HbpA CLEAs supplemented with soluble 
FDH. Lower activities with soluble FDH in comparison to externally supplemented NADH 
could be explained by diffusion limitation which in the presence of stoichiometric amounts of 
NADH was less pronounced. Additionally the apparent Km values of the Combi-CLEAs and 
soluble enzymes were calculated to be 5.2 and 4.2 µM for soluble enzymes and Combi-
CLEAs respectively. 
 
 
Figure 3-5: Light microscope images of 
Combi-CLEAs right after reduction step. 
The sizes of particles vary from sub 
micrometre range to hundreds micrometres. 
Precipitant saturation level 80%, HbpA to 
crosslinker molar ratio 1:2050. 
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Table 3-2: Characterisation of CLEAs in 2LP biotransformation. 
Sample average initial rate
b 
[µmol min-1] 
spec activity 
[U mgprot-1] 
+/- 
CLEAa + 10 mM NADH 0.042 0.110 0.008 
CLEAa + soluble FDH (0.55 U) 0.018 0.046 0.009 
Combi-CLEA 0.016 0.041 0.001 
Soluble HbpA and soluble FDH 0.108 0.280 0.009 
a CLEA prepared with only HbpA 
b rate calculated for 1 mL reaction volume with a phase ratio of 1:1. 
In the case of a successful recycling of CLEAs 15% activity might still be acceptable from the 
practical point of view. Therefore the recyclability of the CLEAs was further evaluated. 
 
Stability and reusability of Combi-CLEAs 
During 2LP biotransformations Combi-CLEAs tend to accumulate at the phase boundary 
making recycling very difficult. Tween 20 proved to be an efficient agent preventing enzyme 
accumulation at the interface, therefore all subsequent experiments were performed in the 
presence of 0.2 mg mL-1 Tween 20. 
 
 
Figure 3-8: Image of Combi-CLEAs after a standard 2LP 
biotransformation without (panel A) and with (panel B) 
Tween 20. A fine precipitate is visible in A while sample B 
shows a clear phase boundary. 
 
Figure 3-7: Determination of the apparent Km value. 
Initial reaction rates with different substrate 
concentrations for soluble enzymes and for Combi-
CLEAs. Reaction conditions are described in the 
material and method section. 
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Repeated batch 2LP system biotransformation on a 200 mL scale 
To compare productivities and the stability of Combi-CLEAs over several batches with that 
of the soluble enzymes, a biotransformation was conducted with an increased amount of 
Combi-CLEAs (Figure 3-9). The initial specific activities of Combi-CLEAs and soluble 
enzymes measured previously in the 2 mL reaction tubes were 0.04 U mgprot-1 and 0.28 
U mgprot-1 respectively. Therefore 7 times more Combi-CLEAs than soluble enzyme have 
been used to match the initial reaction rates of both setups.  
The space time yield reached in the first batch with soluble enzymes and Combi-CLEAs was 
0.24 g L-1 h-1 and 0.13 g L-1 h-1 respectively, matching up with previously published values 
for the soluble enzymes.21 On a long term basis Combi-CLEAs showed higher stability than 
the soluble enzyme. Already during the 2nd cycle, Combi-CLEAs performed significantly 
better, than the soluble counterparts. Overall the product titres achieved with soluble enzyme 
and with CLEAs are comparable reaching 2.5 and 2.7 mmol of 2,3-dihydroxybiphenyl 
respectively after three consecutive cycles. Despite being applicable in a 2LP system 
HbpA:FDH Combi-CLEAs do not supersede soluble enzymes without additional mechanical 
reinforcement. However it was possible to stabilise and preserve HbpA:FDH Combi-CLEA 
activity up to 90 hours. 
 
Figure 3-9: A – Comparison of Combi-CLEAs and soluble HbpA/FDH performance for the conversion of 2-
hydroxybiphenyl (20 mM in decanol) in a repeated batch experiment at a 200 mL scale in a bioreactor in the 
presence of 0.2 mg mL-1 Tween 20. Arrows 1 and 2 indicate the start of a new batch by changing the organic 
phase. At the beginning of each new batch the aqueous phase was supplemented with 0.5 mM of NAD+ and 0.2 
mg mL-1 of Tween 20. The 3rd batch was additionally supplied with 100 mM of formate. B – Product formation 
rates for the consecutive batches reveal a stabilising effect of CLEAs with respect to the soluble enzymes. 
Values are calculated for the total volume of aqueous and organic phase of 200 mL with a 1:1 phase ratio. 
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DISCUSSION 
The main motivation for the preparation of CLEAs is the application of these immobilised 
enzymes in organic solvents.121a, 131 However, a detailed characterisation of such application 
and the associated problems is, to the best of our knowledge, not existing so far. Still most of 
the work in this field is done on hydrolases which are comparably simple enzymes,132 and 
often function in nearly anhydrous organic solvents without any stabilisation.50 
FDH and HbpA are multimeric enzymes.42, 133 As reported previously poly-functional cross-
linking molecules like dextran polyaldehyde stabilise multimeric enzymes covalently attached 
to a modified solid supports like Sepabeads or Toyopearl.134 Wilson and co-workers reported 
that preparing CLEAs of multimeric enzymes instead of immobilizing them on solid supports 
before cross-linking, is more suited for quaternary structure stabilisation.135 
Recently obtained crystal structure of the HbpA in its apo form (no FAD bound) and with 
bound FAD suggests that both structures differ by the presence of mobile domain that moves 
to accommodate the FAD. Cross-linking of HbpA might therefore impose the presence of one 
form (e.g. apo) over another leading to enzyme being catalytically inactive. The analysis of 
the structure revealed also the presence of the lysine side chains in the vicinity of the active 
site suggesting that crosslinking event might impair substrate/product diffusion (Figure 3-10). 
To achieve the same initial reaction rates seven times more Combi-CLEAs than soluble 
enzyme – with respect to the enzyme used for Combi-CLEA preparation - was used. Despite 
that, at 200 mL scale biotransformation, HbpA:FDH Combi-CLEAs continuously lost activity 
under process conditions, although much slower than the soluble enzyme (Figure 3-9) 
revealing a stabilising effect of the applied preparation method. However, recycling of the 
CLEAs was initially challenging because CLEAs were accumulating in the interface between 
aqueous and organic phase. Similar observations have been reported for multimeric nitrile-
hydratase CLEAs136 in which case CLEA activity was rather low as compared to the soluble 
counterparts and the CLEAs were difficult to handle during recycling. Other examples report 
rather high residual activities e.g. for laccase or tyrosinase CLEAs, which also showed 
increased stability in methanol, acetone and tert-butanol.121a, 137 But in these examples, either 
the CLEAs have only been incubated in the solvents, while the reaction was monitored in an 
aqueous system, or the reaction environment comprised hydrophilic organic solvent with a 
very low water content without an organic-aqueous phase boundary70, 120 making a direct 
comparison of the various approaches difficult. 
Combi-CLEAs have also been prepared from peroxidase and glucose oxidase,131 but also in 
this case overall enzyme performance could not compete with the soluble counterparts. Hyper 
activation of CLEAs prepared of carboxylic acid esterases have also been reported,138 authors 
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explained it by the presence of favourable conformational changes that resulted from the 
aggregated state, but also here the respective CLEAs completely lost activity after the second 
catalytic cycle. 
Addition of Tween 20 had a severe impact on our reaction system. Interestingly, it seemed to 
stabilise the product 2,3-dihydroxybiphenyl, which usually turned yellowish probably due to 
oxidation and/or polymerisation, while in the presence of Tween 20 the organic phase 
remained colourless and transparent. It was also beneficial for stabilising both, soluble and 
immobilised enzymes, minimising the amount of CLEAs sticking to the phase boundary and 
facilitating their recycling. The latter is the key advantage of using the CLEAs, however, 
although the soluble enzyme could not be properly recycled (only the organic phase was 
exchanged between the different batches (Figure 3-9)) it was still possible to synthesise the 
same amount of product by both approaches, but the Total Turnover Number (TTN) for the 
soluble enzyme was nearly 6-fold higher as the TTN for Combi-CLEAs (Table 3-3). 
Table 3-3: Total Turnover Numbers for soluble and Combi-CLEA enzyme in the 200 mL repeated batch 
biotransformation. 
total 
prot 
[mg] 
HbpA 
amount 
[µmol]a 
total 
product 
[µmol] 
TN (µmolprod sek-1 µmolenz-1) TTN 
(µmolprod µmolenz-1) 
 
1st 
batch 
2nd 
batch 
3rd 
batch 
soluble 
enzymes 7.7 0.084 2497 
0.602 
(6h) 
(100%) 
0.115 
(11h) 
(19%) 
0.02 
(24h) 
(3.3%) 
29649 
Combi-
CLEA 49.2 0.53 2777 
0.036 
(10h) 
(100%) 
0.032  
(3h) 
(90%) 
0.008 
(24h) 
(22%) 
5160 
a HbpA content in enzyme mixture was calculated on the base of percentage peak area at 210 nm after gel 
filtration chromatography. SDS PAGE gel confirmed the calculated purity of approx. 70% of total protein. The 
given value represents molar amount of the monomer of HbpA. 
 
Despite lower turnover numbers (TN) the apparent Km values for 2-hydroxybiphenyl 
measured in a 2 mL 2LP system and calculated for both, soluble enzymes and Combi-CLEAs, 
were similar (5.2 and 4.2 µM respectively) and very promising. 
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Figure 3-10: A and B - Apo structure of the HbpA tetramer with lysine residues in dark colour. C – apo (blue) 
and FAD bound form (yellow) superimposed. Lysine residues are in red, FAD in green, His48 in white. 
(copyrights Bartłomiej Tomaszewski) 
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The extent of stabilisation of the enzymes in Combi-CLEA preparations was not sufficient to 
allow for more multiple repeated batches in STR (200 mL). Even though the mixing applied 
was not excessive (400 rpm) and adjusted only to allow for emulsion formation in the whole 
reaction volume, CLEAs disintegrated and when they were eventually recovered after the 3rd 
batch formed a yellowish ‘film’ that did not resemble the initial material used (fine white 
particles). Due to the activity loss and low reaction rates better stabilisation that will preserve 
the structure integrity and CLEAs mechanical properties is necessary. As reported previously 
for tyrosinase CLEAs a simple entrapment of the immobilised enzyme in a calcium alginate 
gel extended its stability to ten cycles without activity loss, whereas only 5 cycles were 
possible without entrapment.121b Similar observations have been published for penicillin G 
acylase CLEAs, which have been encapsulated in a rigid polymeric matrix composed mainly 
of polyvinyl alcohol (LentiKats).139 However, additional coating of the CLEAs will again 
have a negative impact on mass transfer rates of substrates and products and have to be 
carefully evaluated for the specific reactions. One could also think about using an alternative 
reactor system that does not produce high shear forces in order to extend the mechanical 
stability of the CLEAs. 
As shown in Table 3-4 Combi-CLEAs preserved nearly 15% of the initial enzymatic specific 
activity. When CLEAs were prepared solely with HbpA, the residual enzyme activity was 
close to 40% in the presence of stoichiometric amounts of NADH, which is significantly 
higher than the activity recovery for commercially available Candida antarctica lipase B 
(CALB) or Thermomyces lanuginosus lipase (TLL) CLEAs (both in the range of 1%). 
Table 3-4: Comparison of activity recoveries between commercially available CLEAs and HbpA:FDH Combi- 
CLEAs. 
 
Candida antarctica B 
lipasea 
U mgprot-1 
Thermomyces lanuginosa 
lipasea 
U mgprot-1 
HbpA-FDHc 
U mgprot-1 
Max. spec. activity 
(pure or technical 
purity enzyme) 
535 U mg-1 2 780 U mg-1 0.28 U mg-1  
CLEA or Combi-
CLEA 10 U mg
-1 b 50 U mg-1 b 0.041 U mg-1 
Activity recovery % 1.8 1.8 14.6 
a Substrate tributyrin, 25°C, pH 7.0, gum arabicum stabilised emulsion.140 
b Tributyrin 5 vol% in 40 mM Tris buffer, pH 7.5, 25°C, CLEA Technologies, (CLEA-ST) 
(www.cleatechnologies.com 2012). 
c Determined in 2 mL scale reaction tubes in 2LP biotransformation with 20 mM substrate in decanol as 
presented in Table 3-2. 
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CONCLUSIONS 
Initial low activity recoveries of HbpA:FDH Combi-CLEAs were improved by increasing 
precipitant concentrations and handling issues were addressed by Tween 20 supplementation. 
Although CLEAs are reported as easy to prepare and broadly applicable,118 the technique is 
also considered not to be suitable for all the enzymes.141 Without additional modification e.g. 
gel entrapment or encapsulation CLEAs’ mechanical properties are not yet good enough for 
application in STR in industrial scale biotransformation.142 However, findings presented in 
this study show that CLEAs are not restricted to intrinsically stable enzymes like lipases but 
may also be applied to much more complex enzymatic systems. This work presents a 
promising basis for further development of this cheap and simple immobilisation method. 
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ABSTRACT 
Hydrophobic formic acid esters have been established as alternative co-substrates for the 
formate dehydrogenase (FDH)-catalysed regeneration of reduced nicotinamides. With this 
approach challenges related to the ionic nature of the commonly used formate salts, 
particularly their exclusive water-solubility, can be overcome. Octyl formate was 
demonstrated to serve as organic phase solubilising hydrophobic reagents as well as serving 
as a source of reducing equivalents to enable FDH-catalysed regeneration of NADH. This 
system was used to drive a monooxygenase-catalysed hydroxylation reaction. Phase transfer 
limitations appear to be the overall rate-limitation of the biphasic reaction system. 
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INTRODUCTION 
Formate dehydrogenase (FDH, E.C. 1.2.1.2) is certainly one of the most widely applied 
cofactor regeneration systems12, 26, 143 used to promote NADH-dependent reductions,144 and 
oxidations.21, 63, 102, 145 Especially the quasi-irreversibility of the formate-driven NAD+ 
reduction reaction (yielding volatile CO2 as by-product) makes it an attractive cofactor 
regeneration system. 
One drawback of the FDH regeneration system is its dependence on highly polar formic acid 
and/or formates as sacrificial electron donors to drive the regeneration reaction. As a result, 
classical FDH-based reaction systems are limited to mainly aqueous media. Considering that 
the majority of the (industrially) relevant substrate/product couples are rather hydrophobic, 
purely aqueous reaction systems suffer from poor substrate loadings and inherently poor 
STYs. One possible solution to this dilemma is the use of aqueous/organic two-liquid phase 
systems (2LPs) wherein the bulk of reagents is dissolved in the water-immiscible organic 
phase and partitions into the, biocatalyst-containing, aqueous phase for transformation 
according to their partition ratio.21, 63, 102, 146 However, large volumetric ratios of organic phase 
to aqueous phase (which are desirable envisaging high volumetric productivities) will 
necessitate very high formate concentrations in the aqueous layer to attain stoichiometric 
amounts of the sacrificial reductant. The resulting high ionic strength in the aqueous phase 
can pose a significant challenge to activity and stability of the dissolved biocatalysts.  
Inspired by a recent contribution by Frohlich et al.31 who reported FDH-activity on formate 
esters, we hypothesized that hydrophobic formic acid esters may serve as sacrificial electron 
donors to promote NADH-dependent reactions in 2LPs. Hence, hydrophobised formates can 
be furnished in the apolar organic phase in equimolar concentrations without impairing the 
biocatalyst(s) due to high ionic strengths in the aqueous layer. Ideally, the formic acid esters 
themselves form the organic phase thereby further reducing the solvent ballast. Provided the 
alcohol part of the formic acid ester is a hydrophobic alcohol its accumulation in the organic 
phase in the course of the reaction should not alter the (hydrophobic) properties of the organic 
phase too much.  
To test our hypothesis we chose 2-hydroxybiphenyl 3-monooxygenase (HbpA, E.C. 
1.14.13.44) as a model enzyme.20-21, 32, 41a, 42, 102 As organic phase we chose octyl formate 
since both the ester and 1-octanol are sufficiently hydrophobic to serve as second, water-
immiscible phase. Overall, a biphasic reaction setup as shown in Figure 4-1 was envisaged. 
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Figure 4-1: The ‘hydrophobised formates concept’ to promote a NADH-dependent oxyfunctionalisation reaction. 
Formic acid esters, such as octyl formate, form the organic phase also serving as substrate reservoir and product 
sink. Formate dehydrogenase (FDH) mediates the oxidative hydrolysis of the formic acid esters into CO2 and 
alcohol while regenerating NADH.31 The latter is consumed in the course of the HbpA (2-hydroxybiphenyl 3-
monooxygenase)-catalysed hydroxylation of 2-hydroxybiphenyl.  
 
MATERIALS AND METHODS 
Cultivation of biomass and enzyme purification 
hbpA (encoding 2-hydroxybiphenyl 3-monooxygenase, HbpA) was expressed in E. coli 
JM101 carrying the plasmid pHBP461 as previously described,101 and purified using 
established methods.21, 102 fdh (encoding formate dehydrogenase, FDH) was expressed in E. 
coli JM101 carrying the plasmid pBTac2 (C23S) following a published procedure.112a  
UV spectrophotometric activity measurements 
The activities of both HbpA and FDH were determined using a spectrophotometric assay 
following the depletion (HbpA) or formation (FDH) of the characteristic UV-absorption band 
of NADH at 340 nm (ε = 6220 M-1 cm-1). The experiments were performed using 1.5 mL 
disposable UV cuvettes (polystyrene) at 30°C on a Shimadzu UV-2401 PC spectrophotometer 
with a Julabo F12 refrigerated/heating circulator. All experiments were performed at 30oC. 
The following buffers and stock solutions were used: buffer (50 mM KPi pH 7.5), NADH (25 
mM in buffer), NAD+ (10 mM in buffer), HbpA (3.98 mg mL-1 in buffer), FDH 
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(1.74 mg mL-1 in buffer), NaHCO2 (2 M in buffer, pH adjusted to 7.5), 2-hydroxybiphenyl 
(25 mM in methanol), FAD (0.2 mM in buffer). 
HbpA assay: HbpA was diluted in buffer to a final concentration of 0.04 mg mL-1 and 
supplemented with FAD (0.002 mM final). The assay was started by addition of NADH 
(0.3 mM final) to determine the non-substrate related NADH oxidation rate (background 
activity). After one minute, 2-hydroxybiphenyl (0.2 mM final) was added to determine the 
total NADH oxidation rate. The specific 2-hydroxybiphenyl hydroxylation activity of the 
HbpA preparation (1.66 U mg-1) was obtained by subtracting the background activity from the 
total activity.  
FDH-assay: FDH was diluted in buffer to a final concentration of 0.017 mg mL-1 and 
supplemented with NAD+ (1 mM final) and NaHCO2 (100 mM final). The specific NAD+ 
reduction activity of the FDH-preparation used was 1.06 U mg-1. A spectroscopic 
determination of the FDH activity towards octyl formate proved to be very difficult due to its 
poor solubility in aqueous media (diffusion limitation and/or formation of optically not 
transparent emulsions upon mixing) and the slow hydrolysis of octyl formate leading to the 
formation of aqueous formic acid. 
Stability measurements 
The stabilities of HbpA and FDH under reaction conditions were determined by incubating 
5.4 U mL-1 of each enzyme at 30oC for 30 hours in a 2 mL reaction tube containing a biphasic 
mixture (phase ratio 9:1 organic to aqueous) consisting of 100 µL of KPi buffer (50 mM, pH 
7.5) and 900 µL of octyl formate, in the absence or presence of Tween 20 (0.2 mg mL-1). 
Tween 20 was chosen as surfactant to facilitate the formation of stable emulsions with 
minimal shear force.146c At intervals, 10 µL samples of the aqueous phase were withdrawn 
and analysed using the photometric assay described above.  
Coupling of FDH catalysed NADH regeneration to the HbpA reaction. 
Unless mentioned otherwise, the coupled reaction of FDH and HbpA was performed in 2 mL 
tubes at 30°C and mixed at 1200 rpm. The reaction mixtures consisted of a biphasic mixture 
of KPi buffer and octyl formate with the ratio 1:9 (v/v). The organic phase contained 
2-hydroxybiphenyl in a concentration range of 10-500 mM and the aqueous phase contained 
5.4 U mL-1 HbpA, 5.4 U mL-1 FDH, 2 mM NAD+, and 20 µM FAD. The reaction mixture 
was supplemented with 0.2 mg mL-1 Tween 20. We have refrained from adding catalase to 
the experiments since the cell crude extracts (originating from aerobic E. coli cultivations) 
presumably contained endogenous catalase activity. Aliquots of 10 µL of the organic phase 
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were withdrawn at intervals, diluted with 990 µL of acetonitrile containing 0.1% of TFA (v/v) 
and analysed by RP-HPLC.  
The time course of 2,3-dihydroxybiphenyl formation was determined under the 
aforementioned conditions at 10 mL scale (50 mL tubes) with an initial ratio between the 
organic and aqueous phase of 9:1 (v/v). The final phase ratio was approximately 8.84:1 (v/v) 
after 16 samples of 10 µL. 
In one experiment the effect of lipase addition was investigated under these conditions: The 
coupled reaction of FDH and HbpA was performed as described in a standard procedure in 
50  mL tubes using NAD+ (0.2 mM) and 2-hydroxybiphenyl (500 mM). To the reaction assay 
(Vtotal = 10 mL), 0.1 g of immobilised Lipase B (CALB) from Candida antarctica (Novozym 
435) was added. 
It should be mentioned here that all experiments had been performed in duplicates 
(unfortunately not always sampling at identical times). Therefore, no error bar are given in the 
figures. Nevertheless, the deviation between the single experiments was maximally 14%. 
Determination of reactants using HPLC analysis 
The progress of the reactions was measured by RP-HPLC on a Shimadzu LC-20 system 
equipped with a Shimadzu SPD-20A Photo Diode Array detector using a Waters XTerra 
column (RP18, 3.5 μM, 4.6×150 mm). The temperature was controlled at 40°C by a 
Shimadzu CTO-20AC column oven. As eluent an acetonitrile/water (containing 0.1% TFA) 
(40/60) mixture was used isocratically. The flow rate was set to 1.1 mL min-1 and the 
detection wavelength to 210 nm. Retention times were 2.94 min for 2,3-dihydroxybiphenyl, 
3.67 min for 2-hydroxybiphenyl and 6.47 min for octyl formate. 1-Octanol was not quantified 
due to its low response in the detection method (UV). Data were processed using the LC 
solution software. The final concentrations were calculated based on standard curves obtained 
using 2-hydroxybiphenyl and 2,3-dihydroxybiphenyl standards in the concentration range of 
10-500 mM. 
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RESULTS 
In a first set of experiments we examined the influence of increasing formate concentrations 
on the activity of both HbpA and FDH (Figure 4-2).  
 
Interestingly, both enzymes showed an opposite behaviour with increasing sodium formate 
concentrations. Whereas FDH was apparently not inhibited by the presence of up to 1 M 
sodium formate, HbpA activity decreased significantly. Already in the presence of 100 mM of 
sodium formate HbpA activity was reduced by 50%. This is in line with previous 
observations made with HbpA.42 Suske et al. have observed a significant influence of 
monovalent anions (such as azide and chloride) on the stability of the intermediate 
hydroperoxyflavin,147 which may also account for the apparent inhibition observed with 
formate. Also, a negative influence of the increasing ionic strength on the structural integrity 
of the biocatalyst may be hypothesised. Further studies will be necessary to fully understand 
the nature of the apparent inhibition of HbpA by sodium formate. Overall, we concluded that 
HbpA catalysed hydroxylation reaction (being inhibited by already comparably low sodium 
formate concentrations) is a suitable model system to evaluate the ‘hydrophobised formates 
concept’. 
Next, we went on to test the feasibility of the ‘hydrophobic formates concept’. Under 
arbitrarily chosen reaction conditions (see Figure 4-3, caption) we were pleased to observe 
stable hydroxylation activity over at least 3 weeks wherein the desired product 
2,3-dihydroxybiphenyl continuously accumulated in the organic phase (Figure 4-3). In the 
absence of either HbpA, FDH or NAD+, no conversion was observed. 
The high robustness of the overall reaction was astonishing as control experiments in the 
absence of substrate and NAD+ under otherwise identical conditions to the reaction shown in 
Figure 4-2: Influence of [NaHCO2] on the activity 
of HbpA () and FDH ().General conditions: 
KPi buffer 50 mM, pH 7.5, V = 1 mL, T = 30oC, 
(): [HbpA] = 0.066 U mL-1 = 0.04 mg mL-1, 
[2-hydroxybiphenyl] = 0.2 mM, [NADH] = 0.3 
mM, [FAD] = 20 µM; () [FDH] = 0.018 U mL-1 = 
0.017 mg mL-1, [NAD+] = 1 mM. 
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Figure 4-3 indicated half-life times of 16 h and 24 h for HbpA and FDH, respectively. Under 
these conditions also a significant acidification of the aqueous layer (ranging between pH 4 
and pH 6) was observed. We attribute this to slow, spontaneous hydrolysis of octyl formate 
and subsequent accumulation of formic acid in the aqueous medium, leading to an 
inactivation of the biocatalysts. Under reaction conditions (i.e. in the presence of a NAD+) 
formic acid is consumed by the NADH regeneration reaction and therefore does not 
accumulate maintaining the overall pH value constant. In fact performing the coupled reaction 
in the presence of a lipase (accelerating the hydrolysis of octyl formate), only trace amounts 
of product were observed accompanied with a pH drop to less than 2 (data not shown). 
Overall, provided the consumption of formic acid proceeds faster than its formation via 
hydrolysis, a pH-stable system can be achieved. 
 
 
It should be mentioned here that the productivity of the reaction system (shown in Figure 4-3) 
significantly fell back behind the values expected from the enzyme activities applied. An 
initial product formation rate of a bit more than 1 mM h-1 (in the organic phase, corresponding 
to approx. 9 mM h-1 in the aqueous layer) was determined. This corresponds to a formal 
specific HbpA activity of 0.15 U mL-1, which is significantly lower than (approx. 3%) the 
theoretical HbpA activity of 5.4 U mL-1 determined in independent spectrophotometric 
experiments. Obviously, the same calculation also applies for the formal activity of FDH. We 
hypothesise that the phase transfer rate (of 2-hydroxybiphenyl and/or octyl formate) into the 
aqueous layer was overall rate limiting thereby accounting for the low formal specific enzyme 
activities (vide infra). On average (over the whole period), the productivity reached was 
0.1 m Mh-1org. Nevertheless, the reaction yielded the desired 2,3-dihydroxybiphenyl at 12% 
Figure 4-3: Time-course of 2,3-
dihydroxybiphenyl formation in a 2LP system 
using octyl formate as a second organic phase. 
General conditions: octyl formate : KPi = 9:1 
(v/v); Vtotal= 10 ml, T = 30oC; aqueous 
concentrations: [HbpA] = 5.4 U mL-1 = 3.6 mg 
mL-1, [FDH] = 5.4 U mL-1 = 5.1 mg mL-1, [NAD+] 
= 2 mM () or 0.2 mM (); organic 
concentrations: [2-hydroxybiphenyl] = 500 mM. 
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yield with very promising turnover numbers (TN=final amount of product divided by amount 
of catalyst used) for NAD+ and HbpA of 3680 and 18880, respectively. Also the extraordinary 
high robustness of the reaction (steadily accumulating the product over at least 3 weeks) is 
worth pointing out. 
Despite these promising features, the preparative value of this reaction is impaired by the 
rather sluggish reaction rates. To clarify this, we systematically varied the concentrations of 
all reagents and catalysts to identify the overall rate-limiting component. Very interestingly, 
varying the concentration of either HbpA, FDH or NAD+ did not significantly influence the 
overall rate of the system; within experimental error, all rates were identical. Exemplarily the 
influence of varying [NAD+] is shown in Figure 4-3 (open circles 2 mM and black squares 
0.2 mM). Similar results were also obtained when changing the biocatalyst concentration. 
As the catalysts concentrations had no apparent effect on the overall reaction rate, we 
suspected that diffusion limitation over the interface might be overall rate-limiting. If so, then, 
amongst other factors, the surface area and the concentrations of the reagents in the organic 
phase influence the diffusion rate. In fact, changing the concentration of both octyl formate 
and 2-hydroxybiphenyl had a clear impact on the reaction rate (Figure 4-4 and Figure 4-5). 
 
 
Figure 4-4: Influence of octyl formate concentration 
on the rate of 2,3-dihydroxybiphenyl formation 
(determined in the organic phase). General 
conditions: organic phase: KPi = 9:1 (v/v), aqueous 
conditions: [HbpA] = 5.4 U mL-1, [FDH] = 
5.4 U mL-1, [NAD+] = 2 mM; organic phase: different 
ratios of 1-decanol to octyl formate were used 
resulting in the molar octyl formate concentrations 
shown; [2-hydroxybiphenyl] = 10 mM. 
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In both series a saturation-type behaviour of the reaction rate on the concentration of 
2-hydroxybiphenyl and octyl formate in the organic layers was observed. We like to interpret 
these findings in terms of phase-transfer limiting the overall rate of the reaction system. 
Hence, the interfacial area of aqueous and organic layers should also have a significant 
influence on the overall rate.146c Indeed, changing the reaction setup from gently shaken to 
vigorously mixed (i.e. performing the reaction in baffled Erlenmeyer flasks) almost doubled 
the reaction rate albeit at the expense of a significantly reduced stability of the production 
system: under the mechanically very demanding conditions the production enzymes denatured 
rapidly leading to an almost complete loss of activity after 1 h. 
DISCUSSION 
For many biocatalytic reactions water is not the ideal solvent as hydrophobic reactants are 
only poorly solubilised. The resulting low reactant concentrations, combined with sometimes 
tedious reaction work-up, render biocatalytic procedures unpractical. Therefore it is not 
astonishing that a growing number of publications aim at ‘water-free’ or at least minimal 
water-content biocatalysis. In case of hydrolytic enzymes, this now can be considered to be 
state of the art,148 and more and more examples for the emerging oxidoreductases (especially 
using alcohol dehydrogenases) can be found in the literature.49, 146b, 149 For production systems 
necessitating diffusible nicotinamide cofactors (for example monooxygenases where a 
NADH-regenerating enzyme is inevitable), the so-called two-liquid phase system (2LP) 
approach may be a good compromise as here a hydrophobic organic solvent serves as 
substrate reservoir and product sink enabling overall high substrate loadings. In addition, 
2LPs can also render biocatalytic reactions more efficient by controlling the aqueous 
concentrations of substrates and products. Thereby, inhibitory effects of excess reagents can 
Figure 4-5: Influence of 2-hydroxybiphenyl 
concentration on the rate of 
2,3-dihydroxybiphenyl formation (determined in 
the organic phase). General conditions: octyl 
formate : KPi = 9:1 (v/v). Aqueous conditions: 
[HbpA] = 5.4 U mL-1, [FDH] = 5.4 U mL-1, 
[NAD+] = 2 mM. 
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be minimised as well as undesired side reactions such as the non productive uncoupling of 
NADH oxidation from substrate hydroxylation as observed e.g. with HbpA.42, 147 However, 
high substrate loadings are difficult to achieve using formate salts as stoichiometric reductants 
as the resulting high ionic strengths in the aqueous layer may significantly impair the 
biocatalysts’ activity and stability. In the current contribution we have demonstrated the 
principal feasibility of using hydrophobised formic acids (by means of hydrophobic formic 
acid esters) in the 2LP approach. Thereby, hydrophobic formic acid esters not only serve as 
substrate reservoir and product sink but also as source of reducing equivalents. 
The major limitation of the current reaction setup is the sluggish phase transfer kinetics of 
both 2-hydroxybiphenyl and octyl formate. Possibly also O2 availability contributes to the 
overall slow reaction rate. Increasing the phase transfer rate, especially via emulsification will 
be in the focus of our further investigations. Here, the major challenge to be addressed is to 
reduce the mechanical stress induced by the emulsification process and to protect the 
biocatalysts e.g. via immobilisation. 
Despite the early stage of development of this system and the many challenges still to be 
faced en route to becoming a truly practical reaction system we believe that hydrophobised 
formates represent an interesting future pointing development in FDH-based redox 
biocatalysis. 
CONCLUSIONS 
In this contribution we have demonstrated the principle applicability of the ‘hydrophobised 
formates concept’ to promote NADH-dependent redox reactions. Hydrophobic esters of 
formic acid can serve as organic phase in biocatalytic 2LP reactions, and as source of 
reducing equivalents at the same time; thereby paving the way towards low-water content 
redox biotransformations. The current setup is limited by poor mass transfer rates over the 
interface, which will be addressed in the future e.g. by conducting the reaction in 
microreactors to reduce phase transfer limitation. 
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ABSTRACT 
Microreactors provide higher mass transfer rates than do conventional batch reactors. A tube-
in-tube microreactor was used for the NADH-dependent in vitro conversion of 2-
hydroxybiphenyl to 3-phenylcatechol that was catalysed by 2-hydroxybiphenyl 3-
monooxygenase (HbpA). A biphasic reaction system allowed high substrate loadings, 
whereas the microreactor ensured excellent mass transfer rates between organic and aqueous 
phases. Oxygen was supplied continuously via membrane aeration over the whole reaction 
compartment. The productivities achieved in the tube-in-tube microreactor were 38 times 
higher than those in previously described batch reactors and almost 4 times higher than for the 
same reaction in a microreactor in which aqueous, organic and air phases were delivered 
through consecutive segments. This setup is a promising concept for oxygen-dependent 
biocatalytic reactions in microreactors, and is developing as a basis for applications in gram-
scale organic biosyntheses. 
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INTRODUCTION 
Miniaturised enzymatic reaction systems were introduced in the late 1970s as devices for flow 
injection analysis and continuous segmented flow analysis.85 These systems can be regarded 
as predecessors of microreactors used for high-throughput sample analysis under continuous 
flow conditions. Microreactors provide high mass and heat transfer rates87 and allow better 
control of temperature and reaction times than do conventional stirred tank reactors (STRs).89, 
99 They enable rapid screening of reaction conditions and generation of compound libraries 
with minimal reagent or catalyst use.90 Flow reactors with chemical catalysts have been used 
for laboratory and industrial purposes.91, 150 Synthetic applications of enzymes in 
microreactors have also been reported.76, 92a, 92c, 92e, 94-95, 99, 151 
Enzymatic redox reactions often profit from the introduction of multiple phases as gas/liquid, 
liquid/liquid, or gas/liquid/liquid, to supply low-soluble hydrophobic substrates and/or to 
overcome substrate and product inhibition by partitioning the reactants in different phases. In 
such a reaction environment, interfacial mass transfer could play a key role in increasing 
reaction rates. In a recent study, the enzymatic reaction performance was maximised by 
applying aqueous/organic two-liquid phase segmented flow.95 A segmented flow is formed 
when two immiscible liquids are delivered to the microreactor to form elongated capped 
bubbles (also called slugs, plugs, or segments). Surface tension and viscous forces dominate 
in such a reactor, providing good local mixing (circulation within segments), which is 
beneficial to the interfacial mass transfer152 and rapid equilibrium establishment. However, 
the use of aqueous/organic/air three-phase segmented flow for maximising the interfacial 
mass transfer between aqueous/air and aqueous/organic phases is limited owing to flow 
stability and controllability issues. In addition, the delivery of oxygen in segmented flow 
fashion coupled to high oxygen mass transfer (kLa 0.01-0.5 s-1)78 and a high oxygen 
consumption rate results in the depletion of this compound within seconds to minutes, which 
again limits the residence time and thus effects the respective conversion. To overcome flow 
instability and oxygen limitations but still benefit from the high mass transfer rates achieved 
in microreactors, a tube-in-tube reactor (TiTR) (Figure 5-1) is an interesting concept. A TiTR 
consists of a gas permeable Teflon AF-2400 membrane tube placed in an outer polymeric 
tube; thus the respective gas is delivered directly from a pressurised tank through the inner 
membrane to the liquid phase(s). Gas is therefore separated from the liquid reaction 
components, which simplifies reactor operation, stabilises the flow, and allows for continuous 
supply of oxygen throughout the length of the system. 
The tube-in-tube concept has been used for gas-dependent chemical syntheses in flow 
reactors.153 A similar device has been proposed for safer and scale independent hydrogen 
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supply for STRs.154 Although efforts have been made to develop TiTRs for chemical 
syntheses, a rational design of such a reactor format for enzymatic reactions, to our 
knowledge, has not been reported. 
Herein, 2-hydroxybiphenyl 3-monooxygenase (HbpA) was used as a model enzyme for regio- 
and chemoselective oxidation of 2-hydroxybiphenyl with molecular oxygen to produce 
3-phenylcatechol. Formate dehydrogenase (FDH) was chosen for NADH recycling.27, 155 
n-Decanol was used as water immiscible organic phase to overcome low solubility of the non-
polar substrate and product.21, 102 The inner tube in TiTR constituted aqueous/organic 
segmented flow for maximising the aqueous/organic mass transfer, whereas bubble-free 
continuous oxygen supply and continuous carbon dioxide removal to prevent a pH shift were 
obtained through the outer tube.156 Overall, four concepts – biocatalysis in a water/organic 
two-liquid phase system, enzymatic cofactor regeneration, bubble-free aeration, and 
microreactors – were integrated for the efficient synthesis of 3-phenylcatechol in a TiTR. 
Different factors affecting HbpA activity, such as NADH cofactor regeneration, hydrophobic 
substrate supply, and product removal, and their effect on final product titre and 
hydroxylation rate are discussed as a case study and proof of concept. 
 
Figure 5-1: A – HbpA-catalysed hydroxylation of 2-hydroxybiphenyl to 3-phenylcatechol with concomitant 
NADH regeneration by FDH. B – Schematic representation of a TiTR with aqueous/organic two-liquid 
segmented flow; S=reagents, P=products. C – Scheme of a 4 m TiTR used herein. 
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MATERIALS AND METHODS 
Chemicals 
NADH disodium salt and n-decanol were obtained from Applichem (Darmstadt, Germany); 
sodium formate, NAD+ disodium salt and flavin adenine dinucleotide (FAD) from Fluka 
(Buchs, Switzerland); 2-hydroxybiphenyl from Sigma-Aldrich (Taufkirchen, Germany) and 
3-phenylcatechol from Wako Pure Chemical Industries Ltd. (Osaka, Japan). All other 
chemicals were purchased either from Fluka, Applichem or Sigma-Aldrich and used as 
received. 
Assembly and operation of the TiTR 
 
Figure 5-2: A – Schematic representation of the TiTR setup. Two syringe pumps are used to deliver the aqueous 
and organic liquid that are united in a four-way V100T valve or T-shaped PEEK capillary connector and 
continue inside a coiled Teflon AF-2400 membrane in a segmented fashion up until the outlet, at which they are 
collected and subsequently analysed. B – Simplified diagram of the air-line connection; o.d.=outer diameter, 
i.d.=inner diameter. C – Close-up of the TiTR system with a Teflon AF-2400 membrane placed inside Tefzel or 
PFA tube. Gas is delivered in a countercurrent fashion and flows outside the Teflon AF-2400 membrane. Along 
the way gas diffuses into the inner tube and saturates the liquids with oxygen, whereas formed carbon dioxide is 
continuously removed. 
 
The setup of the TiTR is shown in Figure 5-2. A 1-m-long Gastropod® reactor (0.5 mL 
volume inside the Teflon AF-2400 membrane) was purchased (Cambridge Reactor Design, 
Cambridge, UK), whereas the 4-m-long (2 mL volume) version was assembled on-site with 
commercially available interconnects (Swagelok, Kings Langley, UK). The inner tube of the 
TiTR was made of Teflon AF-2400. The gas permeability of this membrane for oxygen and 
CO2 is 990 and 2800 Barrer [1 Barrer=3.348×10-19 kmol m (m2 s Pa)-1], respectively. For a 
2-m-long Teflon AF-2400 membrane (1 mL volume) (i.d.: 0.08 cm; o.d.: 0.1 cm) these values 
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translates to 20.8 µmol min-1 (0.41 µmol min-1 cm-2) or 39.9 mg h-1 oxygen at 0ºC and an 
oxygen partial pressure difference of 20.8 kPa (15.6 cmHg converted to SI units), that is, 
when the pressure around the tube is equal to atmospheric pressure and liquid in the tube is 
oxygen free. The membrane was kept in a polymeric tube such as PFA tube (with 10-20 times 
lower oxygen permeability157) for 4 m TiTR; or Tefzel tube (with approx. 170 times lower 
oxygen permeability158) for the 1 m TiTR. 
This assembly allows the precise control of the pressure of the delivered gas. Two Chemyx 
Nexus 6000 syringe pumps (KR Analytical, Sandbach, UK) were used to pump aqueous and 
organic phase streams. Liquids were united in a four-way V100T valve (i.d.: 1 mm; 
UpChurch Scientific, Göhler HPLC, Chemnitz, Germany), which formed a stable oil-in-water 
segmented flow pattern as illustrated in Figure 5-3. Air was delivered to the outer membrane 
directly from the pressurised air tank at approx. 60 g h-1 (as determined by using EL-FLOW 
mass flow meter/controller, Bronkhorst Ltd, Newmarket, UK). 
Enzyme production and purification 
The production and purification of HbpA and FDH was performed as previously published,21, 
102 and as described in chapter 2. The enzymes were of technical purity (FDH: 1.3 U mg-1 
approx. 25% pure; HbpA: 1.5 U mg-1 approx. 40% with respect to the maximum reported 
specific activity of a pure protein) and were used directly as 50 vol% glycerol stocks stored at 
-20ºC. Both enzymes catalysed irreversible oxidation reactions. The pH range in which HbpA 
demonstrated good activity (>80%) was pH 7.2-7.8, with an optimum at pH 7.5,42 which was 
also the optimal pH for FDH activity.109, 112a Therefore, this pH was the pH of choice for the 
biotransformation reaction. Cofactor stability (NADH and NAD+) was confirmed at this 
pH.159 KPi buffer (100 mM) was chosen to provide stable pH during the biotransformation at 
all residence times. Nevertheless, the carbon dioxide was removed continuously, which made 
the medium acidification unlikely. 
HbpA activity assays 
HbpA-activity determined by NADH consumption in an UV spectrophotometer 
HbpA activity was determined by measuring the consumption of NADH (ε = 6220 M-1 cm-1) 
at 340 nm using a Cary 300 Bio UV-Vis spectrophotometer (Varian, Darmstadt, Germany). 1 
U of enzyme activity referred to 1 µmol of NADH consumed in 1 min at the 30°C. A standard 
assay was conducted as follows: KPi buffer (960 µL of 100 mM, pH 7.5) supplemented with 
NADH (12 µL of 25 mM, 0.3 µmol) and FAD (10 µL, 2 mM, 0.02 µmol) was mixed in a 1.5 
mL PMMA cuvette, which was thermostated at 30°C for 5 min. Then, HbpA solution (10 µL, 
approx. 0.03 U) was added and mixed with a pipette; and the background activity, that is, a 
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futile endogenous NADH oxidation in the absence of a substrate (oxidase activity), was 
determined. Subsequently the reaction was started by the addition of methanolic solution of 
2-hydroxybiphenyl (8 µL, 25 mM, 0.2 µmol). The reaction was monitored for 1 min. 
Substrate specific activity was corrected for endogenous NADH oxidation. 
HbpA activity determined by product formation via RP-HPLC analysis 
The HbpA-catalysed biotransformation reaction was monitored by determining the 
concentration of the product 3-phenylcatechol in RP-HPLC. Measurements were performed 
either with a Hitachi Elite LaChrom HPLC system equipped with a Hitachi Elite LaChrom L-
2450 Diode Array Detector (Merck Hitachi, Darmstadt, Germany) or Gilson HPLC system 
equipped with a Gilson 151 UV/Vis detector. All measurements were performed at 40°C on a 
C18 based XTerra RP 18 3.5 µM column (Waters, Dublin, Ireland). ACN-water [65:35, v/v; 
both supplemented with 0.1% v/v TFA] was used for isocratic elution at a total flow rate of 1 
mL min-1. For sample preparation, the reactor effluent (100 µL) was collected directly in a 
tube containing ACN (400 µL, 0.1% v/v TFA). The tube was immediately shaken, which led 
to the precipitation of enzyme and buffer salts, and then centrifuged (4 min, 4ºC, 14900 rpm) 
in a benchtop centrifuge. The supernatant (100 µL) was transferred to a HPLC vial containing 
ACN (900 µL, 0.1% v/v TFA); the solution was mixed and analysed directly. The product 
3-phenylcatechol and the substrate 2-hydroxybiphenyl were detected between 2.5 and 2.7 and 
between 3.1 and 3.4 min retention times, respectively. Results were analysed using the LC 
Solution software or Gilson Uni-Point software. The concentrations of 3-phenylcatechol were 
calculated as a peak area ratio of 2-hydroxybiphenyl to 3-phenylcatechol, which was possible 
owing to the equal response of both compounds at 210 nm. The application of 244 nm was 
also possible, if required. The validity of the analysis method was confirmed by using 
standard curves prepared for substrate/product samples premixed at different ratios and 
analysed accordingly (Appendix Table A2 and Figure A8). Unless stated otherwise, every 
measurement point represented an average of three consecutive samples and error bars 
represented standard deviation. All STYs, product concentrations and rates were calculated 
for the reaction total volume (aqueous and organic phase). 
FDH-activity determined by NADH formation in an UV spectrophotometer 
FDH activity was determined similarly as was HbpA activity. A standard assay was 
performed as follows: KPi buffer (840 µL, 100 mM, pH 7.5) supplemented with sodium 
formate (100 µL, 2 M, 0.2 mmol) was mixed in a PMMA cuvette, which was thermostated at 
30°C for 5 minutes. Subsequently, the FDH solution (10 µL, approx. 0.03 U) and of NAD+ 
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solution (50 µL, 10 mM, 0.5 µmol) were added to start the reaction. The reaction was 
monitored for 1 min. 
Biotransformation in 1 mL scale batch reaction 
Small scale batch experiments were conducted in a 2LP setup and reaction conditions were as 
follows: HbpA (9.5 U mL-1), FDH (9.85 U mL-1), FAD (20 µM), sodium formate (100 mM), 
NAD+ (1 mM), it was adjusted to a final volume of 500 µL with KPi buffer (50 mM, pH 7.5) 
and mixed with equal volume of a solution of 2-hydroxybiphenyl (200 mM) in n-decanol 
containing Tween80/Span80 mixture (0.043 mg mL-1; hydrophile-lipophile balance index 6 
according to160 for an W/O emulsion) in a 2 mL reaction tube. Reaction tubes were left open 
to facilitate oxygen supply. The tubes were thermostated at 30°C in an Eppendorf thermo 
mixer comfort (Eppendorf, Hamburg, Germany) with a constant agitation of 1200 rpm for 1 h 
with a regular sampling and subsequent HPLC analysis. 
Biotransformation in microreactor 
 
 
Unless stated otherwise, all biotransformation reactions were performed in the TiTR. 
Residence time was controlled through total flow rates. Relative flow rates were kept constant 
by maintaining the aqueous to organic phase ratio of 1:1. The aqueous phase was 
complemented by adding 50% glycerol solution of HbpA and FDH (for final volumetric 
activities of 1-20 U mL-1), sodium formate (100 mM), NAD+ (1 mM), FAD (20 µM), and 
Tween 20 (0.6 mg mL-1) for facilitating flow stability and preventing enzyme inactivation, 
and the reaction mixture was adjusted with KPi buffer (100 mM, pH 7.5) to the respective 
volume for achieving the required volumetric activities. The aqueous phase was filtered 
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through a 0.22 µm Millex-CP syringe filter with a polyethersulfone membrane to remove any 
particles that would have otherwise deposited in the reactor and resulted in flow instabilities 
later. 2-Hydroxybiphenyl (5-1000 mM in the organic phase) in n-decanol formed a separate 
organic phase. If required, the initial saturation of both the aqueous and organic phases with 
oxygen could be performed before the reaction by bubbling air through the aqueous phase 
(before adding enzymes) and the organic phase for 15 min. Unless stated otherwise, the 
reactor was thermostated at 30°C in a water bath. Product formation rates were calculated for 
the total working volume of the reactors as specified in the captions of Figure 5-7 and Figure 
5-8 (i.e. the sum of the aqueous and organic phase). 
Additional experiments were conducted in an aqueous/organic/air three phase microreactor 
constructed of PTFE (length: 13.3 m; i.d.: 1 mm) (Figure 5-3B). Instead of Tween 20, the 
organic phase was supplemented with a mixture of Span80/Tween80 (0.043 mg mL-1; 
(hydrophile-lipophile balance index 6 according to160 for a water-in-oil segmented flow); 
HbpA (8.67 U mL-1), FDH (8.57 U mL-1), other components were used as described above. 
The aqueous and organic phase flow rates were each equal to 0.4 mL min-1. Air was merged 
with the aqueous phase in a T-shaped capillary connector (UpChurch Scientific, Göhler 
HPLC, Chemnitz, Germany), and its flow was regulated by manually controlling the air inlet 
pressure for achieving equal phases ratio (approx. 300 kPa overpressure – 3 bar converted to 
SI units –was needed to introduce an air segment); the average residence time was 8.5 min. 
Enzyme inhibition study 
The effect of sodium formate, 3-phenylcatechol, and NAD+ on HbpA activity was studied by 
using a standard spectrophotometric assay, as described above. Either an aqueous sodium 
formate solution (2 M), an aqueous NAD+ solution (20 mM), or the methanolic solution of 
3-phenylcatechol (21 mM) was added to match the required final concentration and adjusted 
to the final volume with KPi buffer (100 mM, pH 7.5). 
Effect of high NAD+ and NADH concentrations on HbpA activity 
The effect of varying NAD+ and NADH concentrations (1-50 mM) was studied in a 1 
mL-scale batch reaction supplemented with FAD (20 µM), sodium formate (100 mM), 
Tween 20 (0.6 mg mL-1), completed with HbpA (6.9-9.2 U mL-1) and FDH (5.6-7.5 U mL-1) 
in KPi buffer (500 µL). 2-Hydroxybiphenyl (500 µL, 200 mM) in n-decanol was added to the 
above mixture in a 2 mL reaction tube. The reaction was started by adding the required 
cofactor amount (1-50 mM). The tubes were thermostated at 30°C in an Eppendorf 
Thermomixer comfort (Eppendorf, Hamburg, Germany) with a constant agitation of 1200 
rpm. After 1 h, the reaction was stopped by addition of ACN (1 mL, 0.1% TFA v/v) and the 
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reaction mixture stirred for 1 min under the continued reaction conditions. Respective phases 
were separated by subsequent centrifugation (1 min, 16200 g, RT), and the upper phase (10 
µL) was transferred to the ACN solution (990 µL, 0.1% TFA v/v) for direct RP-HPLC 
analysis. 
Determination of partition ratio KD for 2-hydroxybiphenyl and 3-phenylcatechol in 
n-decanol 
Solutions of 3-phenylcatechol (200 mM) or 2-hydroxybiphenyl (1000 mM) were prepared in 
n-decanol and were combined with equal volume of water. Samples were vortexed for 30 sec 
and subsequently incubated in a thermoshaker (1400 rpm, 30 min, RT) to achieve 
equilibrium. Afterwards, the phases were separated by centrifugation (13300 g, 2 min, RT) 
and diluted in ACN before the measurement. The concentration of the respective compounds 
were determined spectrophotometrically at 286 nm for 2-hydroxybiphenyl and 288 nm for 
3-phenylcatechol in ACN. Concentrations were determined from the standard curves. 
RESULTS 
The hydroxylation reaction catalysed by HbpA depends on an efficient supply of three unique 
substrates, namely, the cofactor NADH, the hydrophobic substrate undergoing hydroxylation 
and molecular oxygen. A detailed investigation of the kinetics and inhibition of HbpA by the 
product 3-phenylcatechol was performed by Suske et al.42 and was taken as a basis for the 
study presented herein. The cofactor dependency of HbpA necessitated the addition of FDH 
and formate for NADH regeneration. The impact of this regeneration system on HbpA 
activity was studied to determine optimal reaction parameters for maximising reaction 
performance. 
Cofactor regeneration system affects the hydroxylation reaction performance 
The effect of the cofactors on HbpA activity was evaluated by varying their concentrations 
with or without the regeneration enzyme system in a batch reaction. With a stoichiometric 
amount of NADH (no cofactor regeneration), a low final product titre was achieved (Figure 
5-4A), indicating a strong inhibition of HbpA by the cofactor, which was not observed in the 
presence of the regeneration system. Thus, HbpA is inhibited by high concentrations of 
NAD+, which accumulated owing to the consumption of NADH in the hydroxylation reaction, 
whereas in the presence of FDH, the NAD+ pool was low owing to its direct reduction to 
NADH (Figure 5-4A). Furthermore, as the product titre remained constant with the increase 
in the cofactor amount, the reaction rate was found to be independent of the NADH 
concentration and the reaction operated at zero order or maximum reaction velocity because 
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of the low Km values for this compound (HbpA: NADH 0.027 mM;42 FDH: NAD+ 0.044 
mM112a). 
The effect of sodium formate, the substrate for NADH regeneration, on HbpA activity was 
investigated by varying the quantity of formate added to the reaction (Figure 5-4B). This 
substrate strongly inhibited HbpA as its activity negatively correlated with the supplied 
formate concentration. In addition, a futile NADH oxidation (background activity) was 
observed, which resulted from NADH oxidase activity of HbpA. On the basis of these 
findings, 100 mM of formate was defined as a standard condition to minimise its inhibitory 
effect on HbpA activity and still be sufficiently higher than the Km value for FDH for this 
substrate (5.5 mM).112a Thus, it is essential to set a trade-off between HbpA inhibition and 
FDH reaction rate based on the formate concentration in order to maximise the overall 
reaction performance. 
 
Figure 5-4: A - Effect of varying concentrations of NADH and NAD+ on HbpA activity. Reactions were 
performed at 1 mL-scale in reaction tubes on a thermoshaker at 30°C and 1200 rpm for 1 h. An aqueous to 
organic phase ratio of 1:1 was used. The reaction mixture contained HbpA (6.5-9.2 U mL-1), FAD (20 µM), KPi 
buffer (100 mM, pH 7.5), and 2-hydroxybiphenyl (200 mM) in n-decanol. In the case of reactions with cofactor 
regeneration, FDH (5.6 -7.5 U mL-1), and sodium formate (100 mM) were also added. B - Effect of different 
concentrations of sodium formate on HbpA activity. Activities were measured by using a spectrophotometric 
assay by monitoring the NADH absorbance of at 340 nm (see Enzyme inhibition study in the experimental 
section). Background activity was defined as the consumption of NADH in the absence of substrate 
(2-hydroxybiphenyl). 
Tween 20 stabilises HbpA activity under aqueous/organic segmented flow conditions 
in the TiTR 
To exploit the TiTR system for biocatalytic reactions, it is crucial to determine enzyme 
stability under reactor operating conditions. Significant enzyme inactivation in an 
aqueous/organic segmented flow system has been reported, which mainly results from the 
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large aqueous/organic interfacial area. This problem was solved by addition of Tween 20, a 
surfactant.66a Herein, HbpA and FDH stability under aqueous/organic segmented flow 
conditions in the TiTR was investigated in the presence and absence of Tween 20. In terms of 
flow stability, a stable oil-in-water flow pattern was observed in both cases. The final 
substrate conversion measured for 10 min of residence time was 7.6±0.4% without surfactant 
and 9.6±0.5% in the presence of 0.6 mg·mL-1 of Tween 20. Spectrophotometric 
measurements revealed 20% loss of volumetric HbpA activity in the absence of surfactant, 
which accounted for the lower conversions observed without surfactant addition. Thus, 
Tween 20 (0.6 mg·mL-1) was added to prevent enzyme inactivation in the following 
experiments. 
Enzymatic reaction performance in the TiTR 
The efficient use of HbpA depends on the optimal supply of three unique substrates: NADH, 
hydrophobic 2-hydroxybiphenyl, and oxygen. For the interfacial transfer of substrates, the 
contacting patterns of various phases are important. This section discussed the use of different 
contacting patterns such as dispersionless contact for oxygen transfer by using a membrane 
barrier and aqueous/organic segmented flow for the supply of 2-hydroxybiphenyl. 
Oxygen transfer through dispersionless contact: improvement of flow stability and 
oxygen availability 
We initially focused on the synthesis of 3-phenylcatechol in an aqueous/organic/air three-
phase segmented flow reactor. However, owing to difficulty in obtaining a stable flow as well 
as technical difficulties in delivering air, the investigation of this three-phase segmented flow 
was abandoned. Then, HbpA activity (turnover rate) was investigated in the TiTR system 
under the aforementioned conditions and the effect of continuous oxygen supply in TiTR was 
compared with that in a setup in which oxygen was delivered only through the aqueous phase. 
This was achieved by flushing the outer tube with either compressed air (first setup) or 
nitrogen (second setup). The beneficial effect of the continuous oxygen supply throughout the 
reactor is depicted in Figure 5-5. In the first setup, the product concentration increased 
steadily with the increase in the residence times, whereas in the second setup, the product 
concentration reached a plateau after 6 min residence time when all available oxygen was 
consumed (Figure 5-5). This result was an initial validation of the TiTR concept for the 
HbpA-catalysed hydroxylation, which formed the basis for further characterisation and 
optimisation of reaction conditions in the TiTR system. 
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Cofactor turnover does not limit reaction performance in the TiTR 
The regioselective hydroxylation of 2-hydroxybiphenyl depends on the availability of NADH 
(Figure 5-1A) and therefore FDH-catalysed NADH regeneration needs to be fast enough to 
provide sufficient reducing equivalents for HbpA. Thus, the two reactions must operate at 
rates sufficient to keep the cofactor pool above their Km values. When the volumetric activity 
of HbpA was kept constant at 3.7 U mL-1, the relative FDH concentration was varied in the 
range of 1-20 U mL-1, and the respective 3-phenylcatechol formation rate was determined. 
The final levels of reaction product remained constant at all FDH concentrations tested, and 
no distinct optimum value could be observed (Figure 5-6), which suggested that the HbpA 
reaction was not limited by the FDH-catalysed NADH regeneration. 
 
 
 
 
Figure 5-5: The product concentration profile 
obtained in a 1 m TiTR in relation to the residence 
time. First setup (air): outer tube flushed with air 
(triangles); second setup (nitrogen): tube flushed 
with nitrogen (squares). The aqueous to organic 
phase ratio was equal to 1. The total flow rates 
were 0.05–0.8 mL min-1 and respective residence 
times were 16.8–1.4 min. Reactor working volume 
was 0.8 mL. Reaction conditions used were: HbpA 
(4 U mL-1), FDH (4 U·mL-1), sodium formate (100 
mM), NAD+ (1 mM), FAD (20 µM), Tween20 (0.6 
mg mL-1), KPi buffer (100 mM, pH 7.5), 
2-hydroxybiphenyl (50 mM) in n-decanol, temp 
19°C. 
Figure 5-6: The effect of changing the FDH to 
HbpA unit ratio on the 2-hydroxybiphenyl 
hydroxylation rate. The HbpA loading was kept 
constant at 3.7 U mL-1 and FDH loading was varied 
accordingly. The aqueous to organic phase ratio was 
equal to 1. Total flow rate was 0.2 mL min-1 with an 
effective residence time of 4.92-5.58 min. Reactor 
working volume was 0.8 mL. Standard reaction 
conditions used were sodium formate (100 mM), 
NAD+ (1 mM), FAD (20 µM), Tween 20 (0.6 
mg mL-1), KPi buffer (100 mM, pH 7.5), 
2-hydroxybiphenyl (50 mM) in decanol, temp 20°C. 
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Substrate and product mass transfer affects the reaction performance in the TiTR 
To reveal the key limiting factor that affected the reaction performance, the mass transfer of 
2-hydroxybiphenyl from the organic to the aqueous phase and its effect on the reaction rate 
were studied. The important parameters that affect substrate mass transfer in the segmented 
flow are substrate concentration, flow velocity and phase ratios.95 In aqueous/organic two-
liquid phase biotransformation reactions, the substrate and product are located mainly in the 
organic phase owing to their partition ratios, KD. For 2-hydroxybiphenyl and 
3-phenylcatechol, KD values between the organic and aqueous phase were determined to be 
480 and 380 respectively (e.g., 200 mM of 2-hydroxybiphenyl in n-decanol results in an 
aqueous concentration of 0.41 mM). The increase in substrate concentration in the organic 
phase resulted in higher substrate availability in the aqueous phase, which affected the HbpA 
activity (Figure 5-7A). A plot of product formation rates (µmol min-1) versus the initial 
substrate concentrations is presented in Figure 5-7A. Each single line represents an 
experiment with a constant flow rate and increasing concentration of 2-hydroxybiphenyl in 
the organic phase. In each case, the hydroxylation rate increased steadily with the increase in 
the concentration of 2-hydroxybiphenyl until it reached a maximum and then plateaued. A 
maximum rate of 3.8±0.4 µmol min-1 (productivity of 17.7±1.8 g L-1 h-1) was calculated at an 
initial substrate concentration of 200 mM in the organic phase and a total flow rate of 0.8 
mL min-1. The visible trend resembles apparent Michaelis-Menten kinetics. The increase in 
the product formation with flow rates at substrate concentration below 200 mM reveals that 
the reaction was substrate mass transfer limited, which means that above 200 mM, the 
reaction must operate at zero order and the product formation rate should be independent of 
the flow rates. However, the product formation rate differed with the applied flow rates. This 
could owe to a slower product mass transfer from the aqueous to the organic phase, which 
resulted in concentrations of 3-phenylcatechol close to the Ki value (0.0016 mM) of HbpA in 
near vicinity of the enzyme. However, the effect of lower substrate availability was more 
pronounced than product inhibition (Appendix Figure A7). 
Another parameter that affects substrate mass transfer is the aqueous to organic phase ratio, 
which correlates with the available surface area as segments change their size. Thus, the 
substrate transfer over the phase boundary is affected.161 In addition, the enzyme to substrate 
ratio is affected. Higher phase ratios increase enzyme to substrate ratios, which may enhance 
substrate conversion but simultaneously move the reaction into a mass transfer controlled 
regime.95 The effect of different aqueous to organic phase ratios on product formation was 
studied by changing the individual flow rates while keeping the total flow rate constant at 0.4 
mL min-1 and thus obtaining the same residence times. In the experiment, the aqueous phase 
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had to account for at least 50% of the total reactor volume for the formation of a stable flow 
pattern because of the required capillary wetting. Although the product concentration in the 
organic phase increased with higher phase ratios, the total amount of product decreased 
because the product formation rate was lower. The highest amount of product was reached at 
a phase ratio of 1:1, whereas the highest conversion and product concentration in the organic 
phase was achieved at a phase ratio of 1:7 (Figure 5-7B). Thus, there is a trade-off between 
percentage conversion and reaction rate, which later affects downstream processing and 
biocatalyst costs. Furthermore, it is essential to know whether full conversion is not limited by 
the thermodynamics such as in the case of some alcohol dehydrogenases. Therefore, it is 
recommended to accomplish full conversion in the batch experiment before performing 
continuous reactions in flow reactors. For HbpA-catalysed reaction full conversion was 
possible and the reaction was not limited by substrate/product equilibrium (Appendix Figure 
A3). 
 
Figure 5-7: A - Effect of 2-hydroxybiphenyl concentration in the organic phase on the hydroxylation rate in a 4 
m TiTR under reaction conditions. Total flow rates were 0.1-0.8 mL min-1, and respective residence times varied 
between 23 and 3 min. Aqueous to organic phase ratio: 1:1; total reactor volume: 2.4 mL. B - Effect of the phase 
ratio on the final product concentration (organic phase) and product amount (considering two phases and total 
reactor volume of 2.4 mL) Total flow rate: 0.4 mL min-1, residence time: 5 min 40 s, initial substrate 
concentration in the organic phase: 200 mM, total reactor volume: 2.4 mL. Reaction conditions: HbpA (9.2 
U mL-1), FDH (7.5 U mL-1), sodium formate (100 mM), NAD+ (1 mM), FAD (20 µM), Tween 20 (0.6 mg mL-1), 
KPi buffer (100 mM, pH 7.5). 
Longer residence time by recirculating the organic phase in the TiTR increased 
conversion 
Although high product formation rates were achieved in the TiTR, conversions were below 
10% at a phase ratio of 1:1 (Figure 5-7A). Therefore, a strategy to increase the conversion in 
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this reactor was performed. Typically in flow reactors, the residence time can be maximised 
by decreasing the flow rates, increasing the capillary length, recirculating the organic phase 
several times, or a combination these. A decrease in flow rates for this reaction system was 
not appropriate because the product formation significantly depends on the mass transfer from 
the organic to the aqueous phase and thus low flow rates would directly affect the reaction 
performance (Figure 5-7A). Furthermore, the capillary length was limited to 4 m owing to 
technical problems associated with handling longer, fragile tubes. Instead, the approach to 
recycle the organic phase by collecting it at the outlet and feeding it back into the reactor after 
separating it from the aqueous phase was evaluated. The organic phase was recycled 8 times. 
With each consecutive cycle, the conversion and product concentration increased and the 
product formation rate decreased (Figure 5-8). Because the substrate concentration in the 
organic phase decreased in each cycle, the reaction became mass transfer limited, which led to 
lower product formation rates. Overall, it is necessary to consider not only optimal reaction 
parameters such as initial substrate, cofactor and enzyme concentrations if TiTRs are used for 
enzymatic reactions but also the mode of operation so that the conversion can be maximised. 
 
 
DISCUSSION 
Gas-liquid reactions in microreactors have been given considerable attention,86a, 92b, 162 
addressing issues such as flow characterisation,86a, 92b, 162b improved mixing and residence 
time distribution owing to the presence of gas slugs,86a bubble formation at T junction,162b and 
increased productivities of hydrogenation in flow in microreactors compared to shake 
flasks.162a Microreactors were also used in chemical syntheses for the better control of 
temperature and prevention of hot spot formation.162c These previous studies presented the 
basis for the application of oxygen- or hydrogen-dependent biocatalytic reactions in 
Figure 5-8: Product formation rate and final product 
concentration after multiple cycles of the organic 
phase through the reactor. The initial substrate 
concentration was 100 mM in the organic phase, 
representing 50 mM in the total volume at a phase 
ratio of 1. Residence time of each cycle: 10.5 min, 
total flow rate: 0.2 mL min-1. In every cycle, a fresh 
enzyme solution was used. Upon fitting a third-
order polynomial trend line to the conversion data 
(R2 = 0.99) and extrapolating, the number of cycles 
required for full conversion was calculated to be 
17.7. Reaction conditions used: HbpA (9.2 U mL-1) 
and FDH (7.5 U mL-1), sodium formate (100 mM), 
NAD+ (1 mM), FAD (20 µM), Tween 20 (0.6 
mg mL-1), KPi buffer (100 mM, pH 7.5), total 
reactor volume: 2.4 mL. 
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microreactors. However, enzymatic reactions in gas/liquid microreactors have been rarely 
reported so far. The oxidation of glucose by immobilised glucose oxidase in a gas/liquid 
monolith reactor is to our knowledge, the only example of a biological reaction in such 
reactor systems.163 Using soluble enzymes in multiphasic systems poses certain challenges 
that emerge from their inactivation at the aqueous/organic interface63 or at the gas/liquid 
interface,164 which were studied in detail for traditional reactor systems. Enzyme inactivation 
at the gas/liquid interface could be prevented by using bubble-free aeration systems for 
minimising the hydrodynamic stress causing interfacial enzyme inactivation. The bubble-free 
aeration concept has been developed by the Wandrey group (Forschungszentrum Jülich)165 
and has since been applied, for example, by using a silicone tube or a hollow fibre membrane 
for reactor aeration and/or radially delivering oxygen to larger reaction compartments. 
Examples have been shown for cyclohexane monooxygenase166 and laccase.167 However, in 
these systems, a low membrane surface area to liquid volume ratio could limit the oxygen 
transfer rate. Therefore, the concept of delivering oxygen through a membrane was further 
modified to increase oxygen mass transfer with the TiTR system. A Teflon AF-2400 
membrane stable in organic solvent and with excellent oxygen permeability values, among 
the highest of all known polymers,168 was used. This maximised membrane surface area to 
liquid volume ratio. 
So far TiTRs have been used for chemical reactions involving carbon monoxide,153a carbon 
dioxide,153c hydrogen,153b, 169 ammonia gas,153d, 170 ethylene and syngas,153f, 153h ozone,171 and 
oxygen,153e These applications mainly used transition-metal-catalysed reactions. To our 
knowledge, no examples of biocatalytic applications of TiTR have been published to date. 
The use of this reactor for a biocatalytic, oxygen-consuming reaction, offered the possibility 
of simplified liquid handling and continuous oxygen supply, which could not be achieved in a 
conventional aqueous/organic-air three-phase microreactor. Using a TiTR allowed precise 
control of the residence time irrespective of pulsations or sudden decompression of air. Thus, 
higher residence times were achieved without facing an oxygen limitation over the length of 
the reactor capillary. 
To maximise the substrate mass transfer, the aqueous/organic segmented flow was delivered 
in the inner tube of the TiTR. Interfacial enzyme inactivation in the segmented flow was 
prevented by adding surface active agents such as Tween 20 along with the enzymes as 
proposed by Karande et al. (2010).66a 
The parameters that affected the enzyme performance in the TiTR were evaluated by 
investigating the effect of oxygen, cofactor and organic substrates on 3-phenylcatechol 
formation rates. The key factor that severely affected the reaction rate and thus the reaction 
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performance was the organic mass transfer. Organic mass transfer in the segmented flow 
could be affected by substrate concentration, phase ratio, flow velocity and capillary 
diameter.84, 95 Our investigation was in line with these findings as a substrate concentration of 
200 mM, a flow velocity of 0.8 mL min-1, and phase ratio of 1:1 revealed improved mass 
transfer and reaction performance. By optimising these parameters, a productivity of 17.7±1.8 
g L-1 h-1 was achieved for 3-phenylcatechol, which is 3.5 times higher than that in a three-
phase segmented flow microreactor (4.5 g L-1 h-1) (Table 5-1). 
Table 5-1: Comparison of productivities between different reactor setups in this study. 
Entry 
Flow rate 
(mL min-1) 
Residence time 
(min) 
Volume 
(mL) 
Conversion 
(%) 
Productivity [c] 
(g L-1 h-1) 
3 phase 
microreactor[a] 
1.2 8.5 10.5 5.2±0.3 4.5±0.3 
TiTR[b] 0.1 23 2.4 22.9±1.1 11.0±0.5 
 0.2 10 2.4 11.0±0.3 12.2±0.4 
 0.4 5.7 2.4 6.8±0.4 13.4±0.8 
 0.8 3 2.4 4.8±0.5 17.7±1.8 
[a] substrate (200 mM), Tween80/Span80 (0.043 mg mL-1), HbpA (8.67 U mL-1), FDH (8.57 U mL-1) 
[b] substrate (200 mM), Tween 20 (0.6 mg mL-1), HbpA (9.2 U mL-1), FDH (7.5 U mL-1) 
[c] calculated for the total volume of aqueous and organic phase 
For fast reactions such as the one presented herein, the mass transfer time has to be shorter or 
equal to the reaction time; otherwise, the reaction will be mass transfer limited. Microreactors 
provide high mass transfer rates, which are beneficial to fast reactions, leading to high rates 
which are often not possible in batch reactor systems (Table 5-2). 
Table 5-2: Selection of processes catalysed by monooxygenases with concomitant NAD(P)H regeneration 
catalysed by formate dehydrogenase (FDH). 
Enzyme Product 
productivity  
[g L-1 h-1] 
time 
[h] 
reference 
styrene monooxygenase [a] methylstyrene oxide 0.9 11 63 
HbpA [b] 3-phenylcatechol 0.5 8 102 
cyclohexanol monooxygenase [c] (R)-ethyl 2-(7-oxo-oxepan-2-yl)acetate 0.8 2h 166b 
cyclohexanol monooxygenase [d] 5-methyloxepan-2-one 0.4 10 166a 
[a] Reaction conditions: FADH2 dependent oxygenase component (StyA) of styrene monooxygenase (2 U mL-1), 
FDH (8 U mL-1), 400 mL-scale, 1:1 dodecane/buffer phase ratio, substrate (50 mM), NAD+ (1 mM). 
[b] Reaction conditions: HbpA (0.2 U·mL-1), FDH (0.3 U mL-1), 200 mL-scale, 4:1 decanol/buffer phase ratio, 
substrate (110 mM) in n-decanol. 
[c] Reaction conditions: cyclohexanol monooxygenase (0.2 U mL-1), FDH (0.6 U mL-1), 30 mL-scale, single 
phase, substrate (20 mM), NADP+ (0.4 mM), bubble-free aeration. 
[d] Reaction conditions: cyclohexanol monooxygenase (0.16 U mL-1), FDH (0.32 U mL-1), 30 mL-scale, single 
phase, substrate (40 mM), NADP+ (0.25 mM), bubble-free aeration. 
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The rationale behind using microreactors is to achieve highest productivities for a given 
reaction, often without reaching full conversion, such as that achieved in slower batch 
reactors, in which the residence time can be almost infinite and is determined only from the 
(bio)catalyst stability. Simple calculations are performed to compare the characteristic time 
needed for mass transfer of the substrate and the reaction time available for its consumption to 
get an insight into the limiting parameters in different reactor formats. 
Three phase segmented flow: Owing to flow instability, productivity in this type of reactor 
could be limited by mass transfer, which depends on internal circulations in well-defined 
segments.87 In addition, the availability of oxygen could become a rate-limiting factor at 
longer residence times. 
Tube-in-tube reactor: In a TiTR, the radial delivery of oxygen throughout the membrane 
improved oxygen availability as compared to the single-point oxygen supply in the three-
phase segmented flow reactor. In this TiTR system, the oxygen mass transfer time throughout 
the membrane (the time to reach saturation) was estimated to be in the range of 1-10 s.172 This 
timescale is in a range similar to that of the organic substrate mass transfer time 1-14 s (kLa 
0.07-1.1 s-1 for 0.75 mm capillary) under segmented flow conditions.84 The reaction time to 
consume organic substrate in the aqueous phase (200 mM in organic corresponds to the 
aqueous phase concentration of 0.41 mM based on a KD of 480) is estimated to be 8 s. 
Because the reaction times and mass transfer times are in the similar range, we concluded that 
the system was mass transfer limited with respect to transfer from the organic to the aqueous 
phase. Thus, changing the organic substrate concentration and flow rate had a positive effect 
on the mass transfer and thus on the reaction performance (Figure 5-7A). The study also 
suggests that the system could face oxygen limitation, as the organic substrate mass transfer 
time and the oxygen transfer time are in a similar range. The TiTR system provides the 
flexibility to maximise oxygen transfer by increasing the pressure of the air phase up to 3 
MPa (30 bar converted to SI units). Thus, according to Henry’s law, the oxygen transfer could 
be increased 30 times. Confirming whether higher oxygen concentrations in the aqueous 
phase (at the same kLa value) partially affect product formation rates opens the door to future 
studies. 
The benchmark example in a STR showed a productivity of 0.46 g L-1 h-1 for the HbpA-
catalysed hydroxylation of 2-hydroxybiphenyl with an FDH-catalysed cofactor regeneration 
system.102 The maximal productivity achieved in the present TiTR system was 38 times 
higher than that achieved in stirred batch reactors because of the high substrate mass transfer 
rates. Obtaining such high productivities in three-phase stirred batch reactors is often limited 
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owing to the stirring speed, which sets a trade-off between substrate mass transfer81 and 
enzyme inactivation from the generated shear-stress.164 
Thus, it is anticipated that the TiTR concept will play a significant role in optimising 
multiphasic oxygen-dependent redox biocatalytic reactions.153g The potential of enzymatic 
membrane reactors has already been recognised,173 and the present work opens up the field for 
gas-dependent biocatalytic reactions. P450 or Baeyer-Villiger monooxygenases coupled to a 
cofactor regeneration system are interesting candidates for future applications in a TiTR. 
Oxygen supply and product inhibition are two major limitations observed previously for 
Baeyer-Villiger whole-cell catalysts.174 These limitations are more pronounced in cell-free 
systems, in which enzyme concentrations are higher, requiring higher oxygen mass transfer 
for higher reaction rates and more efficient product removal to overcome product inhibition. 
Similar examples such as the cyclohexanone monooxygenase-catalysed production of 
ε-caprolactone175 could also benefit from this concept because of their similarities to the 
HbpA-catalysed hydroxylation reaction, such as oxygen and cofactor dependency and 
substrate inhibition. 
Although a numbering-up technique is often proposed for the scale-up of microreactors, the 
TiTR in its current design is not suited for an industrial application yet, unless a cheaper 
material with comparable properties is found, because the Teflon AF-2400 used for the inner 
tubing poses a significant cost factor. The numbering-up technique is, surprisingly, not the 
method of choice for the industry because delivering liquids into multiple capillaries at the 
same time poses a risk in that if one capillary is blocked, the residence times in other 
capillaries are changed, which affects the conversion or product composition.176 Nevertheless, 
application of Teflon AF-2400 TiTRs could emerge in the speciality chemicals and 
pharmaceutical markets, in which small-scale syntheses for toxicology studies or clinical 
trials are needed and chemical routes do not exist. It is also anticipated that the TiTR concept 
will play a significant role for optimising multiphasic oxygen-dependent redox biocatalytic 
reactions just as it did for gas-dependent chemical syntheses.153g 
CONCLUSIONS 
This work shows the feasibility of the tube-in-tube reactor (TiTR) concept and sets a 
milestone for performing gas (particularly oxygen)-dependent reactions in capillary 
microreactors. It is also an example of rational reaction design linking the kinetic 
characterisation of the biocatalyst and optimisation of the reaction parameters. The concept 
presented herein has potential for application in selective redox biocatalysis in 
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aqueous/organic segmented flow reactors for gas dependent reactions with cofactor 
regeneration. 
We have applied the TiTR concept to continuous enzymatic hydroxylation. The productivity 
of 17.7±1.8 g L-1 h-1 achieved is significant for a monooxygenase-catalysed reaction with 
concomitant cofactor regeneration, which emphasises the potential of this technology for 
biocatalytic reactions (Table 5-2). Our study points out the importance of the substrate mass 
transfer, which appeared to be rate limiting at substrate concentrations less than 200 mM. In 
addition, tuning the total flow rate had a strong impact on product formation rates and final 
conversion. The effect of higher oxygen partial pressure should be evaluated for further 
increases in productivity. 
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ABSTRACT 
In previous chapter it was shown that the enzymatic hydroxylation of 2-hydroxybiphenyl 
catalysed by 2-hydroxybiphenyl 3-monooxygenase (HbpA) performs better in the tube-in-
tube reactor (TiTR) system, as compared with conventional batch reactors. In this chapter the 
impact of oxygen on the product formation rate was closely evaluated, as it was assumed it 
was one of the major factors influencing the performance of HbpA. Oxygen concentration 
was effectively controlled by the pressure in the tube-in-tube system. The study revealed that 
enzymes’ stability was not affected by increased pressures, which allowed for recycling of the 
biocatalyst. Quantification of oxygen permeability showed that the reaction was not limited 
by the oxygen transfer rate over the membrane or its availability in the aqueous phase. 
Preparative scale synthesis was possible achieving a space time yield (STY) of 14.5 g L-1 h-1. 
740 mg of product was purified by chromatography and subsequent sublimation. 
Furthermore, an ePTFE hydrophobic membrane TiTR, proved advantageous for easier 
aqueous/organic phase separation, and allowed longer operational stabilities of the 
biocatalysts. 
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INTRODUCTION 
Multiphasic reactions, where different phases are separated by means of a semipermeable 
membrane in a TiTR setup, are of increasing interest for chemical and biological reaction 
systems.153, 170 In comparison to plug-flow reactors, gaseous substrates can be supplied much 
more effectively in TiTR setups,153b providing a constant oxygen concentration during the 
entire residence time. This is the most important feature for all reactions (chemical and 
biological) comprising a gaseous substrate as its concentration in the liquid phase needs to be 
high for quantitative conversions.172 One way to increase gas solubility in the liquid is to 
increase liquid’s and gas’ pressure. Recently the TiTR was evaluated for the enzymatic 
hydroxylation of 2-hydroxybiphenyl catalysed by 2-hydroxybiphenyl 3-monooxygenase 
HbpA (chapter 5) at atmospheric pressure. This reaction requires efficient supply of three 
substrates, namely 2-hydroxybiphenyl, NADH, and oxygen. A second organic phase was used 
as carrier phase for 2-hydroxybiphenyl and was supplied in an aqueous/organic segmented-
flow fashion into the lumen of the reactor. Formate dehydrogenase (FDH) in the aqueous 
phase served for recycling NADH, and oxygen (in air) was continuously delivered from the 
shell side of the membrane. We have demonstrated the potential of the tube-in-tube system 
for gas dependent enzymatic reactions and discussed the challenges related to low 
concentration of oxygen in the liquid. At atmospheric pressures, the oxygen supply was 
assumed to limit the productivity due to the reaction times (oxygen consumption time) being 
similar to the oxygen transfer time. Although existing literature shows the potential of the 
TiTR for fast saturation of liquids with ammonia or hydrogen,153b, 153g the oxygen transfer 
rates or saturation time under here applied conditions was not investigated so far. Reported 
theoretical oxygen permeability through the membrane168 was higher than the reaction rates 
measured in this study. Therefore, the gas permeation needed to be quantified and parameters 
limiting the gas transfer determined. Moreover, it was necessary to evaluate the effect of the 
elevated pressure on the biocatalysts’ stability and on the reaction. Because the TiTR has 
already been successfully implemented for multigram-scale chemical synthesis of anti-
inflammatory compound fanetizole,153g the ultimate goal was to use this technology for a 
biocatalytic preparative scale synthesis of 3-phenylcatechol. 
MATERIALS AND METHODS 
Chemicals 
NADH disodium salt and 1-decanol were obtained from Applichem (Darmstadt, Germany), 
sodium formate, NAD+ disodium salt and FAD from Fluka (Buchs, Switzerland), 2-
hydroxybiphenyl, activated aluminium oxide (neutral, CAMAG 507-C-I, Brockman grade I) 
104 | Chapter 6 
 
from Sigma-Aldrich (Taufkirchen, Germany) and 2,3-dihydroxybiphenyl from Wako Pure 
Chemical Industries Ltd. (Osaka, Japan). All other chemicals were purchased either at Fluka, 
Applichem or Sigma-Aldrich at the highest purity required and used as received. 
Enzymes 
The enzyme production and purification was based on procedures described in Chapter 2. 
Enzyme activity assays 
Monitoring the activity of the HbpA and FDH in a spectrophotometric assay was done as 
reported in Chapter 2. 
HbpA activity determined by product formation – RP-HPLC analysis 
Monitoring of the HbpA catalysed biotransformation reaction was achieved by determining 
the concentration of the product 2,3-dihydroxybiphenyl. Measurements were done using a 
Hitachi Elite LaChrom HPLC system equipped with a Hitachi Elite LaChrom L-2450 Diode 
Array Detector. All measurements were performed either on an XTerra RP 18 3.5 µM column 
(Waters, Dublin, Ireland). An isocratic method at a total flow rate of 1 mL min-1 50:50 (% 
v/v) ACN-water (both supplemented with 0.1% TFA) was used for elution. The product 
2,3-dihydroxybiphenyl as well as the substrate 2-hydroxybiphenyl were detected at 2.69 and 
3.19 min retention time on an XTerra RP column. Concentrations of 2,3-dihydroxybiphenyl 
were calculated as a peak area ratio of 2-hydroxybiphenyl to 2,3-dihydroxybiphenyl. 
TiTR setup 
The TiTR Gastropod® was obtained from Cambridge Reactor Design (Cambridge, UK). An 
exemplary assembly is shown in the Figure 6-1. A basic unit was 1-m-long (0.5 mL volume 
inside the Teflon AF-2400 membrane; i.d.: 0.8 mm, o.d.: 1.0 mm), as indicated. The 
membrane was kept in a 1/8 inch Tefzel tube. The back pressure was controlled by a back 
pressure regulator (BPR) installed on the outlet of the membrane. To avoid pulsation in the 
system caused by difference in liquids viscosities, a coiled 1-m-long 1/8 inch PFA tube was 
connected by a T-connector (UpChurch Scientific, Göhler HPLC, Chemnitz, Germany) to the 
BPR. After equilibrating the system, the air, which was initially present in this tube, 
pressurised and exerted a stable back pressure on the system. TiTR assembly allowed 
independent control of the gas pressure, and partial pressure difference across the membrane. 
Two Chemyx Nexus 6000 syringe pumps (KR Analytical, Sandbach, UK) were used to pump 
aqueous and organic phase streams. Liquids were united in a T-connector (i.d.: 1.0 mm) 
forming a stable segmented flow as sketched out in Figure 6-2.  
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Figure 6-1: Exemplary TiTR setup with the peripherals. 
 
 
Figure 6-2: Schematic view of the liquid/liquid segmented flow setup. HbpA catalysed 2-hydroxybiphenyl 
hydroxylation with concomitant NADH regeneration catalysed by FDH takes place in the aqueous phase (KPi 
buffer). Substrates and products are extracted and delivered via organic phase (n-decanol). 
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Air was delivered from an in-house pressurised air system (nominal pressure 8 bar). Oxygen 
was delivered to the outer membrane directly from the pressurised oxygen tank (200 bar). 
When longer residence times were required either a PTFE tube (i.d.: 1/16 inch) was connected 
to the reactor outlet before the BPR or a 4 m (2 mL volume) version of a TiTR was used, 
which was assembled on site with commercially available interconnects (Swagelok, Kings 
Langley, UK). (chapter 5, Figure 5-1). Reaction temperature was controlled by a keeping the 
reactor in a water bath. 
Reaction in TiTR  
Unless stated otherwise, all biotransformation reactions were performed in the TiTR. 
Residence time was controlled through total flow rates. Relative flow rates were kept constant 
by maintaining the aqueous to organic phase ratio of 1:1. The aqueous phase was 
complemented by adding 50% glycerol solution of HbpA and FDH (for final volumetric 
activities of 2-20 U mL-1), sodium formate (100 or 166 mM), NAD+ (1 or 1.6 mM), FAD (20 
or 100 µM), and Tween 20 (0.6 mg mL-1) for facilitating flow stability and preventing 
enzyme inactivation, and the reaction mixture was adjusted with KPi buffer (100 mM, pH 
7.5) to the respective volume for achieving the required volumetric activities. The aqueous 
phase was filtered through a 0.22 µm Millex-CP syringe filter with a polyethersulfone 
membrane to remove any particles that would have otherwise deposited in the reactor and 
resulted in flow instabilities later. 2-Hydroxybiphenyl (200 or 400 mM in the organic phase) 
in n-decanol formed a separate organic phase. Unless stated otherwise the reactor was 
thermostated at 30°C in a water bath. 
In one experiment a variable length PFA tube (1-4 m long, i.d.: 1 mm, 0.8 mL m-1) was 
connected behind the TiTR unit for increasing residence time. 
Gram scale production of 2,3-dihydroxybiphenyl in a sequential TiTR 
For gram scale production of 2,3-dihydroxybiphenyl a reactor setup presented in Figure 6-3 
was used. It consisted of two connected TiTR units, in which each single unit was followed 
by a coiled 3-m-long PTFE tube (i.d.: 1 mm, 0.8 mL m-1) for increasing residence time. 
Oxygen was delivered from an oxygen tank separately to each TiTR unit. Product was 
collected in a glass flask kept on ice and continuously flushed with nitrogen gas to avoid 
product degradation by over-oxidation. Reaction temperature was controlled at 35°C. 
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Figure 6-3: Schematic view of the sequential TiTR setup for the gram scale production. 
 
Application of ePTFE TiTR for complete phase separation 
The TiTR was modified by implementing an additional reaction compartment consisting out 
of an ePTFE tube (o.d 1/8 inch, 1.5 m, 11.13 mL; FluorTex, Raubling, Germany) combined in 
the tube-in-tube fashion with a PFA tubing (o.d. 1/4 inch, 1.2 m long, 14.8 mL). This reaction 
compartment (reaction module) was supplied with 2-hydroxybiphenyl dissolved in MTBE 
into the inner ePTFE tubing, while the outer shell contained the aqueous enzyme solution 
delivered from the TiTR unit (oxygen saturation module). Liquids were thus kept in separate 
compartments in the reactor allowing for an independent control of their flow rates and 
residence times, as well as for a simplified downstream processing. A schematic view of the 
experimental setup is presented in Figure 6-4. 
A typical experiment contained 5.9 mL aqueous phase comprising HbpA (8.7 U mL-1), FDH 
(8.5 U mL-1), 100 mM sodium formate, 1 mM NAD+, 20 µM FAD, 0.6 mg mL-1 Tween 20, 
filled up to the respective volume with KPi buffer (100 mM, pH 7.5) on the feed side in the 
contact with the 8.9 mL organic phase comprising 200 mM 2-hydroxybiphenyl dissolved in 
MTBE in the lumen. Prior entering the reaction module the aqueous phase was saturated with 
oxygen in the oxygen saturation module (1 m TiTR unit). The reaction was not thermostated 
and was conducted at an ambient temperature of 19°C. Flow rate of the aqueous and organic 
phase was 0.15 and 0.07 mL min-1 respectively, resulting in the residence time of the organic 
phase in the reactor of 127 min. Collected enzymes could be recirculated, whereas the product 
could be separated directly from the organic phase without prior phase separation. 
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Figure 6-4: Schematic view of the setup used for an ePTFE TiTR utilised for achieving complete phase 
separation. The O2 saturation module is a classical 1 m TiTR with a Teflon AF-2400 tubing, whereas the reaction 
module is an ePTFE TiTR. 
 
Product purification 
Product purification was achieved by applying chromatography adapted from Schmid et al 
(2001)21 and scaled-up for our purposes. Shortly, 150 g of activated alumina was suspended in 
methanol and poured into a glass column. 0.5 cm of sea-sand was deposited on top. The 
column was washed with methanol. 360 mL of the decanol containing a mixture of 
2-hydroxybiphenyl (10.4 g) and 2,3-dihydroxybiphenyl (2.0 g) was added and pushed through 
by applying a 0.5 bar overpressure. 200-300 mL fractions were collected. When decanol was 
almost eluted, methanol was applied on top. Elution was monitored by TLC (stationary phase 
– neutral alumina, mobile phase – 0.5 M HCl in methanol). A total of 0.9 L of methanol was 
used to elute decanol and the residual substrate. When no more substrate or decanol could be 
detected the eluent was changed to 0.5 M HCl in methanol for eluting the product. 1 L of 
eluent was used. After first 150-200 mL, fraction volume was changed to 20 mL. Product 
eluted from the column as a green liquid of neutral pH and was followed by an acidic 
brownish/red liquid that contained only residual amounts of product. Green-coloured samples 
1m TiTR
0.8 mL
O
2-5 bar
2
aqueous phase
organic phase
inner ePTFE
membrane outer PFA
tube
flow
substrateprod enzymes
substrate, product
O saturation module2
gas in
organic in
1m TiTR
organic out
enzymes in
enzymes out
enzymes in
reaction module
Materials and methods | 109 
 
were checked on the HPLC and most prominent fractions were pooled (ca. 70 mL, 99% purity 
by HPLC) and dried on a rotary evaporator (initially 40°C and 250 mbar reduced to 28 mbar 
over 3.5 h; final drying step was done at 35°C for 1 h). A total of 4 g of residue was collected 
and successfully sublimated in batches on a ‘cold finger’ (1.5-1.2 mbar, cooling water at 2°C). 
The cold finger was heated up uniformly either by a heat gun or in an oil bath set to 120°C. 
The white powder was removed from the cold finger; the cold finger was washed with 
methanol and the process was repeated. A total of 740 mg of product was collected. 11 mg of 
powder was resuspended in 0.75 mL of CDCl3 and analysed on 300 MHz H-NMR. The 
spectrum measured was compared to that of the standard of the product and substrate and the 
white powder was ultimately identified as 2,3-dihydroxybiphenyl (Appendix, Figure A9). 
Burette method 
To quantify the amount of air passing through the membrane the burette method adapted from 
O’Brien et al. (2011)153b was used (Figure 6-5). A glass burette filled with liquid, was inverted 
and submerged in a cylinder. The burette was closed at the top and the liquid from the reactor 
was delivered to the burette from the bottom. When the liquid decompressed, gas travelled to 
the top and caused the displacement of the liquid in the burette. The volume of the gas was 
quantified and the volume of the oxygen in the collected gas was calculated using Henry’s 
law. 
 
Figure 6-5: Picture and schematic view of the setup used for the burette method of quantification of the gas 
passing through the Teflon AF-2400 membrane. Displaced liquid – A. Bubbles of the gas after decompression – 
B. Entry of the reactor outlet tube – C. (BPR – back pressure regulator) 
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RESULTS 
Factors influencing gas transfer through the Teflon AF-2400 membrane 
For Teflon AF-2400 permeability values of 990 Barrer for oxygen and 490 Barrer for nitrogen 
are published,168 [1 Barrer=10-10 cm3gas(STP) cmmembr (cm2membr s cmHg)-1, or translated to SI 
units 1 Barrer=3.348×10-19 kmol m (m2 s Pa)-1]. The unit ‘Barrer’ is used here as a measure 
for permeability of membranes.177 For a 2-m-long Teflon AF-2400 membrane (1 mL volume) 
(i.d.: 0.08 cm; o.d.: 0.1 cm) these values translates to 20.8 µmol min-1 (0.41 µmol min-1 cm-2) 
or 39.9 mg h-1 oxygen at 0ºC and an oxygen partial pressure difference of 20.8 kPa (15.6 
cmHg converted to SI units), that is, when the pressure around the tube is equal to 
atmospheric pressure and the liquid in the tube is oxygen free. Increasing the partial pressure 
of oxygen either by increasing the total pressure of the gas or by using oxygen enriched air (or 
pure oxygen) will have a positive impact on oxygen transfer. It was our aim to quantify the 
amount of O2 passing through the membrane, characterise the parameters influencing its 
transport and its effect on HbpA performance. Results of gas permeability experiments are 
shown in Figure 6-6. 
In all experiments the liquid in the membrane upstream of the back pressure regulator was 
homogenous (free of gas bubbles), to ensure that the gas collected and quantified in the 
burette outgassed from the liquids. Not surprisingly, the final gas titre was dependent on the 
back pressure in the membrane as the back pressure determined the maximum gas (oxygen) 
solubility in the liquids. In the single phase experiment, when only KPi buffer was fed into the 
reactor, the gas titre was the highest for the 6.9 bar back pressure with a 7 bar air pressure 
around the membrane (Figure 6-6A). In this simple experiment it was confirmed that the 
TiTR offers quick and reliable control of the amount of the dissolved gas by changing the 
pressure on the feed and permeate. Next, the composition of the feed in the context of oxygen 
transfer was investigated. When KPi buffer and decanol as a substrate carrier phase (at 1:1 
phase ratio) were fed simultaneously, the amount of gas collected continuously was higher for 
two-phase flow than for the single phase (KPi buffer only) flow fed at the same flow rate 
(Figure 6-6B). Since the solubility of air is known to be higher in organic solvents,98 the 
higher gas titre in the aqueous/organic two phase flow was not surprising. The effect of the 
flow rate on oxygen transfer was also investigated (Figure 6-6C). At higher flow rates more 
gas outgassed from the liquids in a defined time as compared to slower flow rates. The flow 
rate is an important parameter because it determines the actual concentration of the gas in the 
liquid at a specific time point and therefore impairs or facilitates the transport, as the gas flux 
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is proportional to the difference of the maximum gas concentration minus the actual gas 
concentration in the liquid. 
 
Figure 6-6: Gas (air) transport through the Teflon AF-2400 membrane in a 1 m TiTR (0.8 mL total volume, 0.5 
mL volume inside the membrane) determined by the burette method. A – Influence of the back pressure on the 
final gas titre in KPi buffer (flow rate 0.8 mL min-1). B - Gas transport at 6.9 bar back pressure into KPi buffer 
and into a 1:1 decanol – KPi buffer system. Total flow rate 0.8 mL min-1. C - Effect of the flow rate on the 
amount of transported gas at 6.9 bar back pressure in a 1:1 decanol – KPi buffer system. D – Dependence of the 
final gas titre in a 1:1 decanol – KPi buffer system on the residence time at 6.9 bar back pressure. 
 
Quantifying the gas outgassing from the liquids at different flow rates allowed to determine 
the final gas titre (mL gas dissolved per L of liquid), which could be reached inside the TiTR 
(Figure 6-6D). Although the gas titre was dependent on the residence time almost full 
saturation was reached within 40 seconds. Similar findings were reported for hydrogen 
passing Teflon AF-2400 membranes, where almost complete saturation of a dichloromethane 
phase with H2 was reached within 10 seconds.153b Those results prove that the gas transport 
rate and the final gas titre depend on the composition of the feed (phase to be saturated), and 
its capability to dissolve gas. The same was observed for the transport of ammonia through 
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the Teflon AF-2400 membrane where the amount of ammonia in the permeate was different 
in methanol, dimethoxyethane, or toluene (concentration increased with increasing dielectric 
constants).153g 
The aim of the next experiments was to check the effect of increased oxygen concentration on 
the biotransformation in the TiTR and investigate enzymes’ stabilities with respect to the 
increased pressure. 
Enzyme stability and activity in pressurised TiTR 
The effect of pressure and aqueous/organic two phase flow on biocatalyst stability and 
activity was assessed. In terms of enzyme stability no difference between activity losses in a 
pressurised system (outlet at 6.9 bar), and a non-pressurised system (outlet at an atmospheric 
pressure) was found (Table 6-1). Due to these findings the negative impact of the pressure on 
the enzyme was excluded. 
Table 6-1: Influence of the back pressure in the reactor (6.9 bar at the outlet) on the residual enzymes’ activity 
after passing through 1 m TiTR reactor. Total flow rate 0.1 mL min-1, respective residence time 8.9 min. (n=2)  
 Initial After passage 
enzyme (U mL-1) 0 bar (U mL-1) 6.9 bar (U mL-1) 
HbpA 2.3±0.1 1.9±0.1 1.9±0.0 
8.7±0.1 6.7±0.4 7.8±0.1 
21.6±1.5 23.3±0.5 24.2±1.5 
FDH 1.7±0.1 1.4±0.0 1.5±0.0 
5.6±0.1 5.9±0.1 6.7±0.1 
13.1±0.8 15.8±1.6 14.6±0.4 
 
The results of the abiotic experiment aiming at quantifying the oxygen permeability at 
different flow conditions established process operational boundaries. It was also shown that 
oxygen concentration in the aqueous phase was proportional to its pressure. According to 
Henry’s Law at an atmospheric pressure oxygen solubility in water does not exceed 
245 µM,178 but increases linearly with increasing pressure. To see the effect of higher oxygen 
concentration in the reaction medium, reactions with an increased back pressure were 
conducted. Pressure was controlled by installing a back pressure regulator at the reactor outlet 
and the influence it had on the product formation rate was checked during the 
biotransformation reaction. 
Figure 6-7A gives an overview of the experiment and clearly shows that there is a slight 
impact of the pressure on the reaction rate, but it is not as high as expected, and the reaction 
rate increase does not correlate to the oxygen concentration. Varying the differential gas 
(oxygen) pressure across the membrane also had no further impact. The pressure of the liquid 
was kept low (1.4 bar) while the pressure of the air surrounding the membrane was set to 8 
bar. As a control, the pressure of the liquid was set to 6.9 bar and that of the surrounding air to 
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7 bar. In both cases the product formation rate and the final product titre were comparable 
(Figure 6-7B). Exchange of the air with pure oxygen, and hence increasing the amount of 
available oxygen by the factor of five, also had no further impact on the product formation 
rate. From these findings it could be concluded, that the reaction was not limited by the gas 
transport and oxygen availability and further experiments were conducted to check whether 
the biotransformation rate was limited by catalyst loading. 
 
Figure 6-7: A – Influence of the back-pressure on the product formation rate in a 1 m TiTR (0.8 mL total 
volume). Outer membrane pressure of the air set to 0.0 bar (atm), 1 bar, 2 bar, 4 bar, and 5 bar at subsequent 0.0 
bar (atm), 1.4 bar, 2.8 bar, 5.2 bar, and 6.9 bar back pressure respectively. Product formation rate given is the 
average value, calculated by dividing the final product concentration in the sample by the sample residence time. 
B - Influence of changing differential pressure across the membrane and applying pure oxygen instead of air in a 
1 m TiTR (0.8 mL total volume; flow–rate: 0.8 mL min-1 ). Product formation rate was calculated for one litre of 
reactor working volume. 
 
Influence of the biocatalyst loading on the product formation rate 
Reaction conditions were set to 6.9 bar back pressure and 7 bar of the surrounding air. Under 
these conditions the impact of the catalyst loading on the reaction rate was investigated. 
HbpA and FDH initial volumetric activities in the aqueous phase were raised stepwise (unit 
ratio of the enzymes was kept at 0.81:1 FDH:HbpA U:U). At low enzyme loading (2 U mL-1 
HbpA) the reaction was limited by the enzyme amount, but above 8 U mL-1 the impact of the 
enzyme concentration was negligible and applying more catalyst did not have an impact on 
the product formation rate (Figure 6-8A). The reaction operated at zero order with respect to 
the reactants, which were added in excess, as well as relatively short residence times. 
Similarly to results obtained earlier and presented in Figure 6-7A the product formation rate 
increased with increasing total flow rate. Thus, we assumed that the product formation rate 
was dependent on the mass transfer of the organic substrate between the phases and not on the 
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oxygen availability or the catalyst amount applied. It is known that with increasing flow rate 
the mass transfer increases in a two phase flow microreactors84 as a direct consequence of 
faster internal circulations in the segments.179  
 
Figure 6-8: A - Influence of enzyme loading and flow rates on the product formation rate in a 1 m TiTR (0.8 mL 
total volume) run at 6.9 bar back pressure and 7 bar air pressure in a two liquid phase system. Respective 
residence times reached were 8.9 min, 4.5 min, 2.2 min, and 1.1 for increasing flow rates. Standard reaction 
conditions applied as described in experimental section. Product formation rate given is the average value, 
calculated by dividing the final product concentration in the sample by the sample residence time. B - Product 
formation rate and final product titre in the system aerated with pure oxygen instead of air at various residence 
times. Flow rate: 0.8 mL min-1 with a residence time of 2.1, 3.1, 4.1, 5.1 min respectively for increasing reactor 
length (errors are presented as a standard deviation, n=3). Product formation rate is given for one litre of reactor 
working volume. 
 
Based on the results obtained in the experiment with pure oxygen it became clear that reaction 
was not oxygen limited. We have actually expected that not all oxygen was consumed 
because substituting air with pure oxygen would result in 5-fold higher oxygen concentration 
in the liquids, but conversions remained constant. Therefore, to verify if that surplus of 
oxygen can be utilised, reactions with a residence time unit installed behind 1 m TiTR were 
conducted. With increasing lengths of the residence time unit the conversion of 
2-hydroxybiphenyl increased until it stayed nearly constant at 5.1 min, while the product 
formation rate decreasing gradually (Figure 6-8B). Since aeration was not possible outside the 
TiTR module, the maximum length of an extension unit was dependent on the availability of 
oxygen in the liquid entering this part of the reactor system. As a compromise between the 
product formation rate and the final product titre a residence time unit of 3 m (2.4 mL) was 
chosen, resulting in a residence time of 4.1 min. This setting was the basis for an experiment 
on a preparative scale applying HbpA in a sequential TiTR for the synthesis of 
2,3-dihydroxybiphenyl. 
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Synthesis of 2,3-dihydroxybiphenyl on a preparative scale using a pressurised 
sequential TiTR 
Conducting the reaction in a TiTR longer than 4 m was not possible due to the nature of the 
Teflon AF-2400 membrane. Longer tubes are fragile and more susceptible to snapping while 
handling. In order to access higher product titres a sequential reactor was assembled (as 
schematically presented in the Figure 6-3). After the first TiTR a residence time unit was 
connected, followed by another TiTR, and a second residence time unit. This way the total 
reactor volume was increased to 8 mL and the residence time achieved with a flow rate of 0.7 
mL min-1 was 11.5 min. 
 
 
The system introduced above was operated in a semi-continuous mode. During the first 7 
cycles freshly prepared enzyme solutions were used, whereas for the 8th cycle 50 mL of the 
recycled enzyme solution supplemented with sodium formate (4 mmol) and NAD+ (20 µmol) 
was used instead, to verify if the enzymes could be reused (Figure 6-9). Before the 8th cycle, 
the activity of the recycled enzymes were measured in an independent UV assay and 
compared to the initial ones revealing almost 90% residual HbpA activity while FDH did not 
experience any activity loss (Table 6-2). Surprisingly conversion in the TiTR was 
significantly lower, when using recycled enzyme solution. This could be attributed to the 
composition of the recycled aqueous phase, which also contained residual organic solvent and 
the dissolved product. This could inhibit the HbpA in the TiTR. Activity measured in a 
spectrophotometric assay would not be affected thereby, as the respective samples were 
diluted 300-fold prior to the measurement. 
During the whole experiment the reactor outlet was placed in a bottle continuously flushed 
with nitrogen in order to prevent the hydroxylation reaction continuing outside of the reactor. 
Figure 6-9: Synthesis of 3-phenylcatechol in a 
sequential TiTR reactor. Product concentrations have 
been determined in the sample collected at the reactor 
outlet during consecutive cycles and are given for a 
total volume (combined aqueous and organic phase). 
The 8th cycle was conducted with 50 mL of the 
recycled aqueous phase supplemented with sodium 
formate (4 mmol) and NAD+ (20 µmol). Total 
residence time in the system (8 mL) ca. 11.5 min at 
total flow rate of 0.7 mL min-1. For cycle 5, 6 and 7 
n=1. 
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After every cycle the phases were separated and the collected organic phase was eventually 
used for product recovery. 
Table 6-2: Activity of HbpA and FDH measured in a spectrophotometric assay before and after the reaction in 
the sequential TiTR system (TiTRs and residence time units). Residence time 11.5 min. (errors are presented as a 
standard deviation, n=2) 
enzyme initial volumetric activity [U mL-1] 
final volumetric 
activity [U mL-1] 
residual activity 
[%] 
HbpA 10.26±0.21 9.16±0.19 89.3 
FDH 6.76±0.14 7.51±0.16 111.2 
 
Purification of the product 2,3-dihydroxybiphenyl was successful and 740 mg of the 
product were isolated 
Using the sequential TiTR for 2-hydroxybiphenyl hydroxylation it was possible to synthesise 
12 mmol of product and isolate 4 mmol (740 mg) of pure (>99% by HPLC and H-NMR) 
2,3-dihydroxybiphenyl (Figure 6-10). 
 
Figure 6-10: Summary of hydroxylation of 2-hydroxybiphenyl to 2,3-dihydroxybiphenyl on a preparative scale. 
 
The purification pipeline is schematically shown in the Figure 6-11. The collected sample was 
centrifuged in order to achieve separation of the aqueous and organic phase. From the 400 mL 
organic phase present, only 360 mL were removed as a precaution not to contaminate the 
sample by accidentally transferring precipitated proteins or aqueous liquid. This organic 
sample was directly loaded onto a neutral alumina column. During the elution with acidic 
methanol the top of the column became darker. Over the time the dark ring moved downward 
and become green followed by a brownish/red ring (see Figure 6-11). The pH of the green 
eluent was neutral. It contained most of the product and ca. < 1% of the substrate (as analysed 
by the HPLC). When the green fraction was acidified it turned brownish red like the fractions 
that followed. The overall product isolation yield after all purification steps was 35%, and the 
product was confirmed by the H-NMR. 
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Figure 6-11: Step-by-step product purification procedure: product separation on the neutral alumina column, 
analysis of the consecutive fractions by the TLC and HPLC method, dried sample collected from the column, 
sublimation of the product on the cold finger, and H-NMR spectrum of the standard and the isolated product. 
 
ePTFE module for reaction and phase separation 
To increase enzymes’ stability and simplify biocatalyst recovery the standard TiTR was 
modified by incorporation of an ePTFE membrane tube-in-tube module as described in detail 
in the experimental section. This additional membrane module should enable separation of 
aqueous and organic phase during biotransformation and facilitate biocatalyst recovery, 
making phase separation redundant prior to enzyme recycling. However, the used ePTFE 
membrane proved to be not suited for the applied solvents MTBE and decanol. In both cases 
the solvent soaked through the ePTFE membrane into the aqueous phase turning it cloudy, 
although no second phase was formed. Furthermore the solvent, which bled through the 
ePTFE tube at the entrance of the reactor, evaporated resulting in solidified 
2-hydroxybiphenyl at the respective connectors (Figure 6-12). The organic phase, on the other 
hand, was free of water, which is a clear advantage of this set-up. 
Product concentrations in the MTBE phase were in the range of 4-6.5 mM (approx. 2-3% 
conversion of applied substrate) (Figure 6-13). Substrate was applied at relatively high 
concentrations (200 mM) to maximise the membrane mass transport (no partition ratios 
between organic phase-membrane and membrane-aqueous phase were however determined 
prior to the experiment). 
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Figure 6-12: Schematic view of the ePTFE TiTR during the reaction. Numbers in the scheme refer to the 
respective pictures below. 1 – membrane soaking with MTBE. 2 – MTBE bleeding through the ePTFE 
membrane at the outlet. 3- solid 2-hydroxybiphenyl after MTBE evaporation. 4 – aqueous free organic phase 
collected after reaction. 5 – cloudy aqueous phase containing some MTBE. 
 
In the three consecutive experiment phases (I, II, and III as shown in the Figure 6-13) reaction 
parameters were varied. Initially used fresh enzyme solution was recycled in phase II. 
Enzymes assayed in an UV activity assay after the run with MTBE showed 90% and 88% 
residual activity for HbpA and 62% and 70% for FDH after phase I and II respectively. 
Enzymes did not lose activity after the 2nd consecutive run proving that separate delivery of 
aqueous and organic phase into the bioreactor had a beneficial effect as no aqueous/organic 
interface, where enzymes could denature, was present (aqueous/organic interface is however 
still present in the membrane pores). There was no enzyme precipitation, which is often a sign 
of protein denaturation, and the phase separation was simplified as phases did not mix during 
the reaction. In phase III again fresh enzymes were used, whereas the pressure in the oxygen 
saturating module was increased from 2 to 5 bar, since it was expected that the oxygen 
concentration in the aqueous medium in the phase I and II was too low for the long residence 
time of 40 min. Because only the aqueous phase was saturated with oxygen prior to entering 
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the reaction module it seemed appropriate to introduce air segments into the aqueous phase by 
saturating it at 5 bar and letting it decompress in the reaction module after passing the BPR. 
Product concentration however, did not increase in the phase III, meaning that there is some 
other mechanism limiting the reactor performance (vide infra). 
 
DISCUSSION 
Quantification of oxygen permeability through the Teflon AF-2400 membrane in a 
TiTR – oxygen vs. air 
A simple calculation was proposed for determining the volume of the oxygen in the total 
volume of gas degassing from the liquid after passage through Teflon AF-2400 membrane in 
the TiTR. The air used as a gas phase was composed of 21% O2 and 78% nitrogen. Because 
Teflon AF-2400 is more selective for oxygen, oxygen is transported faster than nitrogen. By 
comparing fluxes of nitrogen and oxygen streams through the membrane determination of that 
ratio was possible. Under the assumption that the driving force is equal to the initial partial 
pressure difference (Δpi), and that it is constant, one may write two flux equations (Equation 
6-1 and Equation 6-2). 
Equation 6-1 
ܬைమ ൌ
ܲ݁ݎܾ݈݉݁ܽ݅݅ݐݕ
ߜ௠௘௠௕௥ ∙ ∆݌ைమ	 
Equation 6-2 
ܬேమ ൌ
ܲ݁ݎܾ݈݉݁ܽ݅݅ݐݕ
ߜ௠௘௠௕௥ ∙ ∆݌ேమ  
For a membrane thickness of δ=0.01 mm and permeability for oxygen and nitrogen of 990 
and 490 Barrer respectively, the theoretical fluxes of oxygen and nitrogen were calculated as 
follows: 
 
Figure 6-13: Concentration of 2,3-dihydroxybiphenyl 
measured continuously in the organic phase after the 
reaction in an ePTFE TiTR. MTBE - I – oxygen pressure 
2 bar, II – oxygen pressure 2 bar and enzymes recycling, 
III – fresh enzymes and oxygen pressure 5 bar with a 
BPR (5 bar) installed behind oxygen saturation module 
before the ePTFE reaction module. Residence time of 
the aqueous and organic phase was approx. 40 and 130 
min respectively. 
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ܬைమ ൌ
990 ∙ 10
ିଵ଴ 	 ∙ ܿ݉ଷைమ. ܿ݉௠௘௠௕௥ݏ ∙ ܿ݉ଶ௠௘௠௕௥ ∙ ܿ݉ܪ݃
0.01	ܿ݉௠௘௠௕௥ ∙ 0.21 ∙ 76	ܿ݉ܪ݃ ൌ 1.58 ∙ 10
ିସ ܿ݉ଷைమ
ݏ ∙ ܿ݉ଶ௠௘௠௕௥	 
ܬேమ ൌ
490 ∙ 10
ିଵ଴ 	 ∙ ܿ݉ଷேమ. ܿ݉௠௘௠௕௥ݏ ∙ ܿ݉ଶ௠௘௠௕௥ ∙ ܿ݉ܪ݃
0.01	ܿ݉௠௘௠௕௥ ∙ 0.78 ∙ 76	ܿ݉ܪ݃ ൌ 2.90 ∙ 10
ିସ ܿ݉ଷேమ
ݏ ∙ ܿ݉ଶ௠௘௠௕௥ 
ܬ௧௢௧௔௟ ൌ ܬைమ ൅ ܬேమ ൌ 4.48 ∙ 10ିସ
ܿ݉ଷ௧௢௧௔௟
ݏ ∙ ܿ݉ଶ௠௘௠௕௥ 
 
JN2 is the flux of nitrogen and JO2 is the flux of oxygen. By dividing the oxygen flux by the 
total flux one could calculate the ratio of oxygen in the total gas flux to be 0.35 (or 0.35 
cmO23 cmtotal-3). Results are summarised in Table 6-3.  
Table 6-3: Oxygen concentration and transport rate in liquid/liquid two phase flow (KPi buffer: decanol at 1:1 
ratio) at 30°C and 6.9 bar back pressure. 
nature of gas Total flow rate [mL min-1] 
O2 concentration in 
reactor [mM] 
O2 transport rate[c]  
[µmol min-1 mLreactor-1] 
air[a] 0.8 5.3 8.4 
 0.4 5.7 - 
 0.2 5.9 - 
 0.1 6.0 - 
pure oxygen[b] 0.8 15.0 24.1 
[a] volume fraction of oxygen in the air after passing through the membrane is equal to 0.35 
[b] assuming that molar fraction of oxygen in the air after passing through the membrane is equal to 1 all 
transported gas is oxygen and it is possible to calculate approximate oxygen concentration and its transfer rates 
[c] because the experiment was conducted in the range close to the oxygen saturation levels only a theoretical 
oxygen transport rate is given. Calculations are based on the assumption that oxygen (air) is transported steadily 
over the residence time and the saturation is not reached earlier. 
 
Quantifying gas transfer through the membrane was important as it was possible to ultimately 
exclude oxygen limitation. It also allowed for establishing the maximum operational 
boundaries of the reaction system. A maximal oxygen transport rate through the Teflon AF-
2400 membrane at a flow rate of 0.8 ml min-1 was calculated to be 8.4 µmol min-1 mLreactor-1 
for air, and theoretically 24.1 µmol min-1 mLreactor-1 for oxygen (vide infra). Compared to the 
reported STY of 26.6 g L-1 h-1 (overall volumetric productivity 3.4 µmol min-1 mLreactor-1) for 
the synthesis of tert-leucine in a process running at Evonik9b in an enzyme membrane reactor, 
the potential of the here proposed reactor setup for oxygen limited reactions becomes clear. 
However, this potential was not utilised for the here applied reaction, as a rate of only 
1.3 µmol min-1 mLtotal-1 (1.3 mM min-1) was reached, leaving room for future improvements. 
Despite these shortcomings the increased concentrations of dissolved oxygen in the liquid 
resulting from the pressurised TiTR system could be efficiently utilised in the sequential 
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TiTR setup and the residence time could be extended to 11.5 minutes, without running into an 
oxygen limitation. 
Overcoming product inhibition of 2-hydroxybiphenyl 3-monooxygenase, HbpA by 
using solvents with higher organic/aqueous partition ratios of product  
As previously reported,42 the 2,3-dihydroxybiphenyl has a detrimental effect on the HbpA 
activity. It inhibits catalysis by almost 30% already at a concentration of 1 µM. Decanol was 
therefore used as a second organic phase to continuously extract 2,3-dihydroxybiphenyl from 
the aqueous phase and prevent product inhibition. The partition ratios for 2-hydroxybiphenyl 
and 2,3-dihydroxybiphenyl for decanol were determined to be 480 and 380 respectively 
(Chapter 5). Thereby, an inhibition of HbpA is to be expected already at 0.5% conversion, i.e. 
when the concentration of product in the organic phase reaches 1 mM. This is well visualised 
in the Figure 6-8B where with increasing conversion the product formation rate steadily 
decreases. Product inhibition could be further suppressed in aqueous/organic segmented flow 
with different solvent systems which have higher partition ratios, e.g. MTBE (2200 and 1425 
for 2-hydroxybiphenyl and 2,3-dihydroxybiphenyl respectively) resulting in lower product 
concentration in the aqueous phase at the same level of conversion. However, due to high 
substrate partition ratio, resulting in low substrate concentrations in the aqueous phase, 
product formation rates might be lower since the reaction could become mass transfer limited 
again. Nevertheless, it is difficult to judge from the results presented in this chapter if the 
MTBE had a beneficial effect, preventing HbpA product inhibition, because detailed 
membrane transport characteristics for 2-hydroxybiphenyl/2,3-dihydroxybiphenyl were not 
known. Thus, judging if the membrane transport or too high substrate partition ratio was rate 
limiting factors is difficult and should be preceded by careful membrane transport 
characterisation. 
Enzyme consumption and strategies for maximising the TTN 
One way to use the catalyst more efficiently is to conduct the reaction with higher residence 
times in longer TiTR systems and consequently reach higher conversions. Initially we were 
limited to a maximum length of 4 m and a residence time of 3 min at a flow rate of 0.8 
mL min-1. By connecting TiTR units in a sequential fashion the residence time was extended 
to 11.5 min improving the conversion (and TTN) and simplifying product separation from a 
substrate/product mixture. Another approach was to recycle the enzymes. In this case the 
phases needed to be separated before and 9.7 mM product were produced (Figure 6-9, cycle 
8). The product concentration was however lower than 15 mM reached with fresh enzymes 
(Figure 6-9, cycles 1-7). Even after accounting for the enzyme activity loss during the first 
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run higher product concentrations were expected. It raised our concerns that there might be 
another reason for lower product formation rates. Shear induced reversible quaternary 
structure loss of the enzymes in the microreactor could be one reason for the low product 
formation rates in the reactor, however, in the UV-assay higher enzyme activities than in the 
reactor were measured. It may be that HbpA was mainly present as a monomer in the reactor 
hence it was not as active as in its native tetrameric form (Table 6-1 and Table 6-2) (for more 
information on that topic see chapter 7). Another hypothesis was the difference in the reaction 
conditions between the UV assay and the 8th cycle. Due to the sample preparation (dilution) 
for the UV activity assay the conditions are assumed to be always constant and most likely 
did not reflect the reaction conditions in the enzyme solution used in cycle 8, which contained 
residual dissolved organic solvent carrying substrate and product. 
Mass transfer 
The overall volumetric mass transfer coefficient (kLa) calculated on the base of the product 
formation rate for the aqueous phase (2.6 mM min-1) and the initial equilibrium substrate 
concentration in the aqueous phase (200 mM/480=0.416 mM) was 0.104 s-1 (2.6 mM min-1/ 
0.416 mM/ 60 s min-1=0.104 s-1), which means that with a certain product formation rate in 
the aqueous phase the equilibrium substrate concentration needed to be renewed at least 0.104 
times per second in order to sustain the reaction. Values measured for the 0.8 mm internal 
diameter Teflon AF-2400 capillary used in this study agrees well with published kLa values 
measured for the extraction of succinic acid in a 0.75 mm i.d. capillary (Table 6-4). There are 
various parameters influencing mass transfer in the system e.g. flow rate, capillary inner 
diameter, interfacial tension, and viscosity of the liquid. All of them are interconnected e.g. 
mass transfer depends on the internal circulations within segments, which depend on the 
differences in liquid viscosities and interfacial tensions. With increasing viscosity circulations 
within segments decrease therefore the mass transfer by convection is decreased. Addition of 
surfactant reduces interfacial tension subsequently reducing the shear stress, which internal 
circulations depend upon. Eventually, convection is higher with higher slug velocities. 
Because all the systems are different there might be discrepancy in the measured kLa values. 
Therefore even the kLa values measured in the same reactor with different reaction systems 
e.g. water/kerosene (iodine), water/kerosene (acetic acid), or water/n-butanol (succinic acid), 
whereby the first two liquids are the continuous and the aqueous phase, while the compound 
in brackets is being extracted, show significant variations in kLa values of 0.32-1.47 s-1.84 
Another difference between the enzymatic systems and the chemical systems is the fact that 
for the enzymatic systems the kLa is calculated back from the product formation rates hence 
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the mass transfer might be underestimated, since the molecule which travels across the 
interface still needs to diffuse into the active site of the enzyme. To conclude, the mass 
transfer calculated in the present work is in the range of the previously published values, 
therefore we have confidence that it is the reaction rate limiting factor. Because of high 
interfacial area in microreactors, here proposed TiTR with Teflon AF-2400 membrane still 
offers the best reaction conditions for conducting this reaction. 
Actions that can be taken to further increase the mass transfer are simple e.g. increase of the 
flow rate, which will unfortunately reduce the conversions and decrease the TTN. It should 
also be possible to use Teflon AF-2400 membrane with lower internal diameter, which will 
decrease diffusional distance and diffusion time, and increase surface to volume ratio. 
Table 6-4: Overall volumetric mass transfer coefficients (kLa) in various liquid/liquid two phase segmented flow 
microreactors. Compounds given in brackets are extracted. Adapted and modified from Karande, (2012).180 
System 
Phases 
(product) 
Reaction 
Capillary 
diameter [mm] 
Overall mass transfer 
coefficient kLa [s-1] 
Ref. 
Segmented flow tube-
in-tube microreactor 
Decanol/KPi 
(2,3-dihydroxybiphenyl) 
Enzymatic 0.8 0.104 
This 
work 
Segmented flow 
microreactor 
Hexadecane/KPi 
(heptaldehyde) 
Enzymatic 
0.5 
1.0 
2.15 
0.042 
0.025 
0.009 
95, 180 
Segmented flow 
(extractor) 
n-butanol/aqueous 
(succinic acid) 
Non-reacting 
system 
0.5 
0.75 
1.0 
0.12-0.31 
0.07-0.15 
0.02-0.09 
84 
Segmented flow 
microreactor 
Kerosene/aqueous 
Acid base 
reaction 
0.38 0.5 87 
Segmented flow 
(extractor) 
n-butyl formate/aqueous 
Non-reacting 
system 
0.5 
0.75 
1.0 
0.90-1.67 
0.91-1.46 
0.88-1.29 
181 
 
ePTFE membrane shortcomings 
It is not clear why the product concentration in MTBE was decreasing with time. One of the 
possible explanations is that the membrane became saturated with substrate/product as the 
reaction proceeded, resulting in subsequent lower substrate/product transport and lower 
reaction rates. Another reason could be that there was no mixing in the aqueous and organic 
phase and thus, the mass transfer was completely dependent on the diffusion, which would 
decrease if the concentrations of substrate and product in the vicinity of the membrane would 
reach its saturating levels. It is difficult to attribute the decrease in the product concentration 
in the phase II to enzyme activity loss because it was shown that biocatalyst activity was the 
same before and after phase II. Nevertheless, application of the ePTFE membrane TiTR 
allowed separating aqueous and organic phase from one another and increasing operational 
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stability of enzymes since the activity losses of e.g. HbpA were comparable to that measured 
in Teflon AF-2400 TiTR with a direct phase contact, but in the ePTFE module enzymes 
residence times were almost 4 times higher. However, to completely prevent the organic 
phase from dissolving in the aqueous phase, one may deliver the aqueous phase at higher 
pressure than the organic phase resulting in a differential pressure across the membrane. As 
long as the pressure is kept below the break-through pressure, which needs to be determined 
experimentally, the aqueous phase should not pass the hydrophobic membrane, keeping the 
organic phase confined within the membrane. Such a technique was successfully applied for 
separating hexane and aqueous phase in a differential circulation reactor with continuous 
product extraction.182 
CONCLUSIONS 
The sequential TiTR introduced in this chapter was shown to be a suitable tool for conducting 
enzymatic gas dependent reactions at a preparative scale. The applicability of the system was 
proven for 2-hydroxybiphenyl hydroxylation to 2,3-dihydroxybiphenyl by means of 
2-hydroxybiphenyl 3-monooxygenase (HbpA). This reaction was coupled with FDH-coupled 
NADH regeneration. A successful preparative scale biotransformation reaction in a 
segmented flow pressurised TiTR has been shown. The space time yield of 14.5 g Ltotal-1 h-1 is 
the highest reported for this enzyme. It also compares well with an existing industrial process 
employing oxidoreductases for the synthesis of tert-leucine (26.6 g Ltotal-1 h-1). Product 
separation was successful and 740 mg of product with excellent purity was isolated. 
Preliminary studies with an ePTFE tube-in-tube membrane reactor concept proved useful for 
simplifying phase separation. After additional membrane engineering the concept might be a 
good basis for the process scale-up based not on the numbering-up technique but on 
increasing the physical diameter of the capillaries and introducing e.g. static mixers, which 
would provide the same or even higher mass transfer as in conventional capillary 
microreactors.  
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DEFINITION OF THE MICROCHANNEL AND THE DIMENSIONLESS NUMBERS 
Microreactors find their application either for: process optimisation and screening, where 
limited volumes of reactants are available; process intensification of reactions, which are 
mass transfer limited in conventional scale reactors; or process development for an industrial 
manufacturing of fine chemicals that needs to be scaled-up on demand. Throughout this thesis 
the term microreactor and microstructured reactor has been used interchangeably to define a 
small scale device with a channel diameter in the millimetre to micrometre range. More 
precisely microchannel is a device in which the buoyancy is dominated by surface tension 
forces.152a In simple words there exists a threshold diameter of a closed liquid filled 
microchannel, at which the rise of an air bubble cannot be observed any longer, and it is 
defined by the dimensionless Bond number smaller than 3.37.183 This allowed us to calculate 
the minimum capillary diameter, which would fulfil above requirements for the decanol-
buffer system used in this study to be 1.95 mm. This is bigger than the diameter of the Teflon 
AF-2400 membrane used in chapter 5 and 6. Since the calculations are based on the Bond 
number 
ܤ݋ ൌ ∆ఘ௚ௗమఙ       Equation 7-1 
where, Δρ is the fluid density difference (kg m-3), g is the gravitational acceleration (m s-2), d 
is the characteristic length scale, diameter (m), σ is the interfacial tension of the two fluids in 
contact (N m-1), the higher the surface tension the bigger the diameter for which surface 
tension forces will dominate the buoyancy. Such system can be considered a microreactor. 
The list of the parameters of the liquids used in this study is given in the Table 7-1. 
Table 7-1: Parameters of the fluids used in this study 
System Density [kg m-3] Viscositye [mPa s] Interfacial tension [mN m-1] 
Buffera- decanolb 1010.5±2.4 - 8.8 
Buffer (enzc) – decanol 1014.1±3.8 - 2.9 
Buffer (surfactantsd) – decanol 1011.8±3.5 - 4.0 
Buffer (surfactants, enz) - decanol 1033.3±2.1 1.72 (23.2°C) 2.2f 
Decanolb 830.3±5.8 12.65 (23.1°C) - 
a containing 200 mM sodium formate, 1 mM NAD+, 20 µM FAD 
b containing 200 mM 2-hydroxybiphenyl 
c buffer and additionally 9.2 U mL-1 HbpA and 7.5 U mL-1 FDH 
d buffer and additionally 0.6 mg mL-1 Tween 20 
e absolute viscosity i.e. ratio of relative viscosity and specific gravity of a sample 
f it was still dropping, also droplet volume was decreasing, this value was therefore chosen as a compromise 
Drop tensiometry measurements revealed that the interfacial tension of the buffer solution 
with enzyme and surfactant was very low (2.2 mN s-1). Additionally, a competitive adsorption 
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of enzyme molecules and surfactants was observed. The interfacial tension value for the 
mixture of enzyme and surfactant was lower than for the single compounds, revealing a 
synergistic effect and rather heterogeneous surface coverage, as compared to a uniform layer 
of either enzymes or surfactants, which would explain partial enzyme inactivation (chapter 5 
and 6). Surfactants are often used to stabilise segments in microchannels and prevent their 
coalescence.184 When the interface is covered, surfactant stabilises droplets by two distinct 
mechanisms i.e. steric repulsion of the surfactant covered interfaces, and by preventing 
drainage of the continuous phase filling space between two droplets. The latter is a direct 
effect of the surface rigidification, as the surfactant molecule modifies not only the interface 
of the droplet but also affects the flow and mobility of the liquid around it by interacting with 
it e.g. slowing it down.185 However, full and homogenous surface coverage is required for 
preventing coalescence, and any differences in surface tension, caused by surface 
rigidification for instance (so called Maragnoni effect), might lead to instabilities. Pulsations 
of the peristaltic pumps might therefore lead to the surfactant rearrangements on the droplets 
interface and flow instabilities as observed in chapter 2. Reliable flow control was later 
provided by using syringe pumps, which proved to be operating without any pulsation. 
As we are operating in the micro scale, some other dimensionless parameters can be used to 
describe the two phase flow with respect to the channel diameter, viscosity, density, 
interfacial tension of both fluids, and liquid velocity. Those two are the Reynolds number, 
describing relative importance of the inertial force to viscous forces 
ܴ݁ ൌ ఘௗ௎ఓ       Equation 7-2 
where U is the characteristic velocity (m s-1) and µ is the viscosity of continuous phase (Pa s), 
and the Capillary number (Ca)  
ܥܽ ൌ ఓ	௎ఙ       Equation 7-3 
 
Table 7-2: Dimensionless numbers for characterising the flow in the microreactor. Chapter 5 and 6. 
 System Flow velocity [m s-1] Re [-] Ca [-] Bo [-] 
a Buffer (enz) – decanol, 0.8 mm id, flow rate 0.8 mL min-1, 30°C 0.026 15.1 0.011 0.58 
b Buffer – decanol, 0.8 mm id, flow rate 0.8 mL min-1, 30°C 0.026 27.4 0.0013 0.14 
c Buffer (enz) – decanol, 0.8 mm id, flow rate 0.2 mL min-1, 30°C 0.007 3.8 0.0028 0.58 
a buffer with enzymes and decanol containing substrate. σ=0.0022 N m-1, µ=0.00145 Pa s (30°C) 
b buffer and decanol containing substrate. σ=0.0088 N m-1, µ=0.0008 Pa s (30°C) 
c buffer with enzymes and decanol containing substrate. σ=0.0022 N m-1, µ=0.00145 Pa s (30°C) 
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The interpretation of dimensionless numbers given in Table 7-2 allows concluding that the 
flow is laminar irrespective of the flow rate used and diffusion should be the main force 
influencing the mass transfer in the channel. However, due to the presence of the Taylor flow 
the mass transfer is enhanced and occurs mainly via advection-enhanced diffusion, as a result 
of circular movements of the bulk fluid occurring due to shear stress.186 The next 
dimensionless number, which is very important for the two phase flow in a microchannel, is 
the Ca as it determines the way plugs/bubbles/segments are formed at the T-junction in a 
microreactor. For the cross-flow (i.e. continuous phase flows in the main channel and the 
dispersed phase is introduced perpendicularly) three regimes of droplet formation have been 
named with respect to the Ca as squeezing, dripping and jetting.187 Squeezing regime (7·10-4 ≤ 
Ca ≤ 7.6·10-2), dripping regime (1.9·10-3 ≤ Ca ≤ 8.2·10-2) and jetting regime (2.2·10-2 ≤ Ca ≤ 
1.1·10-1). It can be seen that for condition a in Table 7-2, the jetting regime is expected, this 
would also explain formation of the parallel flow at the inlet, and subsequent segment pinch-
off (chapter 5). For condition b no such phenomena was observed which is reflected in the 
low Ca in the squeezing regime and formation of segments right at the T-connector. Since the 
Ca is proportional to the viscosity of the continuous phase and inversely proportional to the 
interfacial tension between liquids, the Ca was low when no enzymes and surfactants were 
present and the interfacial tension was high. 
Another important aspect of two phase flow in the microchannel under pressure is the relative 
viscosity of aqueous and organic phase. Decanol was almost exclusively used as an organic 
phase throughout this thesis. Because it is 7 times more viscous than the aqueous phase (Table 
7-1) it was challenging to obtain a stable flow (even with the syringe pumps) with the back 
pressure regulator (BPR) installed at the reactor outlet (chapter 6). Because of the differences 
in the viscosity, decanol and buffer passed through the BPR with different velocities, causing 
pulsation upstream of it. This problem did not exist when hexadecane and buffer were used as 
they have similar viscosities, but hexadecane could not be used as an organic phase as it did 
not dissolve the 3-phenylcatechol, the reaction product. To solve the problem, a simple device 
consisting of a gas filled tube, coupled with the system by the T-connector was used. It 
exerted constant back-pressure (equal to the pressure in the system) on the liquids in the 
microreactor and allowed for a smooth operation because all the pulsations, which happened 
downstream of it, were isolated and did not affect the flow. This ‘damper’ is presented in 
Figure 7-1. 
Definition of the microchannel and the dimensionless numbers | 129 
 
 
This device has been successfully implemented into the microreactor system being operated 
with aqueous/organic flow. In the aqueous/organic/air three phase system like the one in 
chapter 5, air presents another challenge. An air segment that followed surfactant containing 
aqueous phase removed the thin film of continuous aqueous phase wetting the PTFE capillary 
and destabilised the flow. In an aqueous/organic two phase flow the complete wetting of the 
capillary by the aqueous phase (containing Tween 20) allows stable formation of the oil-in-
water emulsion.188 Presence of the thin aqueous film is therefore essential for stable operation. 
After introducing the third phase air, film removal occurs faster than its renewal making the 
whole system is unstable (Figure 7-2). Those difficulties were overcome by introducing the 
TiTR to uncouple the air flow from the aqueous/organic flow and separate both by Teflon 
AF-2400 membrane (chapter 5 and 6). 
 
 
 
damper loop
BPR
from reactor for building up
pressure
outlet
Pulsation control unit
A
B
C
D
1 mm
Figure 7-1: A damper for pulsation free 
flow operation in the system with 
liquids of two distinct viscosities. 
 
Figure 7-2: Images of flow pattern in a capillary 
operated with aqueous/organic two phase flow 
with few air segments introduced initially. Total 
flow rate 0.4 mL min-1, 1 mm i.d. PTFE 
capillary. Aqueous phase: HbpA and FDH 4 
U mL-1, 0.6 mg mL-1 Tween 20; organic phase: 
decanol. A - Aqueous/air two phase flow. Arrow 
shows the last air segment followed by an 
aqueous/organic two-phase flow. B - Pear 
shaped organic segments as a result of liquids’ 
viscosity difference and removal of the thin 
aqueous film wetting the capillary wall. C - 
Partial stabilisation of the flow. D - Stable 
aqueous/organic two-phase flow achieved ca. 1 
min after the last air segment. Following images 
A, B, C, and D were taken in 15-20 sec 
intervals. 
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HOW DO SHEAR AND INTERFACIAL FORCES INFLUENCE PROTEIN STABILITY 
AND CAN THEY INDUCE A QUATERNARY STRUCTURE LOSS? 
There are two mechanisms in microreactors that might reversibly or irreversibly affect 
enzymes, namely shear stress (mechanical forces caused by the velocity gradients of moving 
liquids) and interfacial effects (interaction of protein with aqueous/air, aqueous/organic, 
and/or liquid/solid interface) and they are summarised in a review by Thomas and Geer 
(2011).53 Shear stress alone should however be excluded because the forces present in the 
laminar or turbulent flow in a monophasic system are too low to denature the enzymes.189 
Indeed circulation of the enzymes through the PTFE tube did not itself lead to enzyme 
inactivation (chapter 2). Application of a second organic phase might however have a 
negative effect on the enzyme stability. In this work the effect of the interface was minimised 
by applying surfactants like Tween 20 as proposed earlier.66 However, denaturation caused by 
contact with a hydrophobic solvent cannot be completely prevented as the coverage of the 
aqueous/organic interface with Tween 20 is a dynamic process and requires time to distribute 
the surfactant.67 Within that process enzyme molecules may get in contact with the liquid 
interface and might as well adsorb to the solid PTFE surface and denature.68 All those effects 
might cause a loss of secondary, tertiary and/or quaternary structure.53 If those effects are 
reversible the tetrameric HbpA could dissociate in the flow but once the ‘effector force’ 
would be removed monomers should re-assemble to an initial quaternary structure. This 
hypothesis would hold true if the interfacial effects would cause a reversible structure loss 
only. As suggested earlier190 the non-covalent aggregation of proteins is reversible and 
aggregates dissociate to release monomers. We propose here a reverse effect where the 
interfacial forces act to dissociate the multimeric protein. Because there is an equilibrium 
between the folded multimeric protein and its monomers191 it seems plausible that an 
additional force (interfacial force) might shift the equilibrium and promote the existence of 
the single monomeric form over the multimeric form. It could explain why product formation 
rates in the reactor are lower than expected from the catalyst loading and why the activities 
measured in the UV-assay are higher than those in the reactor because the monomeric form of 
HbpA is less active than the tetramer. 
KINETIC MODEL OF THE REACTION 
The above, was one of the hypotheses raised to explain and understand why the product 
formation rates measured in the TiTR (chapter 6) were lower than expected from the initial 
aqueous biocatalyst loadings (U mL-1). By using a similar approach as Karande (2012),180 a 
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kinetic model for the reaction was built and the reaction was simulated. Rate equations are 
shown below. 
Equation 7-4 
ݎு௕௣஺ ൌ ܸ݉ܽݔ ൬ ܥைଶܭ݉ைଶ ൅ ܥைଶ൰൮
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ܭ݉ଶைு ൬1 ൅ ܥ௣௥௢ௗܭ݅ܿ ൰ ൅ ܥଶைு
൲൮ ܥே஺஽ு
ܭ݉ே஺஽ு ቀ1 ൅ ܥே஺஽ܭ݅ே஺஽ቁ ൅ ܥே஺஽ு
൲൮ 1
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Equation 7-5 
ݎி஽ு ൌ ܸ݉ܽݔ	 ൬ ܥிைோܭ݉ிைோ ൅ ܥிைோ൰൮
ܥே஺஽
ܭ݉ே஺஽ ቀ1 ൅ ܥே஺஽ுܭ݅ே஺஽ுቁ ൅ ܥே஺஽
൲	
	
The rate of the HbpA reaction in the aqueous phase, rHbpA, is dependent on the concentration 
of oxygen, CO2; aqueous concentration of hydrophobic substrate, C2OH; and the cofactor 
concentration NADH, CNADH. The reaction is additionally inhibited by increasing product 
concentrations, Cprod. The rate equation is simplified, and includes only competitive product 
inhibition indicated by enzyme-product dissociation constant Kic, and not as predicted earlier 
mixed type non-competitive inhibition.42 In mixed type inhibition the Kiu dissociation constant 
for the formation of the enzyme-substrate-product complex has a significant effect on the 
reaction rate because the formed complex is not catalytically active. On the attempt to include 
the mixed type inhibition in the model the output values were lower than the measured ones, 
therefore the equation was simplified. The HbpA reaction is also competitively inhibited by 
the NAD+, CNAD. On the contrary, the FDH catalysed reaction is competitively inhibited by 
the NADH. The negative effect of the sodium formate, CFOR, on the HbpA was also included 
in the model. Inhibition of HbpA with 2-hydroxybiphenyl (Ki=6.5 mM) was disregarded as it 
would only exert negligible effect on the HbpA activity. 
In order to calculate the actual aqueous concentrations of 2-hydroxybiphenyl, C2OH(n), NADH, 
[NADH]n, and NAD+, [NAD]n the following formulas were used. 
	
Equation 7-6 
ܥଶைு	ሺ௡ሻ ൌ ܥଶைுሺ௡ିଵሻ ൅ ݇௅ܽ൫ܥ௘௤ െ ܥଶைுሺ௡ିଵሻ൯ ∙ ݐ௜ െ ݎு௕௣஺ሺ௡ିଵሻ ∙ ݐ௜	
Equation 7-7 
ሾܰܣܦܪሿ௡ ൌ ሾܰܣܦܪሿ௡ିଵ ൅ ൫ݎி஽ு ∙ ݐ௜ െ ݎு௕௣஺ ∙ ݐ௜൯	
Equation 7-8 
ሾܰܣܦሿ௡ ൌ ሾܰܣܦሿ௡ିଵ െ ൫ݎி஽ு ∙ ݐ௜ െ ݎு௕௣஺ ∙ ݐ௜൯ 
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The n=0 indicates initial reaction conditions. The equations were solved by the iterative 
method with a very small time interval ti. The parameters used in the model are given in the 
Table 7-3. 
Table 7-3: Parameters used in the model. 
HbpA42  FDH180  
Km2OH [mM] 0.0028 KmFOR [mM] 22 
KmO2 [mM] 0.0292 KmNAD [mM] 0.316 
KmNADH [mM] 0.0268 KiNADH [mM] 0.06 
Kic [mM] 0.0016   
KiFOR [mM] 160   
KiNAD [mM] 0.5 ti [min] 0.0007 
kLa [min-1] 14   
KD org/aq_2OH  480   
KD org/aq _prod 380   
 
With an overall volumetric mass transfer coefficient kLa=6.24 min-1 estimated in chapter 6 on 
the base of the product formation rates, the modelled output values were not always fitting the 
experimental results, therefore the kLa value in the model was increased stepwise and gave a 
good correlation at 14 min-1. It was expected that the kLa calculated in chapter 6 on the basis 
of the average product formation rate was underestimated because the product formation rates 
are not constant. Computed values, fitted to the experimental data show good correlation with 
the results obtained in the chapter 5 and chapter 6 (all the results from TiTR experiments are 
summarised in Table A1 in the appendix section). In the experiments, higher flow rates would 
yield higher mass transfer rates, hence higher kLa values; therefore to exclude the influence of 
the flow rate as another variable, modelling was done for the highest 0.7-0.8 mL min-1 flow 
rate only. For example, predicted product formation rates and product concentrations at 
different initial substrate concentrations show the same trend as experimental results, i.e. the 
optimal substrate concentration, at otherwise identical reaction conditions, is 200 mM and 
further substrate increase does not affect the rate or final product titre (Figure 7-3A). Further 
efforts to validate the model showed good fitting, but at lower kLa value of 6.24 min-1. As 
shown in Figure 7-3B an attempt to fit the model with the kLa of 14 min-1 was not successful 
and the calculated values were overestimated pointing towards a lower mass transfer rate than 
expected. Also obvious is that the last measurement point does not fit well and gives a lower 
product titre and product formation rate than the model, indicating oxygen limitation in that 
particular experiment, resulting from an increasing length of the residence time unit and no 
active aeration therein (chapter 6). 
Kinetic model of the reaction | 133 
 
 
Figure 7-3: Fitting the kinetic model to the experimental data. A – Varying substrate concentration in the decanol 
phase (20-1000 mM). Reaction conditions: 100 mM KPi pH 7.5, HbpA 9.19 U mL-1, FDH 7.47 U mL-1, sodium 
formate 100 mM, NAD+ 1 mM, FAD 20 µM, Tween 20 0.6 mg mL-1. Aeration with air, back pressure not 
regulated. Total flow rate of 0.8 mL min-1 in a 4 m long TiTR with an average residence time of 2.75 min. Point 
marked with (*) had a residence time of 3 min. Therefore, a higher product concentration and product formation 
rate were measured - it does not point to substrate inhibition. B – Varying residence time with the residence time 
unit (PTFE i.d. 1 mm, 1-4 m) attached downstream of the 1 m TiTR, Reaction conditions: 100 mM KPi pH 7.5, 
HbpA 9.19 U mL-1, FDH 9.19 U mL-1, sodium formate 160 mM, NAD+ 1 mM, FAD 20 µM, Tween 20 0.6 
mg mL-1. Aeration with pure oxygen, back pressure 6.89 bar. Total flow rate 0.8 mL min-1 with a respective 
residence time of 2.12, 3.12, 4.12 and 5.12 min. 
 
Additionally, the validity of the model was confirmed by fitting it to the results of the 
experiments with variable initial enzyme loading. Again, the model was accurate when the 
kLa was 6.24 min-1 (Figure 7-4) and showed that a maximum is reached at a HbpA loading of 
ca. 9 U mL-1, and increasing enzyme input further does not lead to higher product formation 
rates because the reaction is mass transfer limited. All the findings presented above point to 
the limitations of the model and/or the influence of dynamic changes of the system e.g. the 
flow stability on the reactor performance. In order to model the reaction with high accuracy it 
is necessary to obtain the same flow characteristic every time, which proved very difficult in 
the current setup characterised by low interfacial tension. Only then the model can be 
optimised and one may conclude whether the discrepancy comes from the inaccurately 
determined kinetic constants (Km, Ki, etc.) or changes in the flow itself e.g. segments merging. 
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Figure 7-4: Fitting the data from the kinetic model to the experimental data. Varying initial enzyme input (HbpA 
1.84–18.38 U mL-1). FDH to HbpA unit ratio was 0.81. Reaction conditions: 100 mM KPi buffer pH 7.5, sodium 
formate 100 mM, NAD+ 1 mM, FAD 20 µM, Tween 20 0.6 mg mL-1. Aeration with pure oxygen, back pressure 
6.89 bar. Total flow rate 0.8 mL min-1 with a residence time of 1.12 min. 
 
Nevertheless, the established model was used further and when the kLa value fitted was 
14 min-1 it predicted with only minor discrepancy, the final product titre and overall product 
formation rate of the preparative scale experiment described in chapter 6. The average product 
concentration measured in the organic phase from 7 consecutive reaction cycles (each 11.5 
min residence time) was 32.1±2.2 mM with an overall product formation rate of 2.8±0.2 
mM min-1 in the aqueous phase. Values given by the model were 30.2 mM and 
2.61 mM min-1 respectively. More important than predicting the end values was the 
possibility to dissect the reaction and look separately on a single reaction component in a time 
resolved manner, e.g. on the profile of the enzyme activity or NADH and NAD+ concentration 
changes (Figure 7-5). Such an approach allows identifying the reaction parameter that might 
be a rate limiting factor. In a given example, where NAD+ was initially used, in the beginning 
of the biotransformation (less than 1 minute) the rate of the FDH catalysed reaction drops 
(cofactor regeneration reaction), whereas the biotransformation reaction catalysed by the 
HbpA quickly reaches its final velocity. At that point reactions acquire the same velocity, 
which decreases slowly over time (Figure 7-5B). As the reaction progresses the product 
concentration in the aqueous phase starts to inhibit the HbpA reaction. The effect of the 
increasing product concentration can be seen in Figure 7-5E. The lines plotted are unit 
components of the rate equation given in the parentheses of Equation 7-4. The influence of 
the product is presented by the red line which shows the relative activity contribution on the 
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total HbpA rate. The total activity (black line) is considering oxygen, substrate and cofactor 
concentration, and product inhibition (Equation 7-4). 
 
Figure 7-5: Modelled reaction parameters. Reaction conditions: 100 mM KPi buffer pH 7.5, HbpA 9.19 U mL-1, 
FDH 7.47 U mL-1, sodium formate 160 mM, NAD+ 1.6 mM, FAD 20 µM, Tween 20 0.6 mg mL-1, 200 mM 
substrate in the decanol phase. Other parameters were constant as in the Table 7-3. 
 
To better understand the influence of the mass transfer on the reaction rate in a given reactor 
setup one may use the dimensionless Damköhler number (Da). It describes the ratio of 
reaction rate and mass transfer rate and indicates that at Da > 1 a given system might be mass 
transfer limited whereas at Da < 1 it might be reaction limited. Around Da = 1 the system will 
be in a transition state, meaning that changing the reaction parameters might move the 
reaction into either of the regimes (Figure 7-6). The Damköhler number is usually plotted 
against the effectiveness factor that is a ratio of the actual reaction rate to its theoretical 
maximum. 
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Figure 7-6: Graphical representation of the relation of the Damköhler number and the effectiveness factor. 
 
Calculating the Da number allows estimating the regime, which will be likely for the 
respective reaction. For the calculation, an assumption has to be made that the reaction rate is 
at maximum at given reaction conditions, i.e. the substrate concentration taken for the 
calculations (C2OH) should be the maximum equilibrium substrate concentration in the 
aqueous phase defined by Equation 7-11. It should however include all possible inhibitions 
(substrate, product). This way it is presumed that the reaction is not mass transfer dependent 
because the substrate concentration is optimal. Similarly, mass transfer is calculated by 
assuming that the driving force is maximal and is equal to the maximum equilibrium substrate 
concentration in the aqueous phase. Then by combining Equation 7-4 and Equation 7-10 one 
may calculate the theoretical Da number. 
Equation 7-9 
ܦܽ ൌ ݎ݁ܽܿݐ݅݋݊	ݎܽݐ݁݉ܽݏݏ	ݐݎܽ݊ݏ݂݁ݎ	ݎܽݐ݁ 
Equation 7-10 
ܦܽ ൌ ݎு௕௣஺݇௅ܽሺܥଶைு_௠௔௫ሻ 
Equation 7-11 
ܥଶைு_௠௔௫ ൌ ܥଶைு_௢௥௚݌ܽݎݐ݅ݐ݅݋݊	ݎܽݐ݅݋	ܭ஽ 
The Da can then be calculated for instance when one reaction component is changed, but all 
the other remain the same. It enables to see what the effect of a single parameter change on 
the reaction rate is, and if varying it drives reaction into the mass transfer limited regime, 
reaction limited regime or whether the regime stays unchanged. With this approach the effect 
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e.g. concentration of the hydrophobic substrate, overall volumetric mass transfer coefficient 
kLa, HbpA input, and FDH input, was evaluated (Figure 7-7). 
 
Figure 7-7: Influence of a change of a single reaction parameter on the Damköhler number in the preparative 
scale reaction at the residence time of 11.5 min. Original reaction conditions: 100 mM KPi pH 7.5, HbpA 9.19 
U mL-1, FDH 7.47 U mL-1, sodium formate 160 mM, NAD+ 1.6 mM, FAD 20 µM, Tween 20 0.6 mg mL-1, 200 
mM substrate in the decanol phase. The red dashed vertical line indicates the reaction conditions in the real 
experiment. 
 
This simple evaluation shows if the reaction is mass transfer limited, or kinetically limited at 
the predetermined residence time (here 11.5 min), and indicates how the system will react to 
the parameter change. For instance, in Figure 7-7A the effect of the initial substrate 
concentration on the Damköhler number is shown. Already at 200 mM hydrophobic substrate 
in the organic phase the Da is lower than 1, indicating that the reaction kinetics is determining 
the reaction rate and increasing the substrate concentration above 200 mM would not affect 
the reaction rate, as could also be seen in Figure 7-3A. Similar investigation was done for  
kLa, HbpA, and FDH and their influence on the Damköhler number is shown in 
Figure 7-7B-D. This approach is useful for deciding which reaction components need to be 
varied in order to transit from mass transfer limited regime to the highly required reaction 
controlled regime, where enzymes would work at full efficiency because of not being limited 
by transfer of the hydrophobic substrate from organic to aqueous phase. With a similar 
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approach one may determine how to increase the productivity e.g. two-fold. The preparative 
scale experiment may be used here as a starting point. Then by doubling the enzyme input 
only 50% increase in the productivity is recorded. The reason for this can be explained by 
looking closer at the Da number. Initially, the reaction is in the kinetically limited regime, 
therefore the enzyme increase is possible. However, when a certain enzyme input is reached, 
at which the theoretical Da number is equal to one, increasing enzyme input further does not 
affect the reaction rate as the reaction enters the mass transfer limited regime, which is 
indicated by the Da = 1.22 (Table 7-4). An integrated approach is therefore needed and two 
independent parameters need to be raised simultaneously. In a given example it was enzyme 
input and substrate concentration which doubled. After such a change Da remained below 1 
and productivity, at least theoretically, increased two-fold. 
 
Table 7-4: Model based determination of the reaction parameters which need to be optimised to double the 
reaction’s productivity. 
 Initial  Optimised  Initial  Optimised 
HbpA 
FDH  
9.19 U mL-1 
7.47 U mL-1 
→ 18.39 U mL-1
14.97 U mL-1 
→→ 
 
Prod. 30.19 mM 
Rate. 2.61 mM min-1 
→ 44.6 mM 
3.86 mM min-1 
50% increase Da = 0.57 → Da = 1.22 
HbpA 
FDH  
Subs 
9.19 U mL-1 
7.47 U mL-1 
200 mM 
→ 18.39 U mL-1
14.97 U mL-1 
400 mM 
→→ 
 
Prod. 30.19 mM 
Rate. 2.61 mM min-1 
→ 62.18 mM 
5.39 mM min-1 
100% increase Da = 0.57 → Da = 0.62 
 
Unfortunately, when respective experiments were conducted to confirm above theoretical 
findings the productivity did not increase (Table A1). A possible explanation might be the 
inaccuracy of the model and/or the discrepancy between the overall volumetric mass transfer 
coefficients, kLa used in the model and the kLa reached in the current experiment. Worth 
mentioning is the fact that with higher enzyme loadings the concentration of glycerol in the 
aqueous phase also increased, because the enzymes were added as 50% glycerol stocks. It 
resulted in the increase of viscosity of the aqueous phase, and could influence the internal 
circulations within the aqueous segments which are responsible for high mass transfer rates. 
Therefore, the mass transfer could be lower and increasing the enzyme input would not affect 
the reaction rate because the reaction would enter the mass transfer limited regime earlier. The 
model would unfortunately not predict it. Additionally, as pointed out earlier, a selection of 
the aqueous/organic phase liquid pair with high interfacial surface tension and similar 
viscosities is recommended for application in microreactors in order to obtain the same flow 
characteristics in every consecutive experiment, and for preventing segment coalescence. 
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Nevertheless, a combined approach of modelling and experimental investigation is needed for 
optimising complicated reactions as the one presented here, because predicting the reaction’s 
outcome is not straightforward when so many variables are involved. Modelling the reaction 
before conducting experiments might however give an early idea if the reaction is likely to be 
mass transfer limited or will the kinetics determine the reaction rate; or what is the maximum 
reaction rate which can be reached. In the current setup there are two enzymes: HbpA and 
FDH; 5 substrates: 2-hydroxybiphenyl, oxygen, NADH, NAD+, and sodium formate; 5 main 
products: 2,3-dihydroxybiphenyl, CO2, NAD+, NADH, and H2O. Moreover, HbpA is 
inhibited by 2,3-dihydroxybiphenyl, NAD+, and formate; whereas FDH is inhibited by 
NADH. Because both reactions have common substrate i.e. NAD+/NADH their kinetics are 
bound and depend on the effectiveness of the cofactor regeneration and transport of 
NAD+/NADH between the enzymes. One may therefore take the model and assume that 
reaction takes place in a single phase with ideal mixing, so that the mass transfer can be 
removed as a variable from the equation. Even at this particular (ideal) case the overall 
reaction rate will not exceed 35-40% rate expected from the HbpA unit input. Such an 
approach would be highly recommended when comparing various cofactor regeneration 
methods and deciding which one would be more suited. 
BEFORE SCALE-UP - UNIT OPERATIONS AND PROCESS INTENSIFICATION 
According to Stankiewicz and Moulijn (2000)192 process intensification “consists of the 
development of novel apparatuses and techniques that, compared to those commonly used 
today, are expected to bring dramatic improvements in manufacturing and processing, 
substantially decreasing equipment-size/production-capacity ratio, energy consumption, or 
waste production, and ultimately resulting in cheaper, sustainable technologies”, meaning 
that any change, which leads to an improvement within any of these areas may be considered 
as intensification. Such a vague definition, despite giving necessary objectives, does not 
provide necessary tools or tells where to start. Therefore for an ease of intensification, a 
process can be divided into three distinct levels depicted in Figure 7-8. A phase level is the 
population of the molecules containing the educts, products and catalysts; a process unit level 
is the space in which a single unit operation e.g. mixing, heating, or separation is performed; 
and a final plant level is the relationship between single process unit levels, which defines 
how the molecules flow within the whole process between single unit operation 
compartments.193 One may then focus on a single level and e.g. use new reaction media, 
shorten reaction time by using different apparatuses for better mass transfer, or even combine 
different levels for better downstream processing or reducing the equipment size. Below 
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discussion focuses therefore on different areas of process intensification which have or could 
be undertaken for intensifying the HbpA-catalysed hydroxylation of 2-hydroxybiphenyl. 
 
Figure 7-8: Graphical representation of a process. 
Enzyme consumption and strategies for maximising the TTN 
In order to intensify the process on the phase level and e.g. reduce the amount of generated 
wastes with respect to applied (bio)catalyst or product titre one should for example minimise 
(bio)catalyst consumption and use it more efficiently. The major disadvantages of the current 
process were relatively short residence time, moderate conversions, and most importantly, 
low TTN of the enzymes. Those resulted from limited volume of the reactor, and prerequisite 
of operating the system at high flow rates for enhanced mass transfer rates. Experimental data 
for the preparative scale experiment is summarised in the Table 7-5. 
Table 7-5: Data for the enzymatic conversion of the 2-hydroxybiphenyl to 2,3-dihydroxybiphenyl by HbpA in a 
sequential TiTR in a preparative scale experiment (chapter 6). 
 
total 
enzyme 
[U] 
residual 
activity 
[%][a] 
enzyme 
used 
[U] 
enzyme 
used 
[mg] 
enzyme 
used 
[mmol][b] 
product 
[mmol] 
enzyme 
consumption 
[U gproduct-1][c] 
TTN 
[molprod molenz-1] 
HbpA 3591 89 384 110 0.0017 10.5 197 6217 
[a] enzyme was recovered after 11.5 min total residence time 
[b] based on the activity of 3.5 U mg-1 of pure HbpA and molecular mass o 65000 g mol-1 
[c] actual consumption of the enzyme based on the amount of the catalyst that lost activity 
 
The system for preparative scale experiment operated in the semi-continuous mode, and after 
supplying 50 mL of each organic and aqueous phase to the reactor system the syringes had to 
be charged again and flow restarted (chapter 6, Figure 6-9). During the first 7 cycles fresh 
enzyme solutions were used. Without considering the 8th cycle, which utilised recycled 
aqueous phase, 3590 U HbpA enzyme solution (= 350 mL) were used in total. Then, the total 
plant level
process unit level
phase level
molecules
mixing, heating, separation, etc
relation between single unit operations
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amount of the enzyme used in the reaction is defined as the amount of the biocatalyst which 
lost activity and cannot be recycled. 
The TTN of the here utilised HbpA was fairly low and was calculated to be approximately 
6·103 for the preparative scale experiment, resulting in a rather huge amount of enzyme which 
needed to be applied. Although enzyme to product ratio was two orders of magnitude higher 
than e.g. for the industrial process of tert-leucine production (0.9 Uenzyme gproduct-1),9b it 
compares well with the epoxidation of styrene derivatives in a STR. In that example enzyme 
consumption was between 200-300 Uenzyme gproduct-1 with a TTN in the range of 2000-3000 
molproduct molenzyme,63 however, herein the product was synthesised faster due to a higher STY. 
In order to reduce enzyme consumption and maximise the TTN (phase level) one may 
integrate two unit operations i.e. reaction and phase separation into one multifunctional 
process unit, which would simultaneously affect the process at the plant level too by 
simplifying the downstream processing and reducing the number of process unit steps. A 
higher level of integration and a promising alternative to the proposed sequential TiTR was an 
ePTFE membrane TiTR that allowed for complete separation of aqueous and organic phase 
and enabled conducting the reaction in the same apparatus. Thereby, aqueous/organic 
interfacial deactivation was prevented, and thus enzyme consumption should be minimised. 
However, the product formation rates were lower than with the direct phases contact pointing 
towards a possible membrane transport limitation or diffusion limitation. Since the phases 
were separated, and thus the system was operated in single phase flow mode inside and 
outside the ePTFE membrane, no convective mixing resulting from internal circulations 
within segments occurred and mass transfer was therefore almost entirely dependent on 
diffusion. Previous studies have found that the membrane itself can indeed be a serious mass 
transfer resistance and pointed out that careful investigation of the membrane transport 
properties is critical.194 By applying different membrane material and/or introducing static 
mixers, such a setup would significantly improve the TTNs because flow of the aqueous 
phase would be uncoupled from the organic phase. Circulating the aqueous phase in a small 
loop would minimise enzyme consumption and formation of a two liquid phase emulsion 
would be prevented. This new reactor concept is similar to a microfluidic reactor containing 
immobilised enzyme,195 as it gives the ability to stop the reaction at any time by removing the 
organic or aqueous phase independently from the system, and appears an attractive alternative 
to segmented flow microreactors. Moreover the ePTFE tube-in-tube membrane reactor opens 
a possibility to a truly continuous process with an integrated downstream processing (vide 
infra) and offers a potential for a scale-up. 
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It is possible, that by using an immobilisation technique, as opposed to the soluble 
biocatalysts, performance of the reaction presented in chapter 6 with respect to the TTN and 
biocatalyst cost could be improved. Various methods of enzyme immobilisation in 
microreactors exist and have been reviewed previously151a and could be checked in the future 
for validating this hypothesis. 
Solvent selection and downstream processing 
A solvent used as an aqueous immiscible phase has two tasks: the first is to control 
substrate/product concentration and thereby toxicity, and the second is to facilitate 
downstream processing (DSP) by extracting the product of choice in situ from the aqueous 
phase. The choice of the organic solvent is important, as it needs to be tolerated by the 
biocatalyst, and also influences the process itself when such physical features like viscosity, 
solubility in water (logPo/w) or partition ratio of substrate/product between aqueous and 
organic phase are considered. Throughout this thesis 4 organic solvents were tested. Those 
were decanol, octanol, toluene and MTBE and their physical properties are summarised in 
Table 7-6. 
Table 7-6: Physical properties of organic solvents used in this study. 
Solvent Boiling point [°C] Partition ratio KD(org/aq) for substrate Partition ratio KD (org/aq) for product 
Decanol 233 480 380 
Octanol 195 1200 470 
Toluene 111 600 30 
MTBE 55 2200 1425 
 
For instance, in decanol concentration of 2-hydroxybiphenyl in organic phase will be 480 
times higher than in the respective aqueous phase. MTBE used in the aqueous/organic 
segmented flow TiTR resulted in the lowest hydroxylation rate and subsequently lower 
product titre at the same residence time, which was associated with its negative impact on 
enzyme stability due to the low logPo/w value (0.94) and highest partition ratio for the 
substrate resulting in the lowest substrate concentration in the aqueous phase. Nevertheless, 
when MTBE was used in the ePTFE membrane TiTR enzyme inactivation could be 
prevented. As shown in chapter 6 the collected MTBE phase was free from any aqueous 
phase therefore no phase separation was required for further downstream processing. It should 
be possible to place a distillation unit downstream of the reactor and recover MTBE leaving a 
solid substrate/product mixture. This mixture could be further separated by washing with 
organic solvent which exclusively dissolve the substrate e.g. n-heptan, methylcyclohexane, 
limonene, octane, xylene, hexadecane or perfluorodecalin (chapter 2). Thereby, substrate and 
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product can be separated, without time-consuming chromatography and solvents and 
unreacted substrate would be recycled. (Figure 7-9) 
 
Figure 7-9: A schematic representation of an exemplary setup of a continuous enzymatic process in the ePTFE 
membrane TiTR. 
Taking the process to a bigger scale 
Probably the greatest disadvantage of the current aqueous/organic two liquid phase segmented 
flow microreactor was precipitation of enzymes on the aqueous/organic interface, and 
although significantly minimised by applying surfactants, it could not be completely 
prevented. Moreover viscosity difference imposed flow instabilities. Flow was also affected 
by particulate fouling, i.e. particles or droplets adhering to the microchannel wall.196 Before 
bringing the process to a bigger scale in a segmented-flow based set-up every one of the 
above mentioned issues would need to be addressed properly. Even then it is not guaranteed 
that an ‘optimised’ laboratory-scale process could by scaled-up by a numbering-up technique 
i.e. multiplying the number of the reactors and running them in a sequential (not parallel) 
fashion like e.g. in Lonza’s Universal Reaction Technology.197 Applying reactors one after 
another (increasing the number of microreactor plates), which would undoubtedly increase 
reactor volume and therefore also the residence time, would pose a huge problem related to 
maintaining a stable segmented flow over the entire reactor length. Additionally, a mass 
transfer characteristic would vary in an unpredicted fashion in different sections if segments 
would coalesce. Precipitated enzymes would inflict a risk of reactor clogging, or drastic 
pressure drop if they would deposit on the reactor walls.197 The same problems would exist in 
a scale-up by parallelisation, where feeding the reactants to multiple parallel reaction units 
would pose a risk that when one reaction unit is clogged the residence time would alter in the 
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remaining ones.176 Despite obvious advantages e.g. high mass-transfer and ease of 
manufacturing, scaling-up the microreactor used in this thesis is difficult. For a better control 
of the process in terms of flow stability, residence time distribution, and uniform mass 
transfer rates in a whole reactor, the application of a membrane reactor, which would separate 
aqueous and organic phase, seems a viable option. The application of membrane reactors for 
homogenous single phase reactions is well established on the industrial scale in (C)STR.198 
Ultrafiltration membranes are often applied to keep enzymes in a confined reaction 
compartment allowing for continuous substrate addition and product removal in a stationary 
(batch mode) or mobile (continuous) aqueous phase. After reaction, respective enzymes are 
retained and can be reused in another batch. Similarly, membranes are applied for biphasic 
aqueous/organic reaction systems where they prevent emulsion formation (by separating the 
phases), simplify product recovery and allow for repeated use of the biocatalysts.199 Enzymes 
may be enclosed/immobilised within a membrane that remains in a direct contact with an 
aqueous phase on the once side and an organic phase on the other side of the membrane.200 
Such a setup allows for obtaining aqueous/organic interface at the catalyst level allowing for 
enzymatic reaction and continuous product removal, which is of great importance for 
reactions inhibited by high substrate concentrations. A reactor of this type has been 
successfully applied on industrial scale with a productivity of 145 g m-2membr day-1 of a chiral 
intermediate used for synthesis of hypertension and angina drug,200 as comparison to 
productivity of 70 g m-2membr day-1 in the preparative experiment (14.5 g L-1 h-1, where 1 L 
equals 5 m2membr). 
The ePTFE membrane TiTR combines all the merits of the membrane separation and 
microreactor technology, which after necessary optimisation e.g. membrane engineering and 
introducing static mixers inside the inner membrane –  which are suggested technology for the 
reaction scale-up197 – and baffles on the outside (as in oscillatory baffled reactor201), should 
result in higher mass transfer rate, or at least in higher membrane surface area to the volume 
of the reactants as compared to traditional membrane reactors (Figure 7-10). The advantage of 
the here proposed ePTFE membrane TiTR over the above mentioned immobilised enzyme 
membrane reactor is the fact that enzymes are applied in a soluble form. Using soluble 
enzymes simplifies reactor operation as no extra immobilisation step is required prior to 
starting the reaction. Soluble enzymes are usually more active than their immobilised 
counterparts since immobilisation procedures often lead to unfavourable structural changes 
and activity losses. Higher enzyme loadings can be reached with soluble catalyst than with 
their immobilised counterparts because of lower carrier specific activity and maximum carrier 
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loading capacity in the reactor.198 The proposed ePTFE membrane TiTR has a potential for 
future optimisation and scale-up. 
 
Figure 7-10: A – Schematic representation of an ePTFE tube-in-tube membrane reactor with static mixers inside 
Teflon AF-2400 membrane, and baffles on the outside. B – Membrane immobilised lipase reactor.200 Reactors 
are not drawn in scale. Image of the production plant reprinted from Journal of Membrane Science, 125: 189-
211, Copyright © 1997 with permission from Elsevier. 
CONCLUDING REMARKS – SYSTEM BOUNDARIES DEFINED 
This thesis aimed at applying 2-hydroxybiphenyl 3-monooxygenase (HbpA) and formate 
dehydrogenase (FDH) in a two-liquid phase system in a segmented flow microstructured 
reactor for continuous production of 2,3-dihydroxybiphenyl (3-phenylcatechol). That aim has 
been successfully realised as shown in chapter 6. 3-phenylcatechol has been produced on a 
gram scale in a continuous tube-in-tube aqueous/organic segmented flow microreactor. 740 
mg of pure product has been isolated from the substrate/product mixture in decanol. 
Reaching the thesis objectives was possible by following an engineering approach i.e. taking 
a given reaction, applying it in a certain reactor setup, obtaining product, and defining the 
process constraints. In the next step the process parameters were rationally redefined. Product 
titres and/or product formation rates were parameters defining whether the parameter change 
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was favourable or not. This approach was the only one applicable for a complicated system 
like the one here, where reaction modelling could serve only as an aid for process 
optimisation, due to too many reaction variables. We have followed that path and started in a 
batch reaction with soluble and immobilised enzymes. Soluble enzymes were superior to 
Combi-CLEAs in terms of reaction rates and specific activity, thus after necessary 
stabilisation with Tween 20 surfactant they were taken further. Batch reactions however, 
seemed mass transfer limited thus, in the next step reactions were conducted in a microreactor 
setup. As expected, microreactors offered superior mass transfer rates compared to a batch 
setup (e.g. STRs). Oxygen availability became our next concern, thus the reaction was 
conducted in an aqueous/organic/air three-phase microreactor, which due to limited oxygen 
concentrations and technical issues affecting stable operation was substituted by the 
aqueous/organic segmented flow TiTR. Oxygen delivery was improved, also handling was 
significantly easier. Additionally, product formation rates measured in the TiTR were over 3 
times higher than in a batch and three-phase segmented flow microreactor. The TiTR was not 
a typical plug flow reactor because the concentration of oxygen was constant over the reactor 
length thanks to the radial delivery mode through the gas permeable Teflon AF-2400 
membrane. However, the safety issues related to the use of pure oxygen and organic solvent 
should be considered before further scale-up. Although it was shown that the oxygen transfer 
rate can be higher for pure oxygen instead of air (chapter 6), it might be more feasible from 
economic and safety point of view to use the latter. Using pure oxygen at elevated pressures 
poses a risk of explosion, and although the here used tube-in-tube reactor is designed in a way 
to minimise the volume of oxygen in the system, the safety aspect should not be ignored. 
Reaction parameters in TiTR (concentration of 2-hydroxybiphenyl, NAD+ and FAD, as well 
as the flow rate) have been optimised, which enabled us to synthesise gram amounts of 
product in a continuous fashion with productivities that have never been reported before. 
Additionally, an ePTFE tube-in-tube membrane reactor was shown as a proof of concept, 
which presented potential for reaction scale-up. Therefore, future investigation should focus 
on evaluating different membrane materials regarding mass transfer rates and solvent 
stability. Static mixers need to be implemented in the system. Mixing times need to be 
investigated with respect to different static mixers and increasing diameter of tubes. Ideally 
the mass transfer rates in the liquid in the biggest tube should match that of the segmented 
flow microreactor without static mixers and should be higher or at least equal to the 
transmembrane organic to aqueous phase mass transfer rate in order not to be the rate limiting 
factor. Other parameters, which need optimisation before scale-up are the initial substrate 
concentration and residence time that drives the reaction to completion. As shown previously 
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for the same reaction, its rate in liquid/liquid segmented flow microreactor decreases with 
decreasing initial substrate concentration. (chapter 5) Therefore, lowering the initial substrate 
concentration from 200 mM to 100 mM, while keeping the residence time, would only 
increase the conversion by around 40 %. (chapter 5) In order to drive the reaction to 
completion, at compromised reaction rate, very low substrate concentration would need to be 
chosen and the residence time adjusted accordingly. 
 

  
CHAPTER 8  
 
 
SUMMARY AND OUTLOOK - KEEP THE BIG PICTURE IN MIND 
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Application of soluble oxidoreductases in two-liquid phase biotransformation reaction is a 
complex task. For the first time, after defining the process challenges, with an integrated 
engineering approach, application of a soluble 2-hydroxybiphenyl 3-monooxygenase (HbpA) 
and formate dehydrogenase (FDH) in a two-liquid phase segmented flow microreactor for 
continuous production of 2,3-dihydroxybiphenyl (3-phenylcatechol) was shown. It covered 
upstream and downstream processing from the gene cloning and expression, bacterial 
fermentation, protein purification and characterisation, continuous microreactor design, 
reaction optimisation, to product analysis and purification. In the end, the emphasis was put 
on verifying the scale-up scenarios for the reaction. Detailed analysis of the challenges related 
to the application of soluble enzymes in a two-liquid phase system, like cofactor regeneration, 
biocatalyst stability, oxygen supply, and mass transfer were first defined (chapter 1). 
For the production of both biocatalysts Escherichia coli strain JM101 was chosen. HbpA and 
FDH were purified to technical purity by means of expanded bed adsorption chromatography. 
Keeping enzymes at -20ºC in 50% glycerol solution was an effective technique of preserving 
their activities for long-time storage, and a convenient way of enzymes’ handling. HbpA and 
FDH showed excellent stability in single phase experiments. The continual activity loss when 
an organic solvent was used in a two-liquid phase reaction was effectively surpassed by using 
a Tween 20 surfactant, which covered the interface between organic and aqueous phase, and 
almost completely prevented enzyme denaturation (chapter 2). 
Cross-linking of the HbpA and the FDH (CLEAs) was proposed as an alternative stabilisation 
method for their application in a two-liquid phase system. Preparation of CLEAs was also 
expected to simplify biocatalysts handling and their recovery after multiphasic reaction. 
Although CLEA methodology was reported earlier as easy to prepare and broadly 
applicable,118 the technique is not to suitable for all the enzymes.141 Without additional 
modification e.g. gel entrapment or encapsulation, the mechanical properties of HbpA and 
FDH CLEAs were not good enough for efficient application in STR. It was however shown, 
that CLEA methodology is not restricted to intrinsically stable enzymes like lipases but may 
also be applied to much more complex oxidoreductases. This work is a promising basis for a 
further development of this cheap and simple immobilisation method, especially when a site 
specific cross-linker could be used, with the help of now available three dimensional structure 
of the HbpA (chapter 3). 
A precondition for the application of soluble oxidoreductase is a constant supply of the 
reducing equivalents. An elegant method based on the principle of applying ‘hydrophobised 
formates’ to promote NADH-dependent redox reactions was demonstrated. Hydrophobic 
esters of formic acid served as an organic phase in biocatalytic two-liquid phase reactions, 
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and as source of reducing equivalents at the same time; thereby paving the way towards low-
water content redox biotransformations. Despite its elegance, the setup suffered from the poor 
mass transfer rates over the interface. This issue should be addressed in the future e.g. by 
conducting the reaction in microreactors to reduce phase transfer limitation, which opens the 
door for future studies (chapter 4). 
By combining the enzyme stability study (chapter 2) and the cofactor regeneration methods 
(chapter 1) with a careful characterisation of the reaction kinetics, optimisation of the reaction 
parameters was possible. To alleviate interfacial mass transfer limitations found in the batch 
setup, a soluble HbpA was applied in a segmented flow tube-in-tube microreactor (TiTR) 
along with NADH-regenerating FDH. An example, which shows the feasibility of applying 
TiTR concept for performing gas, (particularly oxygen)-dependent reactions in microreactor, 
was presented. The achieved productivity of 17.7±1.8 g L-1 h-1 was significant for a 
monooxygenase-catalysed reaction with concomitant cofactor regeneration, which 
emphasised the potential of this technology for biocatalytic reactions (chapter 5). 
To address the oxygen limitation suspected to be a reaction rate limiting factor in chapter 5, 
the effect of higher oxygen partial pressure was evaluated by gradually increasing reactor 
back pressure, and eventually substituting air with pure oxygen. Determination of the oxygen 
transfer rates proved that the reaction was not limited by the oxygen transfer over the 
membrane or its availability in the aqueous phase hence, the product formation rate did not 
increase. However, the available oxygen excess was used in a sequential TiTR, (which 
offered extended residence times as compared to original TiTR from the chapter 5) for the 
preparative scale hydroxylation of 2-hydroxybiphenyl to 2,3-dihydroxybiphenyl by means of 
a soluble HbpA. As it was done before, this reaction was coupled to FDH-catalysed NADH 
regeneration. The space time yield of 14.5 g Ltotal-1 h-1 was again significant. Product 
separation was successful and nearly one gram of a product with an excellent purity was 
isolated (chapter 6). 
To verify feasibility of the proposed process, a step-by-step evaluation accompanied by 
reaction modelling was conducted. Different aspects of the process e.g. substrate and 
biocatalyst concentration, solvent selection, or application of an ePTFE membrane to separate 
aqueous and organic phase were discussed. It was followed by examination of strategies for 
process intensification and scale-up (chapter 7). 
AIM HIGHER, DIG DEEPER, BUT LOOK WIDER – AN OUTLOOK 
Inspired by the work of Matt Might, the professor of computer science at the University of 
Utah, who created “The Illustrated Guide to a PhD” to help new students understand what the 
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PhD really is I decided to use the part of his work as an example (Figure 8-1). It struck me 
when I saw those illustrations that ‘the bigger picture’ is different from what it appeared to 
me. Being a scientist is not an easy task, however it is easy to forget, especially when one’s 
focus is only on her/his area of research, that there are scholars and non-scholars that see my 
work only as a small bulge in the circle of knowledge, whereas to me it appeared as 
something next to remarkable. 
 
Figure 8-1: What is a PhD. Images were reprinted from “The Illustrated Guide to a PhD” created by Matt Might 
under the Creative Common License (http://matt.might.net/articles/phd-school-in-pictures/) 
 
What else I did learn is the fact that since the work I have completed is again just a small 
bulge/dent, others might easily overlook its ‘importance’. It would not appear to them how 
my findings and methods, which I have established, might contribute to their own research 
and how they can profit from them. I would like to take this chance and focus now on how 
this thesis findings can be used for further improvements in the field of biocatalysis. 
Below is a selection of enzymatic reactions, which utilize gas (H2, O2, CO, NO) as a substrate 
or yield gas (O2, CO2) in a course of a reaction (Table 8-1). Additionally, few of them have 
hydrophobic substrates or products showing low solubility in water e.g. catechol or trans-
cinnamate. It is therefore envisioned that at certain catalyst loading insufficient substrate 
supply or product removal will become a rate limiting step therefore, optimisation might aim 
at seeking more efficient gas supply and/or aqueous organic two liquid phase system reaction 
formats sustaining high mass transfer rates. 
Ph.D
Ph.D
this dent is called PhD world looks different to me what about the bigger picture?
  
Table 8-1: Selection of catalytically fast enzymes that might profit from enhanced mass transfer and high oxygen (or another gas) transfer rates in tube-in-tube reactor. Data 
selection from www.brenda-enzymes.info 
Enzyme Organism Substrate(s) Product(s) kcat 
[1/s] 
Km 
[mM] 
Activitya 
[U mL-1] 
Comment Ref 
carbon-monoxide dehydrogenase (acceptor) 
EC 1.2.99.2 
Carboxydothermus 
hydrogenoformans 
CO + H2O + methyl 
viologen 
CO2 + reduced 
methyl viologen 
1500 0.018 945 kcat at 20°C, Km at 70°C 202 
catechol oxidase  
EC 1.10.3.1 
Agaricus bisporus catechol + ½ O2 1,2-benzoquinone + 
H2O 
878 0.3 553 - 203 
catalase 
EC 1.11.1.6 
Bacillus sp. H2O2 O2 + H2O 175000 43 110250 50 mM KPi buffer (pH 7.0), 25°C 204 
hydrogen dehydrogenase 
EC 1.12.1.2 
Cupriavidus necator H2 + ferricyanide H+ + ferrocyanide 222 0.054 140 pH 8.0, wild-type enzyme complex 
including HoxI, with NADH 
205
 
hydrogenase (acceptor) 
EC 1.12.99.6 
Hydrogenophaga sp. H2 + oxidised 
methylene blue 
H+ + reduced 
methylene blue 
560 0.025 353 pH 7.0, 30°C 206
 
Benzoate-1,2-dioxygenase 
EC 1.14.12.10 
Pseudomonas putida benzoate + O2 + 
NADH 
2-hydro-1,2-
dihydroxybenzoate 
367 0.0039 231 with saturating amounts of 
NADH-cytochrome c reductase 
207
 
nitric-oxide dioxygenase 
EC 1.14.12.17 
Escherichia coli NO + O2 + NADH NO3- + NAD+ 670 0.1 422 kcat per heme at 37°C 208 
trans-cinnamate-4-monooxygenase 
EC 1.14.13.11 
Ruta graveolens trans-cinnamate + 
NADPH + O2 
4-hydroxycinnamate 
+ NADP+ + H2O 
162 1 102 pH 7.4 209
 
psoralen synthase  
EC 1.14.13.102 
Ammi majus (+)-marmesin + 
NADPH + H+ + O2 
psoralen + NADP+ + 
acetone + H2O 
340 0.0015 214 pH 7.0, 27°C, recombinant 
enzyme in microsomes 
210
 
2-hydroxybiphenyl 3-monooxygenase 
EC 1.14.13.44 
Pseudomonas 
nitroreducens 
2-hydroxybiphenyl+ 
O2 + NADH 
3-phenylcatechol + 
NAD+ + H2O 
15 0.0028 9 reaction with NADH and O2 
(this study) 
42
 
a theoretical maximum velocity in aqueous phase with aqueous enzyme concentration of 0.015 mM. 
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An example will help us understand the potential of the tube-in-tube reactor (TiTR) discussed 
in the previous chapters. For instance, with the water/decanol system and a hypothetical 
concentration of 800 mM of 2-hydroxybiphenyl, which is a hydrophobic substrate and shows 
a partition ratio KD=480 between organic and aqueous phase, a maximum mass transfer rate 
with an overall volumetric mass transfer coefficient kLa=14 min-1 is equal to 23.3 mM min-1. 
It means that if the reaction is limited by mass transfer only, and not by reaction kinetics, its 
rate can be as high as 23.3 mM min-1. On the other hand, if supply of oxygen is a rate 
limiting step, then at a back pressure of water/decanol phase of 6.9 bar, when air is used for 
aeration, oxygen transfer rate through the Teflon AF-2400 membrane can be as high as 
8.24 mM min-1, and 24 mM min-1 when pure oxygen is used. Calculated values are specific 
for the water/decanol solvent system thus, the 2-hydroxybiphenyl mass transfer rate can be 
further increased when a biphasic system displaying lower partition ratios (promoting higher 
aqueous concentrations of the hydrophobic substrate) is used. The same statement is true for 
oxygen transfer rates, therefore different solvents, like perfluorodecalin, might promote 
higher oxygen solubility and improve oxygen transfer even further, until the permeability 
limit i.e. 629 mM min-1 (990 Barrer,168 6.89 bar, membrane thickness 0.01 cm, 30°C, pure 
oxygen) of Teflon AF-2400 is reached. Teflon AF-2400 is also suitable for transporting other 
gases like H2,153b NH3,153d CO,153a and CO2153c therefore, the tube-in-tube setup with this 
material has already been used for various synthetic applications in chemical laboratories, and 
its broad applicability for biotechnology must be validated. For a comparison, and to highlight 
limitations that traditional biotechnological processes are facing, it is necessary to point out 
that industrial scale bioreactors (> 10 m3) operated at 2.5 bar air pressure sustain oxygen 
transfer rates of 1.5 mM min-1,17 therefore, maximum space time yields with oxygen 
dependent oxidoreductases are limited to approx. 10 g L-1 h-1 for non-growing cells used in a 
biphasic system,211 based on the product molecular mass of 100 g mol-1. Selection of the 
biocatalytic reactions shown in Table 8-1 could serve as a benchmark for a TiTR application 
for biotechnology. The reactions display high kcat values, higher than the kcat of 
2-hydroxybiphenyl 3-monooxygenase (HbpA). The maximum theoretical enzyme activity in 
the aqueous phase is a practical tool for comparing these reactions. It was calculated by 
assuming a constant aqueous enzyme concentration of 0.015 mM, i.e. the same as the HbpA 
concentration used in this PhD study. In the midst of operational boundaries of traditional 
biotechnological processes in a stirred tank reactor, every oxygen dependent reaction will be 
limited by a maximum oxygen transfer rate of 1.5 mM min-1. Thus, to operate in a reaction 
controlled regime enzyme concentrations have to be lowered significantly, minimising 
volumetric productivity of the process and operating way below the theoretical maximum 
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reaction velocity. It is unlikely that any of these reactions will ever run at that maximum rate, 
but conducting it in a setup that will provide higher mass transfer and more efficient gas 
(substrate) supply can only increase the reaction rates above those feasible in STRs. 
Next to the kcat, here recalculated into a theoretical enzyme activity in the aqueous phase, one 
needs to consider other parameters like TTN, flow rate and substrate conversion for they will 
determine the cost of the process and the downstream processing. For a simple batch reaction 
increasing the process time increases the product titre. Therefore, even a ‘poor’ (bio)catalyst, 
though displaying high operational stability can yield high final product titres (g L-1), and if 
the reaction is not thermodynamically limited, can even lead to full conversion. This would 
ultimately give high TTNs and low (bio)catalyst cost contribution to the overall process. On 
the opposite, in a continuous process, where the reaction times are limited by the residence 
times, the same (bio)catalyst would give low substrate conversion and low final product titre. 
Although the poor (bio)catalyst might still perform better in a continuous process e.g. reach 
higher turnover if it was previously mass transfer limited, it would not be suitable for a 
continuous process, unless the residence time is significantly extended. It is therefore of 
utmost importance to select a ‘good’ (bio)catalyst characterised by high turn-over numbers 
(kcat), with a good operational stability that will benefit from a continuous process and 
perform at the operational boundaries of the continuous reactor (with respect to the mass 
transfer and e.g. oxygen transfer). Then determination of the operational regime parameters 
(mass transfer, residence time, flow rate, phase ratio, substrate loading), at which the 
reaction will be feasible in terms of TTN and cost of the downstream processing, will be a 
decision-making factor for further reactor improvements, whether in residence time extension, 
(bio)catalyst engineering or increasing the (bio)catalyst loading. 
Designing and optimising a continuous process. To conclude, for setting-up a successful 
continuous process one needs to consider not only the (bio)catalyst itself but also multiple 
factors that are listed in the Figure 8-2. For instance, in a two liquid phase segmented flow 
reactor, changing one parameter e.g. the solvent will influence the (bio)catalyst stability, flow 
stability, safety and downstream processing. Those effects are directly related to a parameter 
(changing solvent). Because there are multiple parameters that need to be considered for 
designing a successful process, changing one of them (solvent) will indirectly influence others 
e.g. flow stability, or mass transfer and for example recalculating the Da number might be 
necessary before proceeding with the reaction. Designing a continuous reaction has therefore 
an iterative nature, and the overall success depends on adjusting multiple parameters and 
measuring the feedback (in the form of conversion of reaction rate), similarly to what nature 
did in the process of evolution. 
156 | Chapter 8 
 
 
Figure 8-2: Graphical representation of some dependencies in a continuous process. Abbreviations: DSP – 
downstream processing. 
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APPENDIX 
Table A-1: Summary of reactions catalysed by 2-hydroxybiphenyl 3-monooxygenase (HbpA) with formate 
dehydrogenase (FDH) for NADH regeneration conducted in TiTR. 
 
HbpA FDH FOR NAD+ subs pressure gas flow rate residence time rate err prod err TiTR comments
U/mL U/mL mM mM mM bar air/O2 ml/min min mM/min mM mM mM
aq aq aq aq org BPR total volume total volume
3.68 1 100 1 50 atm air 0.1 5.58 0.28 0.01 1.55 0.04 1m
3.68 1.99 100 1 50 atm air 0.1 5.08 0.29 0.02 1.47 0.10 1m
3.68 2.99 100 1 50 atm air 0.1 5.33 0.28 0.01 1.51 0.04 1m
3.68 3.98 100 1 50 atm air 0.1 5.42 0.26 0.01 1.41 0.04 1m
3.68 4.98 100 1 50 atm air 0.1 5.12 0.26 0.00 1.34 0.02 1m
3.68 9.96 100 1 50 atm air 0.1 5.03 0.27 0.01 1.36 0.03 1m
3.68 14.94 100 1 50 atm air 0.1 4.92 0.24 0.00 1.20 0.02 1m
3.68 19.91 100 1 50 atm air 0.1 5.30 0.24 0.02 1.01 0.47 1m
0.92 0.75 100 1 50 atm air 0.1 5.42 0.19 0.01 1.01 0.07 1m
1.84 1.49 100 1 50 atm air 0.1 5.07 0.17 0.00 0.87 0.01 1m
3.68 2.99 100 1 50 atm air 0.1 5.35 0.22 0.01 1.16 0.03 1m
7.35 5.97 100 1 50 atm air 0.1 5.33 0.29 0.00 1.54 0.02 1m
9.19 7.47 100 1 50 atm air 0.1 5.55 0.32 0.01 1.77 0.05 1m
11.03 8.96 100 1 50 atm air 0.1 5.62 0.31 0.02 1.72 0.10 1m
12.87 10.45 100 1 50 atm air 0.1 5.33 0.34 0.00 1.80 0.02 1m
14.71 11.95 100 1 50 atm air 0.1 5.08 0.36 0.00 1.83 0.02 1m
16.54 13.44 100 1 50 atm air 0.1 5.20 0.35 0.00 1.82 0.02 1m
18.38 14.93 100 1 50 atm air 0.1 5.38 0.34 0.01 1.79 0.05 1m
9.19 7.47 100 1 50 atm air 0.02 44.5 0.13 0.00 5.78 0.02 1m
9.19 7.47 100 1 50 atm air 0.03 29.67 0.15 0.00 4.45 0.14 1m
9.19 7.47 100 1 50 atm air 0.05 16.83 0.22 0.00 3.68 0.06 1m
9.19 7.47 100 1 50 atm air 0.4 2.58 0.42 0.04 1.08 0.10 1m
9.19 7.47 100 1 5 atm air 0.1 8.98 0.07 0.00 0.67 0.00 1m
9.19 7.47 100 1 10 atm air 0.1 9.08 0.13 0.00 1.19 0.00 1m
9.19 7.47 100 1 20 atm air 0.1 8.95 0.23 0.00 2.03 0.00 1m
9.19 7.47 100 1 50 atm air 0.1 8.67 0.49 0.01 4.21 0.00 1m
9.19 7.47 100 1 100 atm air 0.1 8.65 0.68 0.01 5.90 0.00 1m
9.19 7.47 100 1 200 atm air 0.1 8.45 0.95 0.02 8.03 0.00 1m
9.19 7.47 100 1 5 atm air 0.2 5.92 0.04 0.01 0.27 0.00 1m
9.19 7.47 100 1 10 atm air 0.2 4.88 0.16 0.02 0.78 0.00 1m
9.19 7.47 100 1 20 atm air 0.2 4.63 0.26 0.02 1.18 0.00 1m
9.19 7.47 100 1 50 atm air 0.2 5.03 0.49 0.04 2.46 0.00 1m
9.19 7.47 100 1 100 atm air 0.2 4.55 0.79 0.01 3.60 0.00 1m
9.19 7.47 100 1 200 atm air 0.2 4.55 1.16 0.02 5.29 0.00 1m
9.19 7.47 100 1 20 atm air 0.05 41.08 0.15 0.00 6.25 0.15 4m
9.19 7.47 100 1 20 atm air 0.1 19.22 0.25 0.00 4.74 0.00 4m
9.19 7.47 100 1 20 atm air 0.2 10.95 0.29 0.01 3.13 0.08 4m
9.19 7.47 100 1 20 atm air 0.4 5.58 0.32 0.01 1.79 0.07 4m
9.19 7.47 100 1 20 atm air 0.8 2.78 0.36 0.02 1.00 0.05 4m
9.19 7.47 100 1 50 atm air 0.05 49.67 0.27 0.00 13.60 0.11 4m
9.19 7.47 100 1 50 atm air 0.1 20.47 0.47 0.01 9.62 0.11 4m
9.19 7.47 100 1 50 atm air 0.2 10.50 0.61 0.01 6.43 0.10 4m
9.19 7.47 100 1 50 atm air 0.4 5.55 0.63 0.03 3.52 0.19 4m
9.19 7.47 100 1 50 atm air 0.8 2.82 0.67 0.02 1.88 0.05 4m
9.19 7.47 100 1 100 atm air 0.05 45.42 0.50 0.01 22.90 0.52 4m
9.19 7.47 100 1 100 atm air 0.1 20.58 0.77 0.00 15.78 0.09 4m
9.19 7.47 100 1 100 atm air 0.2 10.97 0.96 0.01 10.51 0.06 4m
9.19 7.47 100 1 100 atm air 0.4 5.33 1.03 0.01 5.51 0.06 4m
9.19 7.47 100 1 100 atm air 0.8 2.72 1.23 0.05 3.34 0.14 4m
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Table A-1: continued 
 
HbpA FDH FOR NAD+ subs pressure gas flow rate residence time rate err prod err TiTR comments
U/mL U/mL mM mM mM bar air/O2 ml/min min mM/min mM mM mM
aq aq aq aq org BPR total volume total volume
9.19 7.47 100 1 200 atm air 0.1 23.27 0.98 0.05 22.86 1.09 4m
9.19 7.47 100 1 200 atm air 0.2 10.00 1.09 0.03 10.92 0.32 4m
9.19 7.47 100 1 200 atm air 0.4 5.67 1.20 0.07 6.79 0.38 4m
9.19 7.47 100 1 200 atm air 0.8 3.00 1.59 0.16 4.76 0.47 4m
9.19 7.47 100 1 400 atm air 0.1 23.58 1.07 0.03 25.13 0.80 4m
9.19 7.47 100 1 400 atm air 0.2 10.50 1.10 0.02 11.55 0.24 4m
9.19 7.47 100 1 400 atm air 0.4 5.25 1.38 0.04 7.23 0.22 4m
9.19 7.47 100 1 400 atm air 0.8 2.80 1.37 0.04 3.83 0.11 4m
9.19 7.47 100 1 600 atm air 0.1 22.50 1.23 0.00 27.66 0.78 4m
9.19 7.47 100 1 600 atm air 0.2 10.50 1.15 0.01 12.12 0.13 4m
9.19 7.47 100 1 600 atm air 0.4 5.17 1.38 0.01 7.11 0.36 4m
9.19 7.47 100 1 600 atm air 0.8 2.72 1.55 0.02 4.20 0.08 4m
9.19 7.47 100 1 800 atm air 0.1 22.25 1.09 0.10 24.28 2.14 4m
9.19 7.47 100 1 800 atm air 0.2 10.20 1.20 0.06 12.23 0.61 4m
9.19 7.47 100 1 800 atm air 0.4 5.25 1.48 0.02 7.77 0.12 4m
9.19 7.47 100 1 800 atm air 0.8 2.67 1.50 0.07 4.00 0.18 4m
9.19 7.47 100 1 1000 atm air 0.1 21.67 0.98 0.01 21.20 0.26 4m
9.19 7.47 100 1 1000 atm air 0.2 10.00 1.13 0.02 11.25 0.23 4m
9.19 7.47 100 1 1000 atm air 0.4 5.13 1.19 0.02 6.08 0.12 4m
9.19 7.47 100 1 1000 atm air 0.8 2.62 1.37 0.06 3.58 0.14 4m
9.19 7.47 100 1 100 atm air 0.2 10.5 0.73 0.00 7.72 0.04 4m
9.19 7.47 100 1 100 atm air 0.2 21 0.59 0.01 14.36 0.07 4m
9.19 7.47 100 1 100 atm air 0.2 31.5 0.51 0.00 19.85 0.02 4m
9.19 7.47 100 1 100 atm air 0.2 42 0.48 0.04 23.87 0.42 4m
9.19 7.47 100 1 100 atm air 0.2 52.5 0.38 0.01 26.67 0.09 4m
9.19 7.47 100 1 100 atm air 0.2 63 0.31 0.00 29.33 0.05 4m
9.19 7.47 100 1 100 atm air 0.2 73.5 0.26 0.03 31.96 0.37 4m
9.19 7.47 100 1 100 atm air 0.2 84 0.23 0.04 33.63 0.45 4m
9.19 7.47 100 1 200 atm air 0.2 10 0.95 0.05 9.45 0.47 4m
9.19 7.47 20 1 200 atm air 0.2 10 0.46 0.01 4.59 0.15 4m
9.19 7.47 10 1 200 atm air 0.2 10 0.37 0.02 3.73 0.18 4m
9.19 7.47 5 1 200 atm air 0.2 10 0.14 0.01 1.38 0.10 4m
9.19 7.47 2 1 200 atm air 0.2 10 0.07 0.00 0.67 0.05 4m
9.19 7.47 1 1 200 atm air 0.2 10 0.01 0.00 0.13 0.02 4m
9.19 0 0 0 200 atm air 0.1 20.13 0.26 0.00 5.20 0.10 4m
9.19 0 0 0 200 atm air 0.2 10.4 0.43 0.01 4.48 0.07 4m
9.19 0 0 0 200 atm air 0.4 5.42 0.88 0.04 5.02 0.23 4m
9.19 0 0 0 200 atm air 0.8 2.53 1.72 0.03 4.95 0.09 4m
9.19 7.47 100 1 200 atm air 0.8 1.12 1.08 0.03 1.21 0.04 1m
9.19 7.47 100 1 200 atm air 0.4 2.23 0.79 0.03 1.77 0.07 1m
9.19 7.47 100 1 200 atm air 0.2 4.46 0.69 0.00 3.06 0.02 1m
9.19 7.47 100 1 200 atm air 0.1 8.93 0.58 0.01 5.21 0.13 1m
9.19 7.47 100 1 200 1.38 air 0.8 1.12 1.25 0.08 1.40 0.09 1m
9.19 7.47 100 1 200 1.38 air 0.4 2.23 0.95 0.01 2.12 0.02 1m
9.19 7.47 100 1 200 1.38 air 0.2 4.46 0.78 0.01 3.49 0.03 1m
9.19 7.47 100 1 200 1.38 air 0.1 8.93 0.62 0.00 5.53 0.03 1m
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Table A-1: continued 
 
HbpA FDH FOR NAD+ subs pressure gas flow rate residence time rate err prod err TiTR comments
U/mL U/mL mM mM mM bar air/O2 ml/min min mM/min mM mM mM
aq aq aq aq org BPR total volume total volume
9.19 7.47 100 1 200 2.76 air 0.8 1.12 1.22 0.01 1.36 0.01 1m
9.19 7.47 100 1 200 2.76 air 0.4 2.23 1.01 0.02 2.25 0.04 1m
9.19 7.47 100 1 200 2.76 air 0.2 4.46 0.83 0.01 3.70 0.04 1m
9.19 7.47 100 1 200 2.76 air 0.1 8.93 0.67 0.01 5.99 0.06 1m
9.19 7.47 100 1 200 5.17 air 0.8 1.12 1.34 0.11 1.50 0.12 1m
9.19 7.47 100 1 200 5.17 air 0.4 2.23 1.06 0.01 2.37 0.02 1m
9.19 7.47 100 1 200 5.17 air 0.2 4.46 0.87 0.01 3.90 0.06 1m
9.19 7.47 100 1 200 5.17 air 0.1 8.93 0.73 0.05 6.48 0.40 1m
9.19 7.47 100 1 200 6.89 air 0.8 1.12 1.31 0.04 1.47 0.04 1m
9.19 7.47 100 1 200 6.89 air 0.4 2.23 1.12 0.01 2.50 0.02 1m
9.19 7.47 100 1 200 6.89 air 0.2 4.46 0.87 0.00 3.86 0.02 1m
9.19 7.47 100 1 200 6.89 air 0.1 8.93 0.75 0.01 6.66 0.07 1m
1.84 1.49 100 1 200 atm air 0.8 1.12 0.67 0.07 0.75 0.08 1m
1.84 1.49 100 1 200 atm air 0.4 2.23 0.34 0.04 0.77 0.08 1m
1.84 1.49 100 1 200 atm air 0.2 4.46 0.37 0.03 1.67 0.14 1m
1.84 1.49 100 1 200 atm air 0.1 8.93 0.36 0.04 3.23 0.35 1m
7.35 5.97 100 1 200 atm air 0.8 1.12 1.11 0.10 1.24 0.11 1m
7.35 5.97 100 1 200 atm air 0.4 2.23 0.86 0.02 1.92 0.06 1m
7.35 5.97 100 1 200 atm air 0.2 4.46 0.77 0.01 3.44 0.02 1m
7.35 5.97 100 1 200 atm air 0.1 8.93 0.49 0.00 4.37 0.04 1m
12.87 10.45 100 1 200 atm air 0.8 1.12 1.18 0.06 1.33 0.07 1m
12.87 10.45 100 1 200 atm air 0.4 2.23 1.09 0.05 2.42 0.12 1m
12.87 10.45 100 1 200 atm air 0.2 4.46 0.73 0.01 3.25 0.02 1m
12.87 10.45 100 1 200 atm air 0.1 8.93 0.58 0.01 5.16 0.10 1m
18.39 14.93 100 1 200 atm air 0.8 1.12 1.14 0.03 1.28 0.03 1m
18.39 14.93 100 1 200 atm air 0.4 2.23 0.72 0.05 1.61 0.11 1m
18.39 14.93 100 1 200 atm air 0.2 4.46 0.80 0.08 3.58 0.35 1m
18.39 14.93 100 1 200 atm air 0.1 8.93 0.54 0.01 4.87 0.10 1m
1.84 1.49 100 1 200 6.89 air 0.8 1.12 0.61 0.05 0.68 0.05 1m
1.84 1.49 100 1 200 6.89 air 0.4 2.23 0.48 0.01 1.06 0.01 1m
1.84 1.49 100 1 200 6.89 air 0.2 4.46 0.43 0.01 1.91 0.03 1m
1.84 1.49 100 1 200 6.89 air 0.1 8.93 0.39 0.00 3.50 0.02 1m
7.35 5.97 100 1 200 6.89 air 0.8 1.12 1.39 0.17 1.56 0.19 1m
7.35 5.97 100 1 200 6.89 air 0.4 2.23 1.00 0.02 2.22 0.04 1m
7.35 5.97 100 1 200 6.89 air 0.2 4.46 0.89 0.02 3.98 0.08 1m
7.35 5.97 100 1 200 6.89 air 0.1 8.93 0.76 0.01 6.81 0.09 1m
12.87 10.45 100 1 200 6.89 air 0.8 1.12 1.34 0.07 1.50 0.08 1m
12.87 10.45 100 1 200 6.89 air 0.4 2.23 1.13 0.07 2.53 0.15 1m
12.87 10.45 100 1 200 6.89 air 0.2 4.46 0.93 0.02 4.14 0.09 1m
12.87 10.45 100 1 200 6.89 air 0.1 8.93 0.78 0.00 6.97 0.04 1m
18.39 14.93 100 1 200 6.89 air 0.8 1.12 1.42 0.03 1.59 0.04 1m
18.39 14.93 100 1 200 6.89 air 0.4 2.23 1.22 0.03 2.72 0.07 1m
18.39 14.93 100 1 200 6.89 air 0.2 4.46 0.98 0.01 4.37 0.06 1m
18.39 14.93 100 1 200 6.89 air 0.1 8.93 0.80 0.00 7.15 0.01 1m
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Table A-1: continued. 
 
Phase ratio of aqueous/organic phase was 1. Abbr. BPR – back pressure regulator 
[a] pressure of air 6 bar 
[b] pressure of air 8 bar 
[c] 100 µM FAD instead of 20 µM FAD 
[d] 1 m TiTR (0.8 mL) and 1 m residence time unit (RTU) (PTFE, 1 mm i.d., 0.8 mL), 100 µM FAD 
[e] 1 m TiTR (0.8 mL) and 2 m RTU (PFA, 1 mm i.d., 1.6 mL), 100 µM FAD 
[f] 1 m TiTR (0.8 mL) and 3 m RTU (PFA, 1 mm i.d., 2.4 mL), 100 µM FAD 
[g] 1 m TiTR (0.8 mL) and 4 m RTU (PFA, 1 mm i.d., 3.2 mL), 100 µM FAD 
[h] 1 m TiTR (0.8 mL) + 3 m RTU PTFE (2.4 mL) + 4 m TiTR (2.4 mL) +3 m RTU PTFE (2.4 mL), 100µM 
FAD, 35°C 
[i] 1 m TiTR (0.8 mL) + 3 m RTU PTFE (2.4 mL) + 4 m TiTR (2.4 mL) +3 m RTU PTFE (2.4 mL), 35°C 
[j] 4 m TiTR (2.2 mL), 35°C 
  
HbpA FDH FOR NAD+ subs pressure gas flow rate residence time rate err prod err TiTR comments
U/mL U/mL mM mM mM bar air/O2 ml/min min mM/min mM mM mM
aq aq aq aq org BPR total volume total volume
9.19 7.47 100 1 200 1.38 air 1.6 0.56 1.56 0.33 0.88 0.18 1m [a]
9.19 7.47 100 1 200 1.38 air 1.6 0.56 1.38 0.09 0.77 0.05 1m [b]
9.19 7.47 100 1 200 1.38 air 0.8 1.12 1.18 0.08 1.32 0.09 1m [a]
18.37 14.93 100 1 200 1.38 air 0.8 1.12 1.47 0.11 1.65 0.12 1m [a]
9.19 7.47 100 1 200 6.89 O2 0.8 1.12 1.12 0.07 1.25 0.08 1m
9.19 7.47 100 1 200 6.89 O2 0.8 1.12 1.14 0.06 1.28 0.06 1m [c]
9.19 7.47 100 1 200 6.89 O2 0.2 4.46 0.85 0.51 3.82 0.23 1m
9.19 7.47 100 1 200 6.89 O2 0.2 4.46 1.00 0.04 4.48 0.19 1m [c]
9.19 9.19 160 1 200 6.89 O2 0.8 2.12 1.26 0.20 2.66 0.42 1m [d]
9.19 9.19 160 1 200 6.89 O2 0.8 3.12 1.18 0.13 3.70 0.41 1m [e]
9.19 9.19 160 1 200 6.89 O2 0.8 4.12 1.13 0.10 4.64 0.40 1m [f]
9.19 9.19 160 1 200 6.89 O2 0.8 5.12 0.99 0.08 5.08 0.42 1m [g]
9.19 9.19 160 1 400 6.89 O2 0.8 4.12 1.17 0.12 4.84 0.49 1m [f]
9.19 9.19 160 0.2 200 6.89 O2 0.8 3 0.41 0.04 1.23 0.11 4m [c]
9.19 9.19 160 1 200 6.89 O2 0.8 3 1.11 0.09 3.32 0.26 4m [c]
9.19 9.19 160 2 200 6.89 O2 0.8 3 1.30 0.08 3.91 0.23 4m [c]
9.19 9.19 160 3 200 6.89 O2 0.8 3 1.24 0.12 3.71 0.35 4m [c]
9.19 9.19 160 4 200 6.89 O2 0.8 3 1.34 0.05 4.02 0.16 4m [c]
9.19 9.19 160 5 200 6.89 O2 0.8 3 1.26 0.06 3.78 0.19 4m [c]
9.19 7.47 160 1.6 200 6.89 O2 0.7 11.5 1.41 0.10 16.05 1.11 [h]
9.19 7.47 120 1 200 6.89 O2 0.7 11.5 1.00 0.03 11.47 0.32 [i]
18.4 14.95 120 1 400 6.89 O2 0.7 11.5 1.43 0.04 16.37 0.46 [i]
9.19 7.47 160 1.6 200 6.89 O2 0.7 3 1.41 0.10 4.23 0.29 4m [j]
36 20 160 1.6 400 6.89 O2 0.7 3 1.11 0.10 3.32 0.30 4m [j]
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Influence of different organic solvents on the product accumulation and 
hydroxylation rate 
 
  
Figure A1: Final product titre of the reaction with 
different solvents used in exchange of decanol in 
dependence of the residence time. Aqueous to organic 
phase ratio was 1. Total flow rates were 0.2 – 0.8 
mL min-1 and respective residence times were 10.5 – 
2.7 min. Product concentrations in octanol, toluene and 
MTBE were measured on HPLC with a detection 
wavelength set at 244 nm. Reactor working volume 
was 0.8 mL. Standard reaction conditions used were 
sodium formate (100 mM), NAD+ (1 mM), FAD (20 
µM), Tween 20 (0.6 mg mL-1), 100 mM KPi, pH 7.5, 
2-hydroxybiphenyl (200 mM in decanol, octanol, 
toluene or MTBE), temp 30°C. 
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Product colour change 
In the experiment when different residence time units were used, when the pressure was 
released, and gas dissolved in liquids was allowed to decompress from 6.89 bar to 
atmospheric pressure, bubbles of gas formed in the tube. Within few seconds the organic 
phase changed pale red and over time (few minutes) turned brownish. When the initial 
product concentration in the organic phase was higher due to longer residence time in the next 
residence time unit and the procedure of changing was repeated the colour change was even 
more dramatic and turned intense red. The colour change was not observed in samples eluting 
from the reactor, collected during the reaction, which were also passing the back pressure 
regulator and decompressing. Similar colour change was observed in the vessel, which 
contained two liquid phase eluent of aqueous and organic phase, on addition of 0.1 M NaOH. 
 
  
prod approx 3 mM
--> atm6.9 bar
prod approx 5 mM
--> atm6.9 bar
before
decompression
after
Figure A2: Change of the colour of the organic 
phase on decompression in a tube. 
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Formation of side product after full conversion in decanol 
 
Figure A3: Influence of different initial substrate concentrations on the conversion after 16 hours reaction time. 1 
mL scale reaction with aqueous to organic phase ratio of 1:1. Reaction conditions used were HbpA (8.5 U mL-1), 
FDH (8.5 U mL-1) sodium formate (200 mM), NAD+ (1 mM), FAD (20 µM), Tween 20 (0.6 mg mL-1), KPi pH 
7.5 (100 mM), 2-hydroxybiphenyl in n-decanol (various initial concentrations), reaction on the thermoshaker 
with 1200 rpm orbital shaking, 16 h, 30°C. Results analysed on RP-HPLC with XTerra C18 column, isocratic 
elution profile 65:35% (v:v) ACN:H20 with 0.1% TFA (v:v), 40°C, flow-rate 1 mL min-1. 
 
 
Figure A4: Chromatograms of substrate, product and side product. 
2-hydroxybiphenyl
nm
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0
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1000
1500
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unknown product (2.13 min)
unknown product
  
Microreactor liquid handling assembly 
 
Figure A5: Assembly of liquid delivery system used for the TiTR experiments. All connectors/parts are commercially available from Göhler HPLC, Chemnitz, Germany. The 
catalogue numbers given are equivalent to IDEX Health & Science numbers. A – check valve (CV-3301); B – PEEK shut-off valve with fittings (P-733); C – 3-way flow 
switching valve (V-100T); D – PEEK Tee for 1/16” OD Tubing (P-714); E – PEEK Bulkhead union (P-441N); F – 4 m TiTR; G – Right angle flow switching valve (V-
100L); H – Back pressure regulator (BPR) assembly with 20 psi cartridge (P-791); optionally cartridges can be changed within the cartridge holder to: 2.8 bar (40 psi) (P-761, 
blue), 5.2 bar (75 psi) (P-762, yellow), 6.9 bar (100 psi) (P-763, red); I – PFA 1/8” OD Tubing; J – 60 ml syringe with luer-lock; a – plug (P-309), b – PEEK Flangeless 
fitting nut for 1/8” OD Tubing (XP-330) with ETFE ferrule (P-300); c – PEEK Flangeless fitting nut for 1/16” OD Tubing (XP-235) with ETFE ferrule (P-200); d – ETFE 
Female Luer to ¼-28 flat-bottom male (P-624). Tubing: Polymeric PTFE Tubing 25m 1/16” x 1.0 mm ID (JR-T-6807-M25) or Polymeric PFA Tubing 25m 1/16'x1.0 mm ID 
(JR-T-4007-M25) from Macherey-Nagel GmbH & Co. Düren, Germany, or PFA Tubing, 1/8” OD x 0.030 in. Wall (PFA-T2-030-METER) from Swagelok, Neuss, Germany 
A B
B
C
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D E
F
E
G D
H
B
B
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J
A
b
a
c
to waste
product collection
from
pumps
d
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Figure A6: TiTR assembly, connectors from Swagelok, Neuss, Germany. A - SS Swagelok Tube Fitting, Bored-
Through Male Connector, 1/16 in. Tube OD x 1/8 in. Male NPT (SS-100-1-2BT); B - SS Swagelok Tube Fitting, 
Female Tube Adapter, 1/8 in. Tube OD x 1/8 in. Female NPT (SS-2-TA-7-2); C - SS Integral Bonnet Angle-
Pattern Needle Valve, 1/8 in. MNPT x 1/8 in. Swagelok Tube Fitting, Regulating Stem (SS-ORM2-S2-A); D - 
SS Swagelok Tube Fitting, Female Run Tee, 1/8 in. Tube OD x 1/8 in. Female NPT x 1/8 in. Tube OD (SS-200-
3TFT); E - quick type connection 1/8” OD tube to NPT (KQ2H01-34AS, SMC Pneumatik GmbH, Egelsbach, 
Germany); F – 1mm OD Teflon AF-2400 tube (Cambridge Reactor Design, Cambridge, UK) in a Polymeric 
PTFE Tubing 1/16” x 1.0 mm ID sleeve (JR-T-6807-M25); G - PFA Tubing, 1/8” OD x 0.030 in. Wall (PFA-
T2-030-METER) from Swagelok, Neuss, Germany. Additional connectors: for connecting stainless steel 50cc 
syringes (KR Analytical Ltd, Sandbach, UK) to 1/16” PTFE Tubing a SS 1-Piece 40G Series 3-Way Ball Valve, 
0.08 Cv, 1/16 in. Swagelok Tube Fitting (SS-41GXS1) was used. 
  
4m TiTR
Teflon tube inlet PFA tube outletSwagelok T-unit
gas in
gas out
liquid in
liquid out
A
A
A
B
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Product inhibition vs. decreasing substrate concentration in the organic phase 
 
Figure above presents comparison of the product formation rate as presented in the Figure 5-
7A and Figure 5-8. By comparing two data sets it became clear that product formation rate in 
the experiments where the organic phase was recirculated multiple times, depends only on the 
substrate concentration in the organic phase more than on the formed product. The trend of 
both lines is linear indicating that the product formed (and its increasing concentration in 
every consecutive cycle) is not exerting an additional inhibitory effect. The difference in the 
initial product formation rates (2.3 µmol min-1 vs. 1.8 µmol min-1) is an effect of variation 
between consecutive experiments, as the initial reaction conditions used for the two 
experiments were the same. 
  
Figure A7: Influence of the substrate (empty 
squares) and the substrate and product (filled 
squares) concentration in the organic phase on the 
product formation rate. For the data set showing the 
concomitant effect of the substrate and product the 
product concentration in the organic phase can be 
calculated by subtracting the substrate concentration 
from 100. Data are also plotted separately in chapter 
5 in Figure 5-7A and Figure 5-8. 
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HPLC Standards 
Table A2: HPLC standards for the estimation of the substrate to product conversion. 
Expected substrate (%) Measured substrate (%) Measured product (%) 
100 100 0 
75 74.39 25.61 
50 48.04 51.96 
25 23.41 76.59 
0 0 100 
 
 
 
Figure A8: Graphical representation 
of substrate and product percentage 
measured on the HPLC and listed 
above in the table. 
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Figure A9: 300 Mhz H-NMR spectrum of A – synthesised product B – the product standard (Wako Chemicals) 
in CDCl3 
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Figure A9 (cont): 300 Mhz H-NMR spectrum of C – substrate standard in CDCl3 
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